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ABSTRACT 
 Though the study of coevolutionary relationships has been a focus of 
evolutionary biology, demonstrating true reciprocity at the molecular and functional level 
in a natural system has remained elusive. Convergent evolution, though a seemingly 
disjunct phenomenon, has been found to be a fundamental aspect of coevolution 
particularly in species-rich interactions. While theoretical frameworks have shown that 
these two processes are intertwined, few empirical examples exist which demonstrate 
how these processes correlate in a natural system, and none have demonstrated the mode 
of both molecular and functional evolution in a coevolving trait. In this work I 
comprehensively review venom resistance as a trait ideal for understanding the 
biophysical and evolutionary dynamics of coevolution. Subsequently, I use this 
framework to examine the roles of molecular and biophysical convergence in two such 
systems hypothesized to be coevolving. Finally, I develop an experimental system which 
explicitly maps the biophysical and molecular evolution of a trait via direct testing of 
ancestral phenotypes, to begin to unveil the true mode of evolution as well as the roll of 
convergent evolution in a trait hypothesized to be coevolving.  
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INTRODUCTION 
CHARACTERIZING THE ROLES OF COEVOLUTION AND 
CONVERGENCE IN THE EVOLUTION OF VENOM RESISTANCE IN MAMMALS 
Since the 1970s, coevolutionary thought has been greatly influenced by the Red 
Queen Hypothesis (Van Valen 1973), which posits that interacting species are 
continuously adjusting to compensatory evolutionary changes to keep up with one 
another—the end result being no net advantage by any one partner within the 
coevolutionary interaction. This and other models of coevolution assume that either 
frequency dependent selection generates cyclic fluctuating polymorphisms, or that 
selective sweeps create an ever-escalating arms race (Thompson 1994, Jokela et al. 
2000). However, other models suggest that coevolutionary cycling or gradual tit-for-tat 
arms races may be rare or nonexistent in empirical systems, and that chaotic, complex, 
and irregular cycling may be the norm (Seger 1988, Thompson 1994). More recent work 
modeling coevolutionary dynamics in the context of species-rich and disperse 
coevolutionary interactions demonstrates that convergent evolution plays a major role in 
trait evolution within coevolutionary interactions, especially in cyclic fluctuating 
polymorphism coevolution among generalists (Guimaraes et al. 2011). The association 
between these two phenomena has also been shown in canonical coevolutionary systems 
through phylogenetic comparative approaches (Thai et al. 2012, Jousselin et al. 2003).  
Coevolution has also been shown to accelerate molecular evolution in genes 
under selection as well as increase evolutionary rates of divergence and polymorphism 
(Mitter et al. 1988, Wiegmann et al. 1993, Becerra 1997, Farrell 1998, Becerra and 
Venable 1999, Forde et al. 2008, Paterson et al. 2010, Bérénos et al. 2011, Marston et al. 
2012, Brockhurst and Kostella 2013). However, the mode of this acceleration has been 
hotly debated since the birth of the field. Many have proposed that coevolution proceeds 
in a gradual manner, while others have pointed out that this type of change does not align 
with our knowledge of constraints of protein biochemistry and suggest that saltatorial 
evolution is likely to dominate even in quickly evolving coevolutionary arms-races 
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(Goldschmidt 1940, Gould 1977, Stenseth and Maynard-Smith 1984, Dawkins 1996). 
Still others have suggested that coevolution sensu stricto, may be a relatively rare 
phenomenon, and many seemingly tightly paired interactions may be evolving at unequal 
rates where one partner has long ‘escaped’ the arms race (Stewart-Oaten 1982, Abrams 
1986, Thompson 2001, Hanfin et al. 2008).  
Convergent evolution, where species evolve the same adaptation in response to a 
similar selection pressure, is well known in cases of mutualistic coevolution (Meyer 
2006, Cote 2000, Jordano 1995), and is predicted to be a characteristic component of 
disperse coevolution (Guamaraes et al. 2012, Nuisimer et al. 2012). Detailed work 
examining the molecular and functional basis of adaptive convergence often reveals 
differing levels of convergence that range from phenotypes with vastly different genetic 
bases, to complete parallelisms at the amino acid level (Shi and Yokoyama 2003, 
Hoekstra et al. 2006, Dean and Thornton 2007, Stern 2013). The spread of these levels 
informs the degree to which constraints influence adaptive function, and can elucidate the 
degree to which adaptive evolution and coevolution may be working across diverse taxa.  
Integrating evolutionary history with an understanding of the biochemical 
consequences of adaptive coevolutionary change will allow biologists to not only 
estimate the tempo of coevolutionary change, but begin to understand how biophysical 
mechanisms and molecular convergence influence this tempo. Several recent studies of 
adaptive evolution have bridged this gap and demonstrated that experimental data on 
ancestral  functionality are critical to understanding the evolutionary and phenotypic 
consequences of molecular change (Hiebl et al. 1987, Jessen et al. 1991, Kornegay et al. 
1994, Yokoyama 1998, Yokoyama and Tada 2000, Shi et al. 2001, Nachman et al. 2003, 
Shi and Yokoyama 2003, Hartley et al. 2006, Hoekstra et al. 2006, Zhang 2006, Dean 
and Thornton 2007, Yokoyama et al. 2008, Harms and Thornton 2013).  While observing 
matched adaptive phenotypes has made it possible for biologists to postulate the 
functional and evolutionary significance of coevolutionary relationships, quantification of 
molecular and biochemical changes underlying phenotypic change allows biologists to 
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finally test the major underlying assumptions about coevolutionary tempo, mode, and 
mechanism. 
In Chapter 1 of this work I comprehensively review the system which I focus 
on— mammalian resistance to snake venom—and outline it as a model system for 
understanding complex coevolutionary adaptations in natural systems (Holding et al. 
2016b). This work was a collaborative effort which was developed extensively and 
equally with my co-first author. I contributed to the writing of all sections of this work, 
and was the primary contributor to the review of molecular mechanisms as well as the 
review of using longer (phylogenetic) time-scales to better understand modes of 
evolution.  
In Chapter 2 I utilize a comparative phylogenetic approach combined with 
extensive background data on the biochemical basis of a seemingly highly constrained 
adaptation to reveal and assess convergent adaptation and potential coevolution. 
Specifically, I examine the evolution of a snake venom target, the nicotinic acetylcholine 
receptor (nACHr), in a mammalian species (Mellivora capensis) thought to be resistant to 
and prey upon snakes whose venoms target this receptor via ɑ-neurotoxins (Drabeck et 
al. 2016). Using publicly available data, museum specimens, and phylogenetic 
comparative methods I showed that the evolution of resistance to ɑ-neurotoxin has 
evolved a minimum of four times across mammals.  Using extensive background data on 
site-directed mutagenesis of nACHr, and maximum likelihood tests of positive selection I 
identify two sites suspected to be responsible for loss of ɑ-neurotoxin binding and 
distinguish at least two different biochemical mechanisms responsible for resistance at 
these sites. This chapter highlights that the combined approach of assessing biochemical 
and comparative phylogenetic evidence for trait function can reveal the prevalence and 
degree of convergence of an adaptive trait, and pinpoint the molecular basis of a trait 
hypothesized to be coevolving. 
 In Chapters 3 and 4 I focus on a second instance of mammalian resistance to 
snake venom, and use this system to fully elucidate the mode of evolution in a trait 
hypothesized to be coevolving. In both chapters I focus on opossums in the clade 
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Didelphini, which exhibit exceptional resistance to snake venom and are thought to be 
co-evolving with the venomous snakes which they are known to prey upon (genus 
Bothrops) (Jansa and Voss 2011). My work examines the functional basis and 
evolutionary mode of a single aspect of their resistance —a blood protein (von 
Willebrand Factor) — thought to protect against venom proteins which target it.  
Using both ex vivo and in-vitro assays, I explicitly test the physiological and 
biophysical function of this interaction across several species of resistant and susceptible 
opossums. I utilize phylogenetic methods to reconstruct hypothesized ancestral states for 
this trait, and tests the biophysical function of ancestral proteins in-vitro. In so doing I 
molecularly and functionally characterized the evolution of an adaptive trait and reveal a 
complex and otherwise hidden evolutionary history.  
Results suggest that the evolution of venom resistance has evolved many times 
(convergently) across opossums, suggesting the interaction between opossums and vipers 
may be much more ecologically and evolutionarily important than previous though. 
Results also reveal that the biochemical mechanisms and sites conferring resistance are 
quite diverse, suggesting either that the evolution of resistance on this protein is relatively 
unconstrained, or that it is evolving in response to diverse venom CTLs. A pattern of 
strict saltatorial tit-for-tat coevolution is apparent when examining ancestral node data. 
Though ancestral node data for partnered venom proteins are necessary to confirm 
reciprocity, this is the first work to explicitly reveal a an evolutionay mode consistant 
with tit-for-tat coevolution using empirical data from reconstructed ancestral phenotypes.  
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CHAPTER 1. VENOM RESISTANCE AS A MODEL FOR UNDERSTANDING 
THE MOLECULAR BASIS OF COMPLEX COEVOLUTIONARY 
ADAPTATIONS1 
Introduction 
 Coevolution between predators and prey is an important evolutionary 
force for the generation and maintenance of adaptive variation. Most studies of 
coevolving traits in nature have focused on accessible morphological variation (Benkman 
et al. 2003, Toju 2008). However, with recent advances in genomic and proteomic 
techniques, as well as an improving understanding of molecular function, we can now 
meaningfully examine coevolutionary dynamics at the molecular level (Hanifin et al. 
2008, Nash et al. 2008, Zangerl et al. 2008, Jansa and Voss 2011, Scanlan et al. 2011, 
Feldman et al. 2012). Among coevolving systems, the interactions between venomous 
and venom-resistant animals hold exceptional promise for investigating molecular 
coevolution. In this review, we outline how population-level, phylogenetic, and 
biochemical approaches can be applied to these systems to study the molecular and 
functional basis of complex phenotypic interactions. Coevolution has been widely 
invoked to explain trait variation in venomous and venom-resistant animals, and is often 
discussed in terms of molecular “arms races” (Casewell et al. 2012b, Vonk et al. 2013). 
Studies of venom evolution have shown that molecular evolutionary processes such as 
positive selection, gene duplication, exon shuffling, and transcriptional splicing, among 
others play major roles in generating venom diversity (Fry et al. 2005, Doley et al. 2009, 
Casewell et al. 2012a, 2014, Vonk et al. 2013, Rokyta et al. 2015). In contrast, few 
studies have focused on the evolution of venom resistance, despite the fact that reciprocal 
evolution of weapons and defenses is required for an explanation based on an arms race 
or other coevolutionary dynamic to apply (Janzen 1980). The molecular basis of venom 
resistance has been investigated in only a few mammals and venomous snakes (Barchan 
                                                          
1 Reproduced with permission from Drabeck D. H., Holding M. L., Gibbs L. H., and S. A. Jansa. 2016. 
Venom Resistance as a Model for Understandinf the Molecular Basis of Complex Coevolutionary 
Adaptations. Integrative and Comparative Biology 56(5): 1032-1043 
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et al. 1995, Sanchez and Rodriguez-Acosta 2008, Jansa and Voss 2011, Drabeck et al. 
2015, Estevão-Costa et al. 2016), and rapid evolution and positive selection have been 
demonstrated for only two proteins that are targeted by venom toxins (e.g., Jansa and 
Voss 2011, Voss and Jansa 2012, Drabeck et al. 2015). 
               Diverse venoms span Animalia, with venom occurring in Cnidaria, 
Arthopoda, Annelida, Bryozoa, and Chordata (reviewed in Casewell et al. 2012b). While 
our review covers recent work focused on mammalian venom resistance due to its 
prevalence in the literature, studies of toxin resistance combined with other ecological 
and physiological data suggest that resistance is likely to have evolved in diverse groups 
of animals (Heatwole and Powell 1998, Heatwole et al. 1999, Voss and Jansa 2012). 
Thus, the mechanisms and approaches we discuss here have the potential to be applied 
across a diverse set of taxa beyond mammals. The diversity of venomous species and the 
broader network of species they interact with represent replicated opportunities to ask 
important questions about coevolution.  
                Here, we provide a brief review of what is known about the molecular 
basis of resistance to venoms, as well as outline research directions which would advance 
our understanding of coevolution between venom toxins and their targets and inhibitors. 
We first summarize the molecular mechanisms that underlie venom resistance, focusing 
on the mammalian systems in which resistance to venoms is best characterized. We then 
discuss conceptual approaches for studying the evolution of resistance within and 
between species. We focus on linking predictions from theory with empirical tests from 
specific systems, with an emphasis on how these approaches inform our understanding of 
coevolutionary interactions between venomous and resistant taxa. Finally, we describe 
gaps in our knowledge that should be addressed to fully pursue research on 
venom/resistance systems and suggest approaches to fill these gaps. 
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Molecular mechanisms of resistance 
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Venom toxins target a wide array of biologically important molecules and disrupt 
numerous physiological functions. As such, understanding the molecular basis of venom 
resistance requires knowledge not only about how venom molecules exert their toxic 
effects but also about how resistant animals cope with these toxins at a molecular level. 
Though we understand some resistance mechanisms, our knowledge of the molecular 
basis of venom resistance lags well behind our understanding of venom composition and 
toxicity (Fig. 1). Consequently, an integrated picture of venom resistance and its role in 
the evolution of venom diversity and toxicity has yet to be realized. An important step in 
understanding how these traits might coevolve is to identify additional molecular 
mechanisms of resistance, because the molecular phenotypic interface between venomous 
and resistant species involves complex interactions between the venom components of 
one species, and the target or inhibitor proteins of the envenomated species. The 
Figure 1.1- A representative HPLC venom chromatogram from a rattlesnake (C. oreganus) with elution 
regions roughly labeled according to the venom protein family based on peak identifications in Margres et 
al. (2014). Below the toxin names, the known mechanisms of resistance to these snake venom toxin 
classes are shown, highlighting that resistance is only known for less than half of the known toxin classes 
(Jansa and Voss 2011). BPP, Bradykinin potentiating peptides; PLA2, phospholipase 2s; LAO, L-amino 
oxidases. 
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interaction of these various molecules forms a complex phenotypic space where the 
outcome of envenomation is decided (Fig. 2). 
In this review, we characterize known mechanisms of venom resistance into four 
categories: (1) venom inhibitors, molecules that deactivate venom toxins before they 
reach their targets and benefit from a match to venom; (2) altered targets, proteins that 
have evolved to no longer bind venom toxins but that still retain their original 
physiological function and benefit from a mismatch to venom; (3) repurposed toxins, 
where venom toxins are used by the victim to short-circuit the physiological effect of the 
toxin and the resistant animal benefits from a match; and (4) acquired immunity, where 
resistance is acquired through repeated sub-lethal exposure to toxins 
 
Venom inhibitors 
Many animal species have evolved at least partial resistance to venom in the form 
of circulating proteins that bind and inhibit venom proteins (Perez and Sanchez 1999, 
Figure 1.2- Conceptual presentation of the molecular mechanisms of venom resistance (ordered 1–4 to 
correspond to order presented in text) in relation to the actions of venom, emphasizing the diverse ways in 
which resistance can be achieved and the evolutionary pressures encountered by all proteins at the 
molecular phenotypic interface of interactions between a venomous and resistant species. Pathological 
response induced by venoms (depicted by the red arrow) is interrupted through both direct and indirect 
mechanisms. 
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Perales et al. 2005, Biardi 2008). These blood-serum factors neutralize snake venom 
metalloproteinases (SVMPs) and phospholipases (Perez et al. 1979, Catanese and Kress 
1993, Perales et al. 2005). They have been identified in at least 30 mammal species from 
six orders (Perez et al. 1978, Biardi 2008, Voss and Jansa 2012), and in a number of 
squamate reptiles that are either resistant to their own venom or preyed on by venomous 
snakes (Perales et al. 2005). 
Most of the known venom inhibitors function through direct interaction with 
venom proteins. For example, the α1β glycoproteins found in opossums, mongooses, and 
some rodents, and the inter-α trypsin inhibitor of ground squirrels irreversibly bind to a 
single venom protein to render it inactive (Biardi 2008). A related mechanism exists in 
the European hedgehog (Erinaceus europaeus), where a β-macroglobulin draws venom 
proteases into close proximity with a string of amino acids that changes conformation to 
enclose the venom, acting as a molecular cage (de Wit and Weström 1987). Both of these 
mechanisms rely on inhibitors recognizing toxic molecules, where affinity of one protein 
for another is a key part of the inhibitory process. Inhibition is also non-enzymatic, with 
inhibitors binding venom proteins in a 1:1 stoichiometry that inactivates both proteins 
(Perez and Sanchez 1999, Biardi et al. 2011). 
Almost all of the known inhibitor proteins are associated with the 
Immunoglobulin (Ig) and Ficolin/Opsonin supergene family, for this reason, it has been 
suggested that these proteins are a derived part of the innate immune system (Perales et 
al. 2005, Sanchez and Rodriguez-Acosta 2008). As such, their evolution may differ from 
other classes of venom-resistant molecules described below. In particular, the serum 
inhibitors identified to date are all members of large, relatively old gene families, 
whereas the “altered targets” described below are typically members of small gene 
families (e.g., nAchR) or are encoded by single genes (e.g., vWF). Whereas positive 
selection may play an important role in the evolution of both toxin inhibitors and altered 
targets, the processes of gene duplication, gene turnover, and neofunctionalization may 
be the primary forces driving the evolution of circulating toxin inhibitors (for review see 
Taylor and Raes 2004). 
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Altered targets 
Resistant mammals can also cope with venom by evolving venom-targeted 
receptors that no longer bind damaging venom proteins, while retaining their essential 
physiological functions (Barchan et al. 1992, Jansa and Voss 2011, Drabeck et al. 2015). 
While therapeutic potential has focused attention on serum inhibitors, few studies have 
examined the role that modified venom targets play in resistance, and the implications of 
these adaptive changes on coevolutionary dynamics remain largely unexplored. Target 
alteration is typically mediated by a small number of point mutations that change the 
protein so that it no longer binds the toxin but still recognizes its endogenous ligand. To 
date, only three venom-targeted proteins have demonstrated resistance to their toxic 
ligands: the muscular nicotinic acetylcholine receptor (nAChR), the blood coagulation 
protein von Willebrand Factor (vWF), and the alpha-l-proteinase inhibitor. 
The muscular nAChR mediates synaptic transmission from nerves to muscles, and 
is targeted by alpha-neurotoxins present in the venom of elapid and hydrophiid snakes 
(Neumann et al. 1989, Barchan et al. 1995). In-vitro and in vivo research showed that the 
nAChR protein of hedgehogs, mongooses, and cobras—three taxa that survive 
envenomation by neurotoxic snakes—shows strong binding resistance for alpha 
nurotoxins (Barchan et al. 1992, 1995, Takacs et al. 2004). Site-directed mutagenesis 
revealed that this loss of toxin binding ability is explained by amino acid substitutions at 
two sites on the molecule’s surface. A larger, comparative study subsequently showed 
that these same two amino acid sites have evolved independently under positive selection 
in four venom-resistant mammalian lineages: hedgehogs, mongooses, honey badgers, and 
pigs. This is the only known example of convergent adaptive evolution of a molecule 
involved in venom resistance; interestingly, the resistance seems to be mediated through 
two distinct biochemical mechanisms (Takacs et al. 2001, 2004). Cobras and mongooses 
have substitutions that confer resistance via glycosylation that leads to steric hindrance, 
whereas hedgehogs, honey badgers, and domestic pigs have substitutions that involve 
charge interference (Drabeck et al. 2015). 
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The second case of target evolution is the blood protein vWF, which mediates 
blood coagulation. The vWF protein is targeted by venom C-type-lectins (such as 
botrocetin), and has evolved under positive selection in a clade of didelphid opossums 
that prey upon venomous snakes and survive their bites (Jansa and Voss 2011). Although 
we do not yet know the functional significance of the observed amino acid changes in 
vWF in these taxa, eight sites are under strong positive selection in this lineage and seven 
of these are critical for botrocetin binding. 
Finally, another altered target apparently exists in the Virginia opossum 
(Didelphis virginiana). The alpha-l-proteinase inhibitor (α1-antitrypsin) serves as an 
important inhibitor of endogenous proteases in the Virginia Opossum, but it is uniquely 
not deactivated by crotaline snake venoms, suggesting that it too has acquired 
functionally important amino acid changes (Catanese and Kress 1993). However, the 
evolution of this molecule has not been examined in any detail. 
 
Repurposed toxins 
A novel mechanism of resistance has been demonstrated in species of grasshopper 
mice (Onychomys sp.) that regularly attack and eat bark scorpions (Centruroides sp.) and 
sustain their stings (Rowe and Rowe 2006, 2008). Scorpion stings are extremely painful 
to most mammals, but grasshopper mice show a reduced pain response compared to 
laboratory mice (Rowe and Rowe 2008). This pain resistance works by binding a 
scorpion toxin to a previously untargeted pain receptor, which induces analgesia, 
blocking the effects of other pain-inducing venom components (Rowe et al. 2013). While 
one bark scorpion venom protein, CvIV4, induces pain by activating the sodium channel 
Nav1.7, it does not directly interact with Nav1.8, a downstream sodium channel which is 
an essential part of the pain signaling pathway (Rowe et al. 2013). However, rather than 
evolving a change to the direct target (Nav1.7), grasshopper mice have been shown to 
have amino acid changes on Nav1.8. These changes on Nav1.8 bind to another venom 
toxin, which induces numbness, negating painful effects of CvIV4, without altering its 
direct target, Nav1.7 (Rowe et al. 2013). 
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Similar to altered venom targets, this molecular adaptation seems to be associated 
largely with a small number of amino acid changes. Comparative work along with 
mutagenesis revealed that although a particular amino acid site determines most of the 
sensitivity to venom (resistance via analgesia) in grasshopper mice, this same residue is 
present across a diverse array of mammals, all with diverse natural histories that are not 
necessarily associated with venom exposure (Rowe et al. 2013). Thus, scorpion venom 
inhibition in grasshopper mice is likely an exaptation which perhaps has predisposed this 
species to exploit a toxic prey item (Rowe and Rowe 2006, 2008, Rowe et al. 2013). 
 
Acquired immunity 
Laboratory mice (Mus musculus) have been used to determine baseline toxicity of 
snake venoms for decades, but recent work suggests that mice may mount an immune 
response via mast cell (MC) activation when injected with venom from various snake 
species. Metz et al. (2006) found that MCs released carboxypeptidase A (CPA) that 
protected against systematic consequences of venom injections. Furthermore, MC-
deficient mice have increased susceptibility to certain venoms (Schneider et al. 2007, 
Akahoshi et al. 2011, Marichal et al. 2013). Mouse IgE, FcεRI-expressing effector cells 
and MCs are all involved in acquired immunity to venom and can result in increased 
survival to lethal doses of venom (Starkl et al. 2016). However, this effect varies between 
strains of mice, suggesting that potential for acquired resistance via type 2 immunity is a 
trait that may be inherited, and as such subject to natural selection. These studies 
represent a mechanism for mitigation of venom morbidity and mortality previously 
undescribed for any species, including those for which venom resistance is well 
documented. 
Though little is known about acquired immunity as a mechanism of venom 
resistance in free-living mammals, it may play a substantial role for both predators and 
prey that survive bites from venomous snakes. Additionally, ophiophagous mammals are 
known to eat the whole snake, including the venom glands (Almeida-Santos et al. 2000, 
Begg et al. 2003). This suggests that venom proteins come into contact with mucus 
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membranes before digestive enzymes are able to degrade them, thus providing an 
additional route of sub-lethal exposure which may subsequently serve to bolster 
immunity to venoms. Whether via mucosal or subdural (injected) exposure, this 
mechanism may serve to supplement general innate mechanisms of resistance described 
above (Mowat and Weiner 1999, Ogra et al. 2001). 
Coevolution of resistance and venom at different evolutionary 
timescales 
Coevolution operates and can be studied at different evolutionary timescales 
(Thompson 2005). At short timescales, coevolution plays out among geographically 
structured populations that are connected by gene flow, creating a selection mosaic across 
the landscape (Thompson 2005). This has been termed the Geographic Mosaic Theory of 
Coevolution, and its predictions have been supported in a variety of predator–prey 
systems (Hanifin et al. 2008, Nash et al. 2008, Toju 2008), where hot-spots of reciprocal 
section and cold-spots without it exist for all pairs of enemy species. Studies have 
documented population-level variation in venom resistance (Poran et al. 1987, Biardi 
2008, Rowe and Rowe 2008, Biardi and Coss 2011, Holding et al. 2016, Pomento et al. 
2016), but the possibility that this variation reflects geographically variable 
coevolutionary selection pressures requires parallel assessments of variation in both the 
venom and venom-resistance phenotypes to determine whether local venom variability 
selects for variable resistance, and vice versa (Janzen 1980, Gomulkiewicz et al. 2007). 
At longer evolutionary timescales, phylogenetic analyses allow us to investigate 
the long-term dynamics of coevolution. Integrating phylogenetic predictions with 
molecular biology techniques for the expression and in-vitro testing of mutations and 
ancestral protein states permits assessment of the evolution of adaptive function. Thus, 
we can empirically test hypotheses about the mode and tempo of adaptive coevolution. 
Below we review the evolutionary and coevolutionary insights that can be gained through 
comparisons made at both timescales for species of venomous and resistant animals. 
 
Short timescales—population-level variation 
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Population-level variation in venom composition is common (Chippaux et al. 
1991, Daltry et al. 1996, Alape-Girón et al. 2008, Gibbs and Chiucchi 2011, Rokyta et al. 
2015) but only a few studies have quantified intra-specific variation in levels of venom 
resistance (Poran et al. 1987, Poran and Coss 1990, Biardi et al. 2006, Biardi 2008, Rowe 
and Rowe 2008, Biardi and Coss 2011, Pomento et al. 2016). These few studies 
demonstrate a general pattern where the frequency of encounters with venomous enemies 
plays an important role in maintaining resistance (Fig. 3). For example, in the southern 
grasshopper mouse, one population that is sympatric with the Arizona bark scorpion was 
more resistant to the venom of this scorpion than a different population living without 
scorpions (Rowe and Rowe 2008). Similarly, squirrels seem to be more resistant when 
sympatric with rattlesnake predators. In the California ground squirrel (Otospermophilus 
beecheyi), LD50 and overall serum-to-venom binding scores are higher, and serum-based 
inhibition of metalloproteinase and hemolytic activity are more effective in areas with many 
snakes, compared to sites where snakes are absent or rare (Poran et al. 1987, Biardi et al. 
2000, 2006, Biardi 2008). The closely related rock squirrel (O. variegatus) shows a similar 
pattern in its ability to limit adverse effects of venom fibrinolytic activity (Biardi and Coss 
2011). Finally, serum from the eastern gray squirrel (Sciurus carolinensis) is more effective 
at inhibiting timber rattlesnake (Crotalus horridus) metalloproteinase activity in a population 
where the snakes occur, than in a population where the snakes are absent (Pomento et al. 
2016). 
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Figure 1.3- Various measures of venom resistance from the four prey species where resistance has been 
analyzed for variation at the population level, where populations were assayed that vary in terms of 
presence/absence or density of specific venomous predators. Each species shows a pattern of local 
adaptation where there is higher venom resistance in locations where selection from a specific venomous 
predator is expected to be stronger due to greater abundance of snake predators (A) southern grasshopper 
mice (O. torridus) require higher lethal doses of bark scorpion (C. exilicauda) venom when sympatric with 
the scorpions (Rowe and Rowe 2008); (B) eastern gray squirrels (S. carolinensis) are more effective at 
inhibiting SVMPs when sympatric with timber rattlesnakes (C. horridus, Pomento et al. 2016) (C) 
California ground squirrels (O. beecheyi) have higher serum to venom binding scores when in areas where 
northern pacific rattlesnakes (C. oreganus) are more dense (Biardi 2008); and (D) the serum of rock 
squirrels (O. variegatus) limits the increase in venom fibrinolytic activities observed when venom and 
serum are mixed when taken from areas where western diamondback rattlesnakes (C. atrox) are more 
common (Biardi and Coss 2011). 
These population-level patterns suggest a significant role for local selection from 
venomous enemies in maintaining high resistance in the face of potential costs; however, 
the role of coevolution in these systems is less certain. For example, the encounter rate 
with scorpions may select for grasshopper mouse resistance, with no reciprocal 
evolutionary response in the scorpion population. Coevolution requires an evolutionarily 
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response in the venomous species to variation in some aspect of the resistance phenotype, 
and vice versa (Janzen 1980). Analysis of selection gradients and reciprocal selection 
(Lande and Arnold 1983, Brodie and Ridenhour 2003), tests for trait correlations among 
populations in each species (Hanifin et al. 2008), and analysis of whether trait variation 
reflects local adaptation to variation in the other species (Blanquart et al. 2013) can 
provide such support. 
 
Case Study 
To provide an example of using measures of local adaptation in venom and 
resistance to study coevolution, we describe our recent work on venomous rattlesnakes 
and their resistant squirrel prey (Holding et al. 2016). Local adaptation was measured 
using reciprocal crosses of venom from northern pacific rattlesnakes (C. oreganus) and 
blood serum from California ground squirrels collected among 12 populations where 
these species interact. The SVMP activity of venoms was measured twice, once on the 
venom alone, and again after incubation with squirrel serum containing inhibitors. This 
allowed venom inhibition to be scored as a measure of the snake–squirrel interaction in 
sympatric and allopatric combinations of venom and serum. The fully reciprocal cross of 
all 12 populations showed that the snakes possessed venom that is locally adapted to 
overcoming inhibition of metalloproteinase activity by squirrel serum factors, while the 
sign and magnitude of local adaptation varied across the sites in a way that is partly 
predicted by environmental variation. Whereas all rattlesnakes maintained some venom 
metalloproteinase activity following treatment with ground squirrel serum, populations of 
snakes retained more SVMP activity with local than with foreign ground squirrels (Fig. 
4). 
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Figure 1.4- A pattern of rattlesnake local adaptation to avoiding metalloproteinase inhibitors in mammal 
serum from a reciprocal crossing study of two California populations of northern pacific rattlesnakes (C. o. 
oreganus) when paired with sympatric and allopatric California ground squirrel (O. beecheyi) serum. 
Shown is the percentage of venom metalloproteinase activity maintained after incubation with inhibitory 
serum relative to venom-only trials (mean ± SE). The venom of 10 snakes and 10 squirrels from each site 
was used, with snake venom and squirrel serum were randomly paired. Animals were collected from Wind 
Wolves Preserve (WW) and Chimineas Ranch Ecological Reserve (CR). 
This work provides evidence that venom resistance does not just vary as a function of 
location, but that different venom and resistance phenotypes can show complex 
interactions in their effect on the outcome of envenomation. The predator-genotype × 
prey-genotype (G × G) interactions necessary for local adaptation, and G × G × 
environment interactions characteristic of geographic selection mosaics (Gomulkiewicz 
et al. 2007), seem to exist for venom and resistance in this system. Furthermore, the 
snake was the locally adapted species in this interaction, suggesting that the prey are not 
always ahead in coevolutionary interactions involving venom and resistance as suggested 
by the general Life-Dinner Principle (Dawkins and Krebs 1979). Finally, the existence of 
local adaptation merits a reappraisal of the idea that escalatory arms races generate much 
of the variation in venom and resistance, as such dynamics are not predicted to lead to 
local adaptation. Instead, the outcome of envenomation in this system appears to be 
determined by how effectively inhibitor X binds to venom protein Y. In the context of 
Fig. 2, the venomous species is hypothesized to benefit from a match to target and a 
19 
 
mismatch to inhibitors, antibodies, and repurposed venom receptors, while the opposite is 
true for the resistant species. These molecular matching mechanisms, which pit venom 
phenotypes against resistance phenotypes in a binding-avoidance-binding-seeking 
fashion (Dybdahl et al. 2014, Cagliani et al. 2016) are distinctly different in action from a 
quantity-based escalatory arms race. The discovery of a role for phenotype matching (as 
in phenotype matching versus phenotype differences: Ridenhour and Nuismer 2007) in 
coevolving venom and venom resistance proteins does not exclude a parallel role for 
arms race dynamics, which could govern the speed of enzymatic action or the overall 
concentration of each protein (Holding et al. 2016). Future work to characterize the role 
alternative coevolutionary dynamics in shaping the overall complex venom phenotype 
will be valuable. 
 
Longer time-scales—phylogenetic and functional reconstruction 
Understanding the evolution of the molecules involved in venom resistance can 
also benefit from the application of phylogenetic approaches at deeper evolutionary 
timescales. For example, the identification of multiple instances of convergent acquisition 
of a venom-resistant nAchR molecule was only revealed through a comparative 
phylogenetic study that included species of resistant and non-resistant mammals 
(Drabeck et al. 2015). Similarly, powerful phylogeny-based tests of positive selection 
(Yang et al. 2005, Yang 2007) have revealed instances of positive selection on particular 
amino acid sites in particular venom-resistant lineages (Jansa and Voss 2011, Drabeck et 
al. 2015). Robust phylogenies also provide the essential framework for reconstructing 
ancestral character states, including ancestral protein sequences (Pauling and 
Zuckerkandl 1963). Integrating these types of phylogenetic approaches with laboratory 
studies of ancestral protein function has been coined the “functional synthesis” (Dean and 
Thornton 2007), and provides much promise for understanding the evolution of protein 
function across diverse systems (for review see Hartley et al. 2006, Hoekstra et al. 
2006, Dean and Thornton 2007, Harms and Thornton 2013) 
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While the phylogenetic approaches mentioned above have laid the groundwork in 
this field of research, the promise of the functional synthesis has yet to be applied to 
understanding the evolution of proteins involved in venom resistance. Golding and Dean 
(1998) suggest the ideal candidates for this empirical functional approach are those in 
which there is a clear and measurable physiological shift, strong evidence for selection, 
and robust phylogenetic histories. With the growing number of identified instances of 
venom resistance in mammals (reviewed in Voss and Jansa 2012), case studies of 
adaptive evolution of venom-resistant molecules (Jansa and Voss 2011, Drabeck et al. 
2015), the explosive growth of phylogenetic knowledge for mammals, and the 
development of heterologous expression systems for these proteins, we are now poised to 
apply the functional synthetic research program to understanding how resistance evolves 
(Appendix figure 1.1). Although much of this research is in its infancy, below we 
highlight a case approach which shows how the functional synthesis could be applied to 
understanding the evolution of molecules involved in venom toxicity and resistance. 
Case study 
Using an existing system as an example, we will expand on one case outlined 
in Appendix figure 1.1 for which the functional synthetic approach is tractable. Specifically, 
molecular models suggest that vWF can no longer bind botrocetin, a venom C-type lectin 
(CTL), in resistant opossums (Jansa and Voss 2011), and recent physiological assays 
provide strong evidence that opossum vWF in fact does not respond to very high doses of 
botrocetin (D. H. Drabeck, unpublished data). Of the nine species of didelphid marsupials in 
the clade Didelphini, seven are either known to eat venomous snakes and/or be resistant to 
vWF-binding venom CTLs. Though members of this clade show accelerated adaptive 
evolution at the CTL binding site (vWF A1), sequence variability at these sites is present 
between species, suggesting that there may be functional variability in vWF resistance across 
Didelphini (Jansa and Voss 2011). A robust species-level phylogeny for New World 
opossums makes it possible to employ powerful modern phylogenetic tools to infer ancestral 
protein sequences of vWF for all members of this clade. Biochemical assays that quantify 
binding affinities of opossum vWF for venom CTLs can provide functional data for each 
21 
 
amino acid site of this protein, including its ancestral states, across the clade on which it has 
evolved. These data can illuminate the molecular and functional tempo and mode of 
evolution of adaptive traits. For example, Fig. 5 illustrates two competing hypotheses for the 
evolution of a resistant target to a venom toxin. In the first hypothesis evolution of resistance 
is gradual, and mutations appear progressively (and perhaps convergently) along the lineages 
leading to the resistant phenotype. In the alternative scenario, evolution is saltational—the 
mutations responsible for resistance all arise at the base of the resistant clade, and subsequent 
mutations (if any) have no effect on the resistance phenotype. Importantly, the only way to 
distinguish between these two hypotheses is through functional laboratory studies of 
reconstructed ancestral proteins. If resistance evolved suddenly at the base of the clade, then 
ancestral proteins will not vary in their binding ability and will have similar binding ability as 
the modern proteins, all of which exhibit the resistant phenotype. Alternatively, if acquisition 
of resistance is a gradual process, then ancestral proteins should vary in their ability to bind 
the toxin protein. 
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Figure 1.5- Alternative hypotheses for the evolution of a venom-resistant protein. Under the gradual-
change hypothesis (A), venom resistance is acquired gradually during the evolution of the venom-resistant 
clade. Under the saltatorial-change hypothesis (B), venom resistance (measured as ability to bind a venom 
toxin) is acquired once at the base of the venom-resistant clade. Under both scenarios, extant taxa have 
equivalently low binding affinities to the venom toxin (indicated with dark green dots at the tips of the 
tree). The only way to distinguish between the two hypotheses is to assess binding affinity for reconstructed 
ancestral proteins, which will vary in their binding affinity under hypothesis (B), but not hypothesis (A). 
Applying these same methods to the evolution of interacting snake venom 
proteins, such as botrocetin, would allow us to examine the functional evolution of a 
potentially co-evolving molecule. Work like this would provide the first example of a 
hypothesized coevolutionary interaction in which both interacting partners have been 
functionally characterized at the molecular level, and would serve to test assumptions 
about how evolutionary and ecological mechanisms shape functional changes in 
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ostensibly coevolving proteins (Gomulkiewicz et al. 2007, Ridenhour and Nuismer 
2007). In particular, the simplest but most important assumption to test is whether there is 
evidence of reciprocal evolutionary change in molecular function in a natural system, 
which has long been an assumption of many canonical studies of coevolution, but has yet 
to be demonstrated (Bull and Molineux 1992, Brockhurst et al. 2003, Mizoguchi et al. 
2003, Jessup et al. 2004, Hanifin et al. 2008, Jansa and Voss 2011, Scanlan et al. 2011). 
Venom resistance is a system which is plentiful with opportunities such as this for 
evolutionary biochemists, as there are several other putative protein–protein 
coevolutionary interactions (Supplementary Table 1), and likely many more to come as 
this field develops. 
Future directions 
Integrated phenotypes and the evolving resistome 
The “resistome” can be considered an “integrated phenotype” in the same sense that the 
term has been applied to a wide variety of morphological traits (Murren 2012). 
Specifically, an integrated phenotype is defined as a set of functionally related traits that 
interact with each other in a way that affects their overall function (Murren 2012). The 
“resistome” then is the collection of molecules that confer venom resistance through the 
mechanisms outlined above. Methodologically, the use of “antivenomics” (Calvete et al. 
2011) to isolate individual molecular components of resistance and then use them in in-
vitro tests of function involving single versus multiple components allows us to address 
how these parts of the “resistome” might interact to confer organismal resistance. Are 
these interactions functionally synergistic or simply additive (Yeh et al. 2006)? Can 
information on functional interactions between proteins be used to organize individual 
molecular components of resistance into functionally defined modules (Yeh et al. 2006)? 
Do components of resistance show negative tradeoffs with other fitness-related traits in 
prey that could limit the evolution of overall resistance? Direct estimates of function are 
difficult to conduct for components of morphological traits, and so we see a special role 
for resistance (and venom) for assessing phenotypic integration in complex phenotypes 
from a functional perspective. 
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This “antivenomics” approach is a specific example of the general approach of 
using high-throughput sequencing, modern bioinformatics, and comparative analysis to 
identify the molecular basis of adaptive traits. Such an approach can also provide a guide 
for researchers to identify venom targets and inhibitors that are currently undetected. 
Subsequent comparative studies of these newly identified molecules holds enormous 
potential for understanding the molecular evolutionary processes involved in generating 
and maintaining variation in venoms as well as in venom resistance. The application of 
these and other integrated methods requires robust species and gene phylogenies, which 
are becoming increasingly common. Additionally, for both venom and resistance proteins 
which are members of large protein families and purported to be rife with gene 
duplication and neofunctionalization, it is vital to understand complete gene histories to 
apply methods such as ancestral reconstruction of phenotypes and tests of positive 
selection. Though only a few mechanisms resistance are known and even fewer examined 
in detail, applying these methods will doubtless illuminate the way forward in this field. 
 
Summary 
The hypothesis that venom and resistance are coevolved traits has been invoked 
because of the matched nature of these traits, yet evidence for reciprocal selection leading 
to evolutionary change in both venom and resistance traits has yet to be convincingly 
demonstrated. Here, we suggest several approaches which aim to provide strong evidence 
for reciprocal molecular coevolution in the context of venom and venom resistance 
evolution. Population level approaches which utilize reciprocal pairwise testing, analyses 
of selection gradients, and tests for trait correlations, can identify sources and strength of 
selection, potential costs and trade-offs, and examine statistical support for correlated 
adaptive variation. Evolutionary biochemical approaches allows the examination of the 
ancestral functional changes of proteins involved in venom and resistance, elucidating the 
mode and tempo of (co)adaptive change. Expanding the examination of single venom-
target interactions to understanding the full complexity of venom resistance is necessary 
to examine this trait as an integrated molecular phenotype, and is now feasible with 
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modern high-throughput approaches. Given these insights, we stress the value of 
understanding venom resistance as a coevolving adaptive trait, and its potential for 
providing insights as to how coevolution occurs at a molecular level. 
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CHAPTER 2. WHY THE HONEY BADGER DON'T CARE: CONVERGENT 
EVOLUTION OF VENOM-TARGETED NICOTINIC ACETYLCHOLINE 
RECEPTORS IN MAMMALS THAT SURVIVE VENOMOUS SNAKE BITES
2 
Introduction 
 Among the handful of mammals known to be resistant to venomous snake 
bites, the honey badger (Mellivora capensis) has a near legendary ability to attack 
venomous snakes (Elapdiae and Viperidae) and survive their toxic bites (Begg et al., 
2003, Hughes et al., 2013, Waxman, 2014). However, the mechanisms by which resistant 
species, including honey badgers, are rendered invulnerable to snake bites are largely 
unknown. Most research into mammalian venom resistance has focused on blood-serum 
factors that neutralize venom metalloproteinases and phospholipases (e.g., Catanese and 
Kress, 1992, Lovo-Farah et al., 1996, Melo and Suarez-Kurtz, 1988, Menchaca and 
Perez, 1981, Neves-Ferreira et al., 2010, Perez et al., 1979, Tarng et al., 1986). 
Comparatively few studies have focused on the role that modified venom targets play in 
conferring toxin resistance. These venom targets are physiologically important protein 
receptors that no longer bind venom toxins, yet retain the ability to bind their endogenous 
ligands (Barchan et al., 1992, Barchan et al., 1995, Jansa and Voss, 2011). 
The muscular nicotinic acetylcholine receptor (nAChR), a well-characterized 
transmembrane receptor that mediates synaptic transmission from nerves to muscles, is 
targeted by α-neurotoxins present in the venom of elapid and hydrophid snakes (Barchan 
et al., 1995, Neumann et al., 1986). Two mammals known to survive elapid bites, the 
Egyptian mongoose (Herpestes ichneumon) and the hedgehog (Erinaceus concolor), have 
mutations in the α1-subunit of their nAChR proteins that eliminate binding of the krait 
(Bungarus multicinctus) venom toxin α-bungarotoxin (Fig. 1B) (Asher et al., 1997, Asher 
et al., 1998, Barchan et al., 1992, Barchan et al., 1995, Haggerty and Froehner, 1981, Kao 
et al., 1984, Takacs et al., 2001, Takacs et al., 2004). Cobra-nAChR receptors (Naja spp.) 
                                                          
2 Reproduced with permission from Drabeck, D. H., Dean, A.M., and S. A. Jansa. 2015. Why the honey 
badger don't care: Convergent evolution of venom-targeted nicotinic acetylcholine receptors in mammals 
that survive venomous snake bites. Toxicon 99(1): 68-72 
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also fail to bind α-neurotoxins, are immune to their own venom, and have convergently 
acquired similar amino acid replacements (Takacs et al., 2001, Takacs et al., 2004).  
 
Figure 2.1- A) The evolutionary tree of mammals depicting relationships among species that have been 
sequenced for the α1 subunit of the nicotinic acetylcholine receptor gene (CHRNA1). The two trees are 
topologically identical, ancestral-state reconstructions of amino-acid sites 187 (left-hand tree) and 189 
(right-hand tree) are indicated with colored branches (legend upper left). The derived amino acid is given at 
the branch terminus for species that differ from the ancestral condition (tryptophan and phenylalanine for 
sites 187 and 189, respectively). Species that are known to survive envenomation by elapid snakes (honey 
badger, mongoose, hedgehog) or have been shown experimentally to have lost (mongoose, hedgehog) 
binding between α-bungarotoxin and the nAChR receptor are shown in red, the reduced binding ability of 
human is indicated with an asterisk. (B) Alignment of the α-bungarotoxin-binding region of nAChR 
(Barchan et al., 1995) for the 11 mammal species that have lost one or both ancestral aromatic residues at 
sites 187 and 189. The reconstructed ancestral placental sequence is shown for reference as is the sequence 
from cobra. Dots indicate sequence identity with this ancestral sequence. (C) Molecular model (Dellisanti 
et al., 2007a, Dellisanti et al., 2007b, UniProt Accession 2QC1) of the α1 subunit of the nicotinic 
acetylcholine receptor (spacefill model) shown binding with α-bungarotoxin (green ribbon model). Sites 
187 and 189 are shown as the ancestral amino acid for placental mammals. 
 
Honey badgers have been observed to survive bites from puff adders (Bitis spp.) 
(Colleen Begg, pers. comm.), have been anecdotally reported to survive arterial injections 
of black mamba venom (Rousseau, 1982), and have a diet comprising up to 25% 
venomous snakes, including puff adders (Bitis arietans) and cape cobras (Naja nivea) 
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(Begg et al., 2003). However, the biochemical basis of their resistance to neurotoxic 
venom has not been examined. 
To investigate the molecular basis of resistance to neurotoxic venoms in honey 
badgers, we examined the region of the nAChR receptor that contains the α-neurotoxin 
binding site and which has been previously implicated in venom resistance (Haggerty and 
Froehner, 1981, Kao et al., 1984). We asked whether the honey badger has independently 
acquired the same amino acid changes that alter toxin binding in other neurotoxin-
resistant species, specifically, the presence of non-aromatic residues at position 187 and 
189 of the nAChR α1 subunit. We sequenced this region of the nAChR receptor from 
honey badgers and other closely related but venom-susceptible mustelids. To extend the 
comparative context for the study, we retrieved 45 mammalian DNA sequences of the α1 
subunit of the muscle cholinergic receptor gene (CHRNA1) from publically available 
sequence databases. We then employed a comparative phylogenetic approach to infer the 
molecular evolution of this receptor across a wide range of mammalian species, including 
those with known resistance and susceptibility to elapid venom. 
 
Materials and Methods 
Whole blood samples from four individuals of M. capensis were provided by the 
San Diego Zoo Institute for Conservation Research (2 samples) and the Fort Wayne Zoo 
(2 samples) (Fort Wayne, IN). We also sequenced five additional carnivores that are not 
known to be resistant to any snake venoms. Tissue samples from Lontra canadensis (J.F. 
Bell Museum tissue collection number MP137), Procyon lotor (MP444), Mustela erminae 
(MP409, MP410), and Mustela vison (MP0083) were obtained from the Bell Museum of 
Natural History (University of Minnesota), tissue samples of Taxidea taxus, were kindly 
gifted by Dr. Emily Latch (University of Wisconsin, Milwakee). Genomic DNA was 
extracted from these samples using a QIAGEN DNeasy kit according to the standard 
protocols for blood and animal tissue (Qiagen, Inc., Valencia, CA, USA). We designed 
primers to amplify an 850 bp piece of the alpha subunit of the muscular nicotinic 
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acetylcholine receptor gene (CHRNA1) that included the ligand binding site 
corresponding to residues 122–205 of the protein sequence. Polymerase chain reactions 
(PCRs) were carried out in 25 uL reactions using 1.0 μl of 10 mM ACH_F1 (5′-
TGCAGATGGTGACTTTGCCATTGTCAAG-3′) primer solution, 1.0 μl of 10 mM 
ACH_R1 (5′AGTCTGTGGGCAGGTAGAACACC-3′) primer solution, 0.125 uL GoTaq 
polymerase (Promega Inc.), and recommended concentrations of GoTaq Green Buffer, 
MgCl2, and dNTPs. Reactions were performed for thirty cycles of melting at 94 °C for 
30 s, followed by annealing at 58 °C for 15 s, and extension at 72 °C for 90 s. Reactions 
were preceded by a 2 min denaturation at 94 °C and included a final extension at 72 °C 
for 7 min. Amplified PCR products were sequenced by Beckman Coulter Genomics on 
an ABI 3730XL DNA Analyzer using BigDye Terminator v3.1 chemistry (Applied 
Biosystems, USA). Resulting sequences were assembled, edited, and aligned using 
Geneious version 5 (Drummond et al., 2010). Sequences generated for this report have 
been submitted to GenBank. 
We searched GenBank and Ensembl for all available mammalian CHRNA1 
sequences (Appendix Table 2.1). We aligned our mustelid DNA sequences along with 
these sequences using MUSCLE (Edgar, 2004) with default parameters specified by 
Geneious (v 5.5) and translated the resulting aligned DNA sequences to amino acids 
(Appendix Figure 2.1). We used recently published mammalian phylogenies (Meredith et 
al., 2011, Koepfli et al., 2008) to construct a tree describing well-established evolutionary 
relationships among the taxa that had CHRNA1 sequences. We used this phylogeny to 
infer ancestral amino acids using parsimony analysis as implemented in MESQUITE 
(Maddison and Maddison, 2011) and as the basis for tests of positive selection on the 
CHRNA1 gene. We tested for selection on the CHRNA1 gene in the three lineages that 
are known to be resistant to snakebite (H. ichneumon, Erinaceus sp., and M. capensis) 
using the branch-site tests for selection in the codeml program of PAML 4.8 (Yang, 
2007). We identified these three lineages on the mammalian phylogeny as “foreground” 
branches that could have sites under selection and designated the remainder of the tree as 
“background” branches. The selection test compares the difference in ln-likelihood 
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values of a model that allows a proportion of positively selected sites on foreground 
branches (ω2 > 1) with one that does not allow positive selection on those branches by 
fixing ω2 = 1 (Zhang et al., 2005). We also used a Bayes-Empirical-Bayes (BEB) method 
to identify sites in the protein that had a high posterior probability of being under positive 
selection (Yang et al., 2005). 
Results and Discussion 
Phylogenetic analysis reveals that most placental mammals have aromatic 
residues at sites W187 and F189, and that the ancestral state for both of these sites 
optimizes as an aromatic amino acid (Fig. 1A). Selection tests strongly support a model 
that allows for a proportion of positively selected sites for CHRNA1 in Herpestes, 
Mellivora, and Erinaceus, the three lineages that are known to be resistant to snake 
venoms and to eat venomous snakes (2Δℓ = 12.9, df = 1, p << 0.01, Table 1). 
Approximately 3% of sites are identified under this model as being under positive 
selection in these lineages (ω2 = 25.95, Table 1), and the Bayes-Emprical-Bayes 
approach identifed sites 187 and 189 as under positive selection with posterior 
probabilities of 0.995 and 1.000, respectively.  
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Table 2.1- Results of branch-site tests for positive selection on the CHRNA1 gene. 
     
 
Model 
and log-likelihood site classa proportion of sites  background  foregroundb 
2 = 1 0 0.840 0.0196 0.00196 
lnL = -1958.65 1 0.070 1.0 1.0 
 2a 0.083 0.0196 1.0 
 2b 0.007 1.0 1.0 
     
     
2 > 1 site class proportion of sites  background  foregroundb 
lnL = -1952.19 0 0.898 0.0218 0.0218 
 1 0.074 1.0 1.0 
 2a 0.026 0.0218 25.95 
 2b 0.002 1.0 25.95 
 
a Site class 0 and 1 apply to foreground and background lineages and include sites under purifying 
selection (0 <  < 1) and neutral sites ( = 1), respectively.  Site class 2 allows a proportion of 
positively selected sites ( > 1) in the foreground lineages, where 2a includes sites under purifying 
selection (0 <  < 1) in the background lineages and 2b includes neutral sites ( = 1) in the 
background lineages.  
b Lineages known to eat snakes and/or to be resistant to snake venom (i.e. Herpestes ichneumon, 
Erinaceus sp., and Mellivora capensis) were included in the foreground class. 
 
Honey badgers, hedgehogs, and pigs 
Ancestral state reconstruction shows that the honey badger (M. capensis) and the 
two hedgehog species (Erinaceus concolor and Erinaceus europaeus) have 
independently replaced both ancestral aromatic residues with an arginine and a leucine or 
isoleucine (W187R, F189L/I, Fig. 1A). Intriguingly, the pig lineage (Sus scrofa) has the 
same replacements as the honey badger (W187R, F189L, Fig. 1A). Experimental work on 
nAchR function has not included pigs, and it is unknown whether the molecule is capable 
of binding alpha-neurotxins in this species or not. For this reason we did not identify the 
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pig lineage as one of the potential lineages under selection in the positive selection tests. 
Nevertheless, anecdotal evidence suggests that domestic pigs will prey on a variety of 
venomous snakes and survive snakebite, wild pigs and neurotoxic elapid snakes also 
share an historical distribution (Calmette, 1908, Gifford-Gonzalez and Hanotte, 2011, 
Giuffra et al., 2000, Klauber, 1972, McDougall, 1997). While most accounts of venom 
resistance in pigs attribute this trait to their thick skin and a large layer of subcutaneous 
fat, our results support early accounts that pigs have some endogenous immunity to 
neurotoxic snake venom (Calmette, 1908, Grasset et al., 1935). 
Prior experimental work has attributed the hedgehog's ability to survive high 
doses of α-bungarotoxin —four times the LD50 for mice — to replacements of ancestral 
aromatic residues at these sites (Barchan et al., 1992, Barchan et al., 1995). Supporting 
this, cloned α1 nAChRs and muscle extracts from hedgehogs fail to bind to α-
bungarotoxin (Barchan et al., 1992, Barchan et al., 1995, Domont et al., 1991, Herter, 
1965, Reeve, 1994). Experimental studies further demonstrate that replacements at sites 
187 and 189 reduce affinities for long and short chain α-neurotoxins (Asher et al., 1997, 
Asher et al., 1998, Barchan et al., 1992, Barchan et al., 1995, Dellisanti et al., 2007a, 
Dellisanti et al., 2007b, Dimitropoulos et al., 2011, Neumann et al., 1986, Takacs et al., 
2001, Takacs et al., 2004). Loss of both aromatic residues is seen in all cases of reduced 
α-neurotoxin binding (Neumann et al., 1986, Tzartos and Remoundos, 1990), although 
the degree to which binding is reduced may depend on the particular replacement and the 
genetic background on which it arises (Dellisanti et al., 2007a, Dellisanti et al., 2007b, 
Dimitropoulos et al., 2011, Takacs et al., 2001). In particular, structural analyses suggest 
replacing the uncharged tryptophan residue at site 187 with the positive guanidinium side 
chain of arginine is likely to abolish binding through charge interference (Fig. 1C) 
(Dellisanti et al., 2007a, Dellisanti et al., 2007b, Takacs et al., 2004). Thus, it appears that 
these three mammalian lineages (honey badgers, hedgehogs, and pigs) have convergently 
evolved the same mechanism to disrupt neurotoxin binding at their nAChR receptors. 
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Mongooses and cobra 
Mongooses survive α-bungarotoxin at ten times the LD50 for mice, prey upon 
venomous snakes, and have α1 nAChR receptors that fail to bind to α-bungarotoxin from 
the krait (B. multicinctus) (Barchan et al., 1992, Barchan et al., 1995). However, 
mongooses do not share the same amino-acid replacements at sites 187 and 189 that are 
present in hedgehogs, honey badgers, and pigs (Fig. 1A). Rather, the W187N substitution 
in mongooses is thought to abolish α-neurotoxin binding through steric hindrance, caused 
by glycosylation of the asparagine residue (Barchan et al., 1995, Dellisanti et al., 2007a, 
Dellisanti et al., 2007b, Takacs et al., 2001). The same mechanism has been well 
documented in the cobra sequence (F189N), where elimination of glycosylation rendered 
mutants venom-sensitive (Takacs et al., 2004). Thus, it seems that resistance to α-
neurotoxins at the nAChR has convergently evolved via steric hindrance in the mongoose 
and cobra, distinct from the charge disruption observed in hedgehogs, honey badgers, and 
pigs. 
 
Primates 
African great apes (members of Homininae) have non-aromatic replacements 
W187S and F189T, the galago (Otolemur) has W187Q only, and the orangutan (Pongo) 
has F189S only (Fig. 1A). The threonine residue at position 189 and the presence of a 
polar neutral residue at position 187 is convergent between African great apes and 
mongooses (H. ichneumon). However, great apes do not share the derived glycosylation 
site present in mongooses and are not immune to α-neurotoxins. Though cloned human 
nAChR has reduced affinity for α-bungarotoxin (intermediate between mongoose and 
mouse), putatively due to loss of these aromatic amino acids, it is unlikely that these 
specific replacements confer any selectively relevant toxin resistance (Barchan et al., 
1995). Little is known about venom resistance in galago or the orangutan, or how 
replacements F189S or W189Q alone on these genetic backgrounds might affect 
neurotoxin binding. 
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Conclusions 
Our results extend the known cases of convergent evolution at venom-targeted 
nAChR receptors to include the honey badger and domestic pig. The honey badger and 
pig lineages independently acquired replacements that are biochemically similar to those 
seen in the hedgehog: W187R (all three species) and F189L, (L in honey badger and pig, 
I in hedgehog). In mongoose, substitutions at these same sites also occur, but they 
eliminate α-neurotoxin binding through steric hindrance via glycosylation rather than 
charge interference via introduction of a positively charged amino acid. Hence, evolution 
of resistance in venom-targeted nAChR receptors shows that convergence in function at 
the same sites can be mediated through distinct biophysical mechanisms. 
The ecological consequence of snake-venom resistance in mammalian predators 
is not trivial as hedgehogs, honey badgers, mongooses, and pigs are able to prey upon and 
survive bites from venomous snakes (Barchan et al., 1995, Domont et al., 1991, Herter, 
1965, Reeve, 1994). Notably, resistance to venom may present these species with 
opportunities to exploit a valuable prey resource that is unavailable to most (venom-
susceptible) mammals (Voss and Jansa, 2012). 
This study adds to examples of convergent molecular evolution revealed by 
phylogenetic analyses, and is suggestive of a convergent adaptive function that has arisen 
in the face of similar ecological selection pressures (Hartley et al., 2006, Hiebl et al., 
1987, Hoekstra et al., 2006, Jessen et al., 1991, Kornegay et al., 1994, Nachman et al., 
2003, Shi et al., 2001, Shi and Yokoyama, 2003, Yokoyama, 1998, Yokoyama and Tada, 
2000, Zhang, 2006). Convergent substitutions at loci known to alter protein phenotype 
implicate the predator–prey relationship between the honey badger and venomous snakes 
in driving selection for adaptations to cope with snake venom α-neurotoxins. These and 
other recent works (Jansa and Voss, 2011, Voss and Jansa, 2012) suggest that venomous 
snakes and resistant mammalian predators may be engaged in an important 
coevolutionary arms race. However, further research is merited to confirm the function of 
these modified receptors, and to elucidate if snake venom evolution has reciprocated. 
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CHAPTER 3. EXAMINING THE RESISTANCE OF SOUTH AMERICAN 
OPOSSUMS TO VWF-BINDING VENOM C-TYPE LECTINS. 
Introduction 
Naturalists have long known that certain opossum species (in Tribe Didelphini of 
the marsupial family Didelphidae, Jansa and Voss 2011), are not only resistant to snake 
venom but also attack and eat pit-vipers with impunity (Oliveira and Santori 1999, Jared 
et al. 1998, Perez et al. 1978). This tribe includes the South American opossum genera 
Didelphis, Philander, Lutreolina, and Chironectes (Figure 3.1).  Although venom 
resistance has not been broadly surveyed across opossum species, observational (Vellard 
1945, Wood 1954, Fitch 1960, Perales et al. 1986, Melo and Suarez-Kurtz 1988, Sazima 
1992, Jared et al. 1998,  Oliveira and Santori 1999, Almedia-Santos et al. 2000) and 
experimental (Kilmon 1976, Werner and Vick 1977, Werner and Faith 1978, Mousattche 
et al. 1978, 1979, Perez et al. 1979,  Menchaca and Perez 1981, Soto et al. 1988, 
Moussatche and Perales 1989, Catanese and Kress 1993, Perales et al. 1994, Lovo-Farah 
et al. 1996) evidence suggest that species of Didelphis, Philander, and Lutreolina can 
survive envenomation by pitvipers (Jansa and Voss 2011).  Whether Chironectes - the 
fourth genus in this clade - is venom resistant remains unknown. Metachirus 
nudicaudatus, the sister taxon to Didelphini, has been shown to have little if any 
resistance to whole venom injections (Perales et al. 1994). Consequently, this species and 
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many other small-bodied opossums (the remainder of family Didelphidae) known to be 
eaten by pitvipers (Voss 2013) are assumed to be susceptible to venom. Thus, it appears 
that snake-venom resistance has arisen at least once among South American opossums (in 
clade Didelphini), possibly as a dietary adaptation allowing them to exploit a dangerous 
prey item otherwise unavailable to non-resistant predators. 
Venom resistance is a complex physiological trait which requires the 
neutralization of a diversity of biologically active venom peptides. Typically, venoms 
comprise proteins recruited from upwards of 14 protein families, resulting in venom 
cocktails containing as many as 40 different toxins (Calvete 2010, Voss and Jansa 2012, 
Fry 2012). Nearly all viper venoms include a combination of both enzymatic tissue 
damaging proteins (e.g. metalloproteinases, phospholipases), as well as integrin-like 
proteins that target and disrupt specific physiological functions (Calvete 2010). Because 
of the diverse function of venom components, venom resistance is also likely a complex 
suite of traits involving multiple mechanisms of toxin neutralization and target alteration. 
Venom resistance for opossums within Didelphini has been convincingly demonstrated 
by numerous in vivo and in vitro assays and is derived at least partially from specialized 
enzyme inhibitors present in the plasma (Kilmon 1976, Werner and Vick 1977, Perez et 
al. 1979, Moussatché and Perales 1989). While the biochemical basis of resistance to 
venom metalloproteinases and phospholipases has been well characterized, relatively 
little is known about how these opossums cope with other (non-enzymatic) venom 
protein classes.   
Non-enzymatic venom proteins are known to cause significant destructive 
physiological effects in susceptible species, thus adaptations which counter these effects 
are likely vital to a successful venom-resistant phenotype (Read et al. 1993, Qi et al. 
1994, Barchan et al. 1995). A particularly destructive class of these proteins known to be 
abundant in South American vipers are venom C-type lectins (CTL) (Arlinghaus and 
Eble 2012). A small subgroup of venom CTLs bind the mammalian blood protein von 
Willebrand Factor (vWF) to form a complex that binds, in turn, to the platelet-associated 
glycoprotein GP1bα, preventing blood clotting (Fukuda et al. 2002). This specific action 
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enhances the effects of other hemorrhagic venom factors and is thought to be responsible 
for the devastating systemic bleeding characteristic of snake bites from several species of 
Bothrops vipers. A wide diversity of mammalian taxa have been shown to be susceptible 
to vWF-targeting CTLs, including primates, carnivores, rodents, lagomorphs, bovids, and 
perissodactyls, in both in vitro and in vivo assays. Similarly, in the presence of an altered 
vWF (von Willebrand’s disease; vWD) in pig and dog, the coagulopathic function of 
vWF-binding CTLs is abolished (Nichols et al. 2010, Sanders et al. 1995). Known venom 
CTLs with this function include botrocetin (from Bothrops jararaca), aspercetin (from 
Bothrops asper), and biticetin (from Bitis arietans). Although surveys of vWF binding 
activity have identified several additional species of Bothrops with vWF-binding activity, 
no other venom CTLs have been isolated and described (Arlinghaus and Eble 2012, 
Rucavado et al. 2001, Read et al. 1978).  
 While it is currently unknown how venom-resistant opossums cope with CTLs 
like botrocetin and aspercetin, recent research on the molecular evolution of vWF in 
marsupials has revealed that members of Didelphini show accelerated evolution in the 
vWF A1 region at sites that bind botrocetin (Jansa and Voss 2011).  Although signatures 
of positive selection suggest adaptive function and possible coevolution, we still require 
explicit evidence that species with rapidly evolving vWF are physiologically resistant to 
vWF-targeting venom CTLs.  Physiological resistance, in this case, is the failure of 
platelets to aggregate – measured by the quantity of platelets that remain suspended in 
solution – in the presence of venom CTLs.   
In this work, we test the prediction that members of Didelphini – especially those 
that are known to prey on pitvipers – exhibit physiological resistance to venom CTLs 
(Jansa and Voss 2011). We expect opossums that eat pitvipers to show physiological 
resistance to CTLs from the species they prey upon (Bothrops jararaca: botrocetin, 
Bothrops asper: aspercetin), but not to CTLs from viper species with which they do not 
share a current or historical range (e.g. the African viper Bitis arietans: bitiscetin). 
Moreover, to assess whether vWF-mediated resistance to venom CTLs id restricted to 
Tribe Didelphini, we also assay a smaller-bodied species (Monodelphis domestica) likely 
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preyed upon by pitvipers and assumed to be susceptible to venom.  We utilize a well-
established ex vivo measure of vWF-mediated platelet aggregation to measure the 
aggregation response of opossum platelets to vWF-targeting venom CTLs both in the 
presence and absence of plasma to exclude the influence of any unknown CTL-inhibiting 
plasma proteins. These assays are well correlated with in vivo aggregation response, 
represent a strong predictor of organismal coagulopathy (Read et al. 1983, Nichols et al. 
2010), and provide the first evidence of physiological resistance to venom CTLs in 
opossums. 
  
Materials and Methods 
Study Design 
Species were selected for our assays based on their membership to clade 
Didelphini (Figure 3.1), as well as their availability for whole-blood draws.  We used two 
opossum species from the clade Didelphini hypothesized to be venom resistant 
(Didelphis virginiana N=3, and Didelphis aurita N=4), as well as one presumably non-
resistant species outside Didelphini (Monodelphis domestica N=2). Both Didelphis 
virginiana and Didelphis aurita were shown to have vWF that is evolving at an 
accelerated rate with respect to the remainder of Didelphidae (Jansa and Voss 2011). 
These species are also well known to exhibit organismal resistance to venom (Voss and 
Jansa 2012). Monodelphis domestica belongs to a distantly related genus of opossum that 
is not part of the clade shown to have accelerated vWF evolution, though this exact 
species was not included in previous work examining rates of vWF evolution (Figure 
3.1). However, M. domestica belongs to a clade not expected to exhibit venom resistance 
and is a readily available laboratory animal.  
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Figure 3.1 A phylogeny of didelphid opossums used for examination of rates of vWF evolution in Jansa 
and Voss (2011) with the addition of Monodelphis domestica. The clade Didelphini, known for both 
organismal venom resistance as well accelerated evolution of vWF, is shown in red (light grey in black and 
white prints). Species used for this work are highlighted in blue (dark grey in black and white prints). 
For our assays using opossum blood, we adapted a standard method of vWF-
mediated platelet aggregation used extensively in biomedical studies of vWF function in 
humans (Rucavado et al. 2001, Hamako et al. 1996, Coller et al. 1975, Read et al. 1983). 
Briefly, this assay uses platelet-rich plasma (PRP) that is isolated by centrifuging whole 
citrated blood at 250 x g, followed by a second centrifugation step at 13,000 x g to 
isolate platelet-poor plasma (PPP) (Saad et al. 1993). Platelet aggregation is measured 
by adding an agonist to PRP and measuring the amount of light that passes through the 
solution over time as compared to a PPP standard.  If the agnoist induces platelet 
aggregation, PRP should become clear and transmit more light as the platelets 
precipitate; if the agonist is ineffective at inducing aggregation, the solution will remain 
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cloudy (Figure 3.2). This test is performed in an aggregometer, a specialized 
spectrophotometer designed specifically for this measurement (Chrono-log Co.; model 
560ca). Aggregometers were calibrated with ddH20 according to standard guidelines, 
accepting a baseline error of 5% (Chrono-log Co.). 
 
Figure 3.2- Principal design of a platelet aggregation assay. Platelet Poor Plasma (PPP) is used as a 
reference. Test sample with platelets, Platelet Rich Plasma (PRP), is measured against PRP for light 
transmittance. A. the test sample at baseline (0% aggregation). B. an agonist (a venom protein or other 
aggregating agent) is added to the PRP. C. Platelets aggregate in response to the agonist, allowing light to 
pass through the cuvette. On the right, an aggregometer sensogram reading of light passing through the 
cuvette for each stage (A, B, C). Aggregation percent is recorded as the transmittance reading (70% 
aggregation, in the above example).   
 
Animal Handling and Blood Collection 
Three individuals of Didelphis virginiana were live-trapped in urban and 
suburban areas of Minneapolis by licensed pest removal companies and transported in 
Tomahawk traps to the University of Minnesota Research Animal Resources facility 
(Minnesota Department of Natural Resources Permit #16312). Animal health was 
assessed upon arrival, and all animals were given a period of adjustment of 7-10 days 
before being used for blood draws. Blood draws were performed without anesthetization 
on the ventral tail vein, into sodium citrate coated syringes and stored in sodium citrate 
vacutainers (Moore 1984). Multiple blood draws were conducted on each individual, with 
intervals of a minimum of two weeks between blood draws. After use in this study, 
animals were released near the site of capture.  
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Four individuals of Didelphis aurita were wild caught in baited Tomahawk traps 
in urban forest at the Instituto Butantan (Brazil), anesthetized with 5% isoflurane by 
inhalation, and used for blood collection via tail vein puncture as previously described 
(CEUAIBU# 8346081018, SISBIO permit #64934-1, Moore 1984). Blood draws for D. 
aurita were not repeated, as all animals recovered within 30 minutes and were 
immediately released near the collection site. Two individuals of Monodelphis domestica 
were kindly gifted from the Oberlin College research colony by Dr. Yolanda Cruz and 
housed at the University of Minnesota according to protocols described in Rousmaniere 
et al. (2010). After a period of adjustment (3 weeks) individuals were anesthetized with 
5% isoflurane and exsanguinated via cardiac puncture using a 3.2% sodium citrate coated 
syringe. All animals were handled in accordance with the American Society of 
Mammologists’ standards, with supervision by veterinary staff at the University of 
Minnesota, and Instituto Butantan, Brazil (Sikes et al. 2011, IACUC Protocol #1303-
3046A). Human samples used for controls and venom fraction isolation were obtained 
from healthy donors who had given informed consent. Volunteers did not consume 
alcohol, ibuprofen, aspirin, or any other drug which is known to disrupt coagulation 
within 24 hours of donation. Human blood draws were performed by University of 
Minnesota nurses either in the Special Coagulation Laboratory or at a clinic, using 
standard 3.2% sodium citrate vacutainers for PRP assays or Acid Citrate Dextrose 
(solution A) vacutainers for vWF purification (BD Pharmaceuticals). 
 
vWF purification 
Opossum and human vWF was purified from fresh blood collected in acid citrate 
dextrose (ACD) Solution A (BD Pharmaceuticals) vacutainers and centrifuged at 5000 x 
g for 10 minutes to remove blood cells, lipids, and large debris. Supernatant was removed 
and centrifuged for an additional 30 minutes at 28300 x g at 4° C to remove any 
remaining large cell or lipid remnants. Clear plasma supernatant was then placed directly 
onto a size exclusion liquid chromatography column (CL4B Sepharose XK26/100 
column 3L volume, GE Life Sciences), and recovered as the first and largest protein in 
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the void volume as a single peak. vWF in circulation exists as very large multimers of 
500-20,000 kDa, representing the largest multimeric protein complex in blood (Furlan 
1996). This method of isolation was chosen as it was adaptable to small volumes of blood 
and excludes the vast majority of plasma proteins other than vWF by size. The only other 
plasma protein close to this size range is fibrinogen (340-350 kDa); other plasma 
proteins, including those known to inhibit venom proteins are much smaller (68 kDa) and 
are easily excluded with this method (Menchaca and Perez 1981). This void fraction 
(containing vWF) facilitated the aggregation of purified human platelets in the presence 
of ristocetin in physiological buffer, demonstrating this fraction contained concentrated 
and active vWF as previously described (De Marco et al. 1981). 
 
DNA Sequencing 
The vWF A1 region was sequenced for all opossum individuals used in 
aggregation assays to assess variation among individuals within each species. DNA was 
extracted from whole blood using a QIAGEN DNeasy Blood and tissue kit.  The vWF A1 
region was amplified with PHIRE polymerase at 90° C for 30 seconds, followed by 35 
cycles of 98° C for 5 seconds, 65° C for 5 seconds, and 72° C for 15 seconds using 
primers DvWF F1 5’-TCACTGTGATGGTGTGAACTT-3’and DvWF R6 5’- 
GTCTGAGCCTTCTAGCACAAA-3’ designed from a Monodelphis domestica genome 
scaffold. Samples were sequenced either at the University of Minnesota Genomics Center 
(Didelphis virginiana and Monodelphis domestica) or at the University of Butantan 
Laboratorio Especial de Toxinologia Aplicada (Didelphis aurita). Chromatograms were 
assembled and verified in GENEIOUS version 7.1.8; MUSCLE (Edgar 2004) was used to 
create alignments. Sequences have been deposited in GenBank (MN384757-59). 
 
Platelet Agonists 
Aspercetin was kindly gifted by Dr Alexandra Rucavado, Universidad de Costa 
Rica, having been purified as previously described (Rucavado et al 2001).  Crude Bitis 
arietans venom was gifted to us by Kristen Wiley at the Kentucky Reptile Zoo. Biticetin 
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was purified first with salt precipitation described previously (Hamako et al. 1996), then 
eluted off both strong (SP-FF), and weak (DEAE-Sepharose-FF) FPLC cation exchange 
columns (GE Life Sciences). Fraction isolation was performed as previously described 
(Hamako et al. 1996).  
  To obtain the volume needed to test multiple replicates in several species, we 
used two sources of botrocetin. The first source (here designated “botrocetin A”) was 
kindly provided by Dr Miguel Cruz (Baylor College of Medicine) and Dr Robert 
Andrews (Monash University). This sample was among several previously used to assess 
botrocetin activity and function (e.g. Dong et al 2001). Botrocetin was also purified from 
pooled Bothrops jararaca venom following the protocol described by Sekiya et al. 
(1999), with some modifications. Lyophilized venom (1.4 g) was reconstituted in 30 mL 
of 84 mM imidizole HCl, 2mM benzamidine pH 7.4, and dialyzed in the same buffer in a 
10 kDa molecular weight cut off dialysis cassette (Thermo Scientific) at 4° C for 2 hours. 
Dialyzed venom was then subjected to ion exchange chromatography via a 15 mL DEAE 
sepharose column equilibrated in the same buffer. Elution buffer (84 mM imidizole HCL, 
2 mM benzamidine, 1 M NaCl, pH 7.4) was applied first in a step gradient of 10%, and 
then in a linear gradient from 10-30%, with subsequent step gradients of 50%, 80% and 
100%.  Resulting fractions were tested for platelet aggregation activity using human PRP. 
Platelet aggregation activity was observed only in a single broad peak eluted at 10-30%. 
To further purify this sample, this peak was concentrated from 65 mL to 4 mL via 
ultrafiltration in 10kDa molecular weight cut off Vivispin columns (Sartorius, 
Goettingen, Germany), and dialyzed into 2 L TBS pH 7.4 at 4°C overnight. The dialyzed 
sample was then applied to a 16/600 200pg Superdex size exclusion column (GE Life 
Sciences). Five separate FPLC peaks were recovered, run out on an 8-20% Tris-Glycine 
protein gel with BlueStain protein ladder (GoldBio), and stained with Coomassie Brilliant 
Blue R-250. Three of these peaks contained bands indicative of botrocetin (subunits at 
15.5 and 16 kDa). 
  To purify these three samples, each was dialyzed separately into 1 L 20mM Tris-
HCl, pH 8.0 at 4° C overnight. Each was applied separately to a strong ion exchange 
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column (MonoQ, GE), and eluted using a linear gradient of NaCl (0-1M). Each recovered 
a fraction eluted at 0.5 M NaCl as the last peak (as in Sekiya et al. 1999). Two of these 
resulting peaks showed double bands at 15-16kDa as the only visible bands in a Tris-
Glycine gel using the same gel conditions as above (indicative of botrocetin). Both 
samples also showed platelet-aggregation activity in human citrated platelet-rich plasma. 
Both fractions also aggregated purified lyophilized platelets reconstituted in 
physiological buffer (Chronolog Co.) only upon addition of a source of vWF (PPP), and 
were thus designated pure isoforms of botrocetin. Pure isoforms were dialyzed into TBS 
and concentrations were determined by absorbance at 280nm measured with a Nanodrop 
model 2000 (Thermo-Scientific), as well as gel-band imaging quantitation using Image J 
1.x (Schneider et al. 2012). Both pure isoforms of botrocetin (named botrocetin B and 
botrocetin C) showed 70% aggregation at a 4 μg/mL test concentration after a 4-minute 
incubation with human platelet rich plasma. This activity matched that of botrocetin A 
provided by the Cruz and Andrews lab (data not shown). Due to limited protein 
availability, botrocetin A was used for all assays on Didelphis virginiana, while 
botrocetin B was used for all assays on Didelphis aurita and Monodelphis domestica. To 
minimize sources of variation we did not use Botrocetin C in any assay.  
Ristocetin (Chronolog Co.), an antibiotic derived from bacteria, is known to 
induce platelet aggregation via vWF in humans and is often used as a control for vWF 
and platelet activity. We attempted to use ristocetin as a positive control for both human 
and opossum assays, however opossum platelets exposed to ristocetin became cloudy and 
formed a chalky precipitate without displaying an aggregation response.  Though 
previously unknown in opossums, a similar response to ristocetin is known for dogs and 
pigs (Nichols et al. 2010, Read et al. 1983). Consequently, ristocetin could not be used as 
a positive control for vWF-mediated aggregation in opossums. Instead adenosine 
diphosphate (ADP) was used as an alternative control. Though ADP aggregates platelets, 
it does not do so via vWF, and so serves as a control of platelet activity only. Ristocetin 
and ADP were purchased (Chronolog Co.) and reconstituted as recommended by the 
manufacturer.   
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Platelet-Rich Plasma Assays 
Platelet-rich plasma (PRP) and platelet-poor plasma (PPP) were isolated by 
centrifugation for all species as described above. For each individual, a single aliquot of 
500μl PPP and multiple aliquots of 450μl of PRP were placed into glass cuvettes 
(Chrono-log Co.). As PPP is not disturbed during data collection, a single PPP sample is 
used for each individual, though multiple PRP samples may be derived from that 
individual. Each individual assay (450μl PRP) was used either for a control (ADP, 
Ristocetin) or a treatment (botrocetin, aspercetin, bitiscetin). PRP samples which did not 
aggregate when exposed to a treatment agonist were either exposed to increasing 
concentrations of that same agonist by simply adding more agonist to the same sample or 
tested against a control agonist (ADP). A complete list of PRP tests performed on each 
individual organism can be found in Appendix Table 3.7.  
Samples were warmed to 37°C and placed into appropriate PPP and PRP cuvette 
holders for a minimum of two minutes. A small disposable stir bar was added to each 
PRP cuvette and the sample was stirred at 1200rpm for the duration of the test. After 
setting a baseline at 0 on the aggregometer, the sample was allowed to sit undisturbed for 
1 minute, after which 50ul of an agonist (botrocetin, aspercetin, bitiscetin, ristocetin, or 
ADP) was added to the PRP cuvette. Aggregation was observed via optical interference 
for 8 minutes. The slope of the aggregation curve (Figure 3.2) is the standard measure of 
aggregation response used for biomedical testing, however variation in platelet and vWF 
concentration can affect this slope and it should be adjusted for platelet counts in each 
test.  Because we were working with species in field conditions and with limited blood 
volumes, we were unable to quantify and standardize these concentrations; therefore, we 
used total percent aggregation as our measure of aggregation response (Figure 3.2, 
Rucavado et al. 2001, Read et al. 1983, Nichols et al. 2010).  
Platelet counts for PRP were estimated initially in both human and D. virginiana 
individuals, determined to be within normal range, and were not further adjusted or 
tested. No platelet counts were conducted for Didelphis aurita or Monodelphis domestica 
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because of sampling and facility limitations.  Agonist concentrations were chosen to 
replicate previously established concentration ranges which produced aggregation in 
human samples, and to accommodate limited availability of venom protein (Hamako et 
al. 1996, Rucavado et al. 2001, Sekiya 1993). The range of final concentrations for each 
agonist are as follows: ristocetin: 1.5-3.75 mg/ml, botrocetin: 2-70 μg/ml, aspercetin: 20-
200 μg/ml, ADP: 850 μg/ml, and bitiscetin: 10-12 μg/ml. PRP assays were carried out as 
previously described (Coller et al. 1975). Assays were prioritized by limited amounts of 
both blood and venom proteins. To accommodate limited plasma, samples which yielded 
no response were subjected to additional doses of agonist (increasing test concentration), 
and a subsequent dilution correction was applied to the final transmittance.  
Fresh PRP from Monodelphis domestica was extremely limited, and thus used to 
test aggregation with botrocetin only. Two individual Mondelphis domestica were 
sampled, however, only one individual produced PRP which aggregated in the presence 
of ADP. The second individual’s PRP did not aggregate in the presence of ADP, and thus 
could not be used for botrocetin testing, as it was uncler whether platelets were active. 
However, because vWF can induce platelet response (agglutination) even in formalin-
fixed platelets, we utilized this sample to assess aspercetin agglutination response (Allain 
et al. 1975).  
 
Washed Platelet Assays 
To isolate the effect that plasma proteins might have on aggregation in PRP 
assays (Allain et al. 1975), an additional assay was conducted with washed platelets 
suspended in physiological buffer. This assay uses the same design as in Figure 3.2, using 
buffer without platelets as a reference. As this procedure removes vWF along with the 
plasma, we purified vWF from PPP and added it along with the washed platelets to each 
assay. This assay was performed only on Didelphis virginiana and human controls, as the 
platelet purification process - as well as the vWF purification process - (Allain et al. 
1975, De Marco et al. 1981) both require repeated blood draws of large volumes, which 
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were only feasible for the larger bodied D. virginiana housed in a research facility. A 
complete list of washed platelet tests performed can be found in Appendix Table 3.8.  
Platelets were washed via centrifugation as previously described (Allain et al. 
1975) and re-suspended in phosphate buffer (0.15 M disodium phosphate diluted in 0.15 
M monosodium phosphate until pH reached 7.0). Platelet preparations for human and 
Didelphis virginiana were prepared in tandem.  
ADP controls were performed on purified platelets from D. virginiana to 
demonstrate that the purification processes did not inactivate platelets. To assess whether 
vWF was inactivated by the purification process, human vWF and pure platelets were 
assayed separately with ristocetin and bitiscetin. Because D. virginiana showed little to 
no aggregation to any vWF-targeting reagent (botrocetin, ristocetin, aspercetin, or 
bitiscetin), a similar control for opossum vWF purification inactivation could not be 
performed. To compensate for the lack of a positive vWF control in Didelphis virginiana, 
two sources of vWF were used to assure vWF activity. Assays were performed using 
either: 1) purified and concentrated vWF, or 2) 10% v/v platelet poor plasma (PPP), 
which contains vWF (Sekiya 1993, Kumar et al. 2006).  
All vWF-binding agonists were added first to pure platelets and allowed to 
equilibrate before adding a vWF source.  While the washing process removed nearly all 
plasma proteins, vWF occasionally remained in quantities sufficient to facilitate some 
vWF-mediated aggregation in human washed platelets in the presence of an agonist 
before the additional of purified vWF. Therefore, all estimates of aggregation in purified 
assays represent a conservative value.  
 
Analyses  
To test for differences in PRP aggregation response by concentration (dose-
dependence), assays were grouped into low (botrocetin 2 μg/ml, aspercetin <50 μg/ml), 
and high concentrations (botrocetin >2 μg/ml, aspercetin >51 μg/ml). Differences in PRP 
aggregation response between high and low concentrations for each venom protein were 
tested using Wilcoxon tests. No significant differences in percent PRP aggregation were 
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observed between low and high concentrations for any venom protein, consequently, 
subsequent analyses did not distinguish between tests run at different concentrations (e.g. 
all D. virginiana botrocetin PRP tests were grouped and compared to all human 
botrocetin PRP test regardless of concentration; Appendix Table 3.2). 
 To compare opossum PRP aggregation with aggregation for the same agonist in 
human PRP, a one-way non-parametric analysis was performed. We used a Dunn joint-
ranking method appropriate for testing each species-agonist treatment against the same 
treatment in human PRP, incorporating a Bonferroni correction for each group by 
agonist, as well as globally (Table 3.1).  
 Virtually no variation in PRP response to any agonist by individual was 
observed, except for Didelphis virginiana response to aspercetin. Because individuals of 
Didelphis virginiana were observed to vary in their PRP response to aspercetin, an 
additional test was done to determine if this variation in PRP aggregation response 
among individuals was statistically significant, using a standard Kruskal-Wallis rank 
sums test. 
Monodelphis domestica PRP agglutination response to aspercetin from a sample 
which failed ADP control was compared against Human PRP and Didelphis virginiana 
PRP exposed to the same venom protein (aspercetin).  A Tukey-Kramer HSD test for 
pairwise comparisons was used to evaluate pairwise differences between human, 
Monodelphis domestica, and Didelphis virginiana PRP aggregation response.  
Differences in aggregation between vWF source (PPP vs purified vWF) in 
washed platelet (WP) assays were assessed using a one-way Wilcoxon test, and were 
grouped where no significant differences were found. The same test for dose-dependence 
used in PRP assays was also used to test for dose-dependent response in WP assays.  No 
significant differences in percent aggregation were observed between low and high 
concentrations for any venom protein in WP assays; consequently, subsequent analyses 
did not distinguish between tests run at different concentrations (e.g. all D. virginiana 
botrocetin WP tests were grouped and compared to all D. virginiana PRP tests regardless 
of concentration) (Appendix Table 3.5). 
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Average values of percent aggregation for all WP assays were compared to the 
same treatment (ADP, or venom protein) in PRP, using one-way Wilcoxon tests, to assess 
whether the removal of plasma significantly altered aggregation results.  
 
Results 
Platelet Rich Plasma Assays 
PRP assays were conducted to compare opossum vWF aggregation response to 
human aggregation response for the same agonist (venom protein). Averages and 
variation for human aggregation are consistent with previous work (Figure 3.3A) 
(Rucavado 2001, Hamako 1996, Sekiya 1993) for all treatments. By contrast, all three 
opossum species showed a significant reduction or loss in aggregation response to all 
venom proteins tested (Table 3.1, Figure 3.3A), but aggregated normally in the presence 
of ADP. Didelphis virginiana PRP did not aggregate in response to botrocetin or 
biticetin. Aspercetin caused Didelphis virginiana PRP to aggregate partially, although 
significantly less than observed in human samples (Figure 3.3A, Table 3.1). Variation in 
response to aspercetin among individual opossums (Didelphis virginiana) was observed, 
but this variation among individuals was not significant (Appendix Table 3.1). Changes 
in agonist concentration did not produce significant differences in aggregation. However, 
variation in response to aspercetin was reduced as all individuals showed at least partial 
aggregation at the highest concentration of aspercetin (100ug/ml) (Appendix Table 3.2). 
Didelphis aurita showed no aggregation response to either botrocetin or aspercetin but 
was not tested for bitiscetin due to limited blood volume available (Figure 3.3A). Two 
individuals of Monodelphis domestica were sampled; however, one of the two samples 
failed to aggregate in the presence of ADP and was thus excluded from analysis. The 
remaining Monodelphis domestica sample showed no aggregation response to botrocetin. 
Monodelphis domestica platelets from the sample that failed to aggregate with ADP did 
ultimately aggregate at an aspercetin concentration of 100 μg/ml (Appendix Figure 3.1).  
Both D. virginiana and M. domestica showed some aggregation in high concentrations of 
aspercetin (Appendix Figure 3.1, Appendix Table 3.3). The magnitude of the aggregation 
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response to aspercetin was similar between the two species, and both showed 
significantly less aggregation than human (Appendix Figure 3.1, Appendix Table 3.3). 
 
 
 
Figure 3.3- Mean percent platelet aggregation calculated as percent light transmittance (error bars 95% 
confidence intervals). N below species names in top panel indicates number of individual animals, numbers 
below each bar graph indicate total number of individual tests done for each agonist. NA indicates this test 
was not performed. 1 this test was performed with a sample which failed ADP control and is reported in 
supplementary material (Appendix Figure 3.1) Panel A are tests performed in platelet rich plasma (PRP); 
asterisks indicate values that are significantly different from the same PRP test in human samples. Panel B 
shows results from tests using washed platelets and purified vWF or 10% v/v PPP as a vWF source; ns 
indicates no significant difference from the same test performed with PRP (see in Panel A for comparison). 
ADP serves as a platelet activity control for all tests. Bitiscetin and ristocetin serve as vWF activity controls 
for washed assays. 
 
 
 
 
Aggregation in Platelet Rich Plasma 
Species  Control  Score Mean Difference Std Err Dif Z-score P-Value 
ADP 
Didelphis virginiana n=7 
Human n=10 
6.8769 3.453393 1.99135 0.1393 
Didelphis aurita n=4 3.425 4.857221 0.70514 1 
Monodelphis domestica n=1 -16.3 8.610932 -1.89294 0.1751 
botrocetin 
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Didelphis virginiana n=13 
Human n=14 
19.772 4.126265 4.79174 <.0001* 
Didelphis aurita n=12 21.9226 4.21447 5.20175 <.0001* 
Monodelphis domestica n=3 -21.7976 6.815705 -3.19815 0.0041* 
aspercetin 
Didelphis virginiana n=11 
Human n=11 
15.39583 4.32599 3.558915 0.0007* 
Didelphis aurita n=3 24.25 6.701795 3.618433 0.0006* 
bitiscetin 
Didelphis virginiana n=12 Human n=2 12.35119 3.553028 3.476244 0.0005* 
ristocetin 
Didelphis virginiana n=4 Human n=5 7.866667 2.453116 3.206806 0.0013* 
 
Table 3.1 – One-way analysis of percent aggregation (% transmittance) in PRP. Analysis is a non-
parametric comparison of PRP mean percent aggregation using Dunn method for joint ranking with Human 
as the control for each group. Dunn methods uses a Bonferroni adjustment within each test group. Between 
test groups (10 tests) Asterisk indicate significance at the Bonferroni adjusted ɑ-value 0.006.  
 
 
 
Washed Platelet Assays.  
Washed platelet assays were done to test the effect of plasma proteins on venom 
CTL induced aggregation. These assays gave similar results to those using PRP: 
Didelphis virginiana showed a significant reduction in aggregation response compared to 
human for to all venom proteins tested, but platelets aggregated normally in the presence 
of ADP (Fig. 3.3B). There were no significant differences between aggregation values 
from the washed platelet assay and those from the PRP assay for either opossum or 
human tests (Figure 3.3B, Appendix Table 3.4). Bitiscetin and ristocetin treatments in 
human assays demonstrated that platelets and vWF remained active after being purified; 
similarly, ADP controls showed no reduction in the ability of opossum washed platelets 
to aggregate (Figure 3.3B, Appendix Table 3.4). Opossum samples treated with ristocetin 
showed increases in opaqueness due to formation of a chalky precipitate but did not show 
platelet aggregation. As with the PRP assays, no significant differences were seen among 
tests performed at increasing agonist concentration (Appendix Table 3.5). The source of 
vWF (PPP vs pure vWF) yielded no difference in response for botrocetin or bitiscetin but 
did for aspercetin (p = 0.021) (Appendix Table 3.6). When platelet poor plasma (as 
opposed to purified vWF) was used as a source of vWF, aggregation increased by an 
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average of 7.5%, suggesting some degradation of vWF during purification, or that a low 
concentration impurity such as a venom serine proteinase is enhancing aggregation via a 
target in the plasma (e.g. fibrinogen). However, an increase of 7.5% is small (only 2.5% 
above machine calibration error of 5%), and thus may not reflect a biologically relevant 
increase. 
 
DNA Sequencing. 
All DNA sequences were invariant within species at the vWF A1 region known to 
be responsible for venom CTL binding (residues 475-710 NCBI accession AAB39987.1). 
Didelphis virginiana sequences from this region were identical to Genbank accession 
JN415020, and Monodelphis domestica sequences were identical to Genbank sample 
accession NM_001246274. Didelphis aurita vWF was not previously available on 
Genbank. 
 
Discussion 
We provide the first physiological evidence that the coagulopathic effects of 
snake venom CTLs are disrupted in opossums, which may contribute to whole-organism 
resistance to pitviper envenomation.  We challenged platelets from three species of 
opossums using vWF-binding venom CTLs from snakes known to currently or 
historically co-occur with those species (botrocetin and aspercetin from species of the 
South American pitvpers Bothrops jararaca and Bothrops asper, respectively), and one 
which is found on a different continent (bitiscetin from the African viper Bitis arietans). 
We confirm that human platelets aggregate as expected in the presence of all three venom 
CTLs and show that platelets from all examined opossum species (D. virginiana, D. 
aurita, and M. domestica) fail to show the same response (Figure 3.3A). Thus, contrary to 
the expectation that only opossums in Didelphini (with rapidly evolving vWF) will 
exhibit resistance to venom CTLs, all opossums tested to date appear to enjoy protection 
from CTL-mediated platelet aggregation. Furthermore, this protection appears to hold 
regardless of the geographic origin of the toxins tested. 
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Physiological Function within Didelphini 
Didelphis aurita inhabits a geographic range which overlaps with that of Bothrops 
jararaca, as well as several other species of Bothrops which have been shown to have 
vWF-mediated platelet aggregating activity (Read et al. 1978, McManus 1974, Caceres 
and Monteiro-Filho 2010).  Though Didelphis virginiana does not overlap geographically 
with Bothrops jararaca, it does share the southern portion of its range with Bothrops 
asper and likely shared a historical range with ancestral Bothrops species before its 
migration to North America ~3 mya (McManus 1974, Voss and Jansa 2012). These 
observations, along with behavioral and experimental data which show venom resistance, 
predation on venomous snakes, and venom targets (vWF) evolving under positive 
selection, lends credence to the assertion that these species are coevolving with 
venomous snakes (Wood 1954, Fitch 1960, Menchaca and Perez 1981, Moussatche and 
Perales 1989, Jared et al. 1998, Jansa and Voss 2011). Specifically, Jansa and Voss 
(2011) suggested that the detection of positive selection in didelphine vWF may be 
evidence of molecular changes that protect these opossums from the effects of vWF-
targeting CTLs such as botrocetin. At first glance, the reduced aggregation response in 
these species to botrocetin and aspercetin shown in this study add support to this 
assertion.  
While lack of aggregation response to botrocetin and aspercetin was expected, the 
same result for bitiscetin was not. This is likely due to a large degree of overlap in 
botrocetin and bitiscetin binding sites. Of 15 bitiscetin binding sites, 13 are within the 
botrocetin binding pocket, 5 directly overlap with botrocetin binding sites, and another 5 
are directly adjacent to a botrocetin binding site (Maita et al. 2003). Given this overlap, it 
is not surprising that we observed similar responses to these two agonists. 
 Didelphis virginiana showed partial though greatly reduced aggregation for 
aspercetin, while all other tests involving opossums showed a nearly complete lack of 
platelet aggregation with aspercetin. Partial resistance to aspercetin in D. virginiana 
suggests that this protective function may not be effective against all venom CTLs in all 
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didelphines. Given that apparent resistance to botrocetin confers resistance to bitiscetin (a 
distantly related African CTL) it is thus surprising that a more closely related CTL 
(aspercetin) would not also fail to function in the same species. This result also suggests 
that aspercetin may be quite divergent from botrocetin particularly at vWF binding 
sites—and may be part of an adaptive radiation of venom proteins evolving to target vWF 
in mammals. Complete resolution of the aspercetin sequence and structure is not 
available at this time, but further work elucidating this would help decipher its divergence 
in form and function from botrocetin.  
The observation of inter-individual variation of D. virginiana aggregation for 
aspercetin (though not statistically significant), suggests some variability in ability to 
resist this venom protein. Because no polymorphism in the vWF A1 region was present 
between these individuals, this result suggests that any variation in resistance to 
aspercetin between individuals of Didelphis virginiana is not due to changes in vWF. As 
vWF mediated aggregation requires that a venom protein first binds to vWF and 
subsequently binds to a platelet binding site (GP1bɑ), the variation in resistance observed 
may be due to aspercetin’s ability to bind to GP1bɑ (variation in opossum GP1bɑ). 
Additional work examining the tertiary complex of vWF-aspercetin-and GP1bɑ, as well 
as variation in GP1bɑ among individual opossums are needed to assess the source of 
reduced aggregation response in this species.  
Washed platelet assays excluded the possibility that opossum plasma inhibitors 
are responsible for the reduction in aggregation observed (Figure 3.3B). For aspercetin, a 
small increase in aggregation (7.5%) was seen when adding plasma to washed platelets - 
a pattern opposite to that expected if plasma proteins inhibited vWF CTLs. This result 
indicates either a small amount of a contaminating venom protein is causing aggregation 
via a plasma protein target, or some functional degradation of vWF caused by the 
purification process. Overall, these data are consistent with the assertion that amino acid 
changes in opossum vWF confer physiological resistance to vWF-binding venom CTLs, 
but do not rule out the role of the platelet site GB1Bɑ in contributing to this resistance.   
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Physiological Function Outside Didelphini 
Surprisingly, Monodelphis domestica, an opossum not included in the clade 
known to be venom resistant (and distantly related to Didelphini), also showed a loss of 
aggregation response to botrocetin. This result is inconsistent with the hypothesis that 
vWF resistance to venom CTLs is restricted to Didelphini. Though several species of 
Monodelphis were included in the original work identifying rapid evolution in Didelphine 
vWF, Monodelphis domestica was not (Jansa and Voss 2011). 
 
Figure 3.4- Topology of Didelphidae from Jansa and Voss (2011) with the addition of Monodelphis 
domestica according to Pavan et al (2014). Branch lengths reprisent the estimated number of amino acid 
substitions in vWF reconstructed with the JTT model of amino acid substitution available in PAML (Yang 
2007).  
  Jansa and Voss (2011) utilized the branch-site test of positive selection which 
requires that a branch or branches thought to be evolving under selection be selected a 
priori to test a specific hypothesis (Yang 2007). Though this method is powerful tool for 
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hypothesis testing, the a priori selection of branches make it susceptible to missing 
instances of positive selection that were previously unexpected. Figure 3.4 shows that 
although Didelphini has a long branch (reflecting several amino acid changes), additional 
branches in Didelphidae outside this clade also exhibit several independent instances of 
long branches. Monodelphis emiliae, Marmosa rubra, Monodelphis brevicaudata, 
Monodelphis domestica, and Metachirus nudicaudatus all have branch lengths which are 
conspicuously long relative to other species (Figure 3.4).  Monodelphis domestica 
specifically exhibits a long branch and shares several changes at botrocetin binding sites 
seen in Didelphini. Of 13 botrocetin binding sites, M. domestica has changes at six of 
these sites, three of which are identical to amino acid changes found in Didelphini. 
Additionally, Monodelphis domestica shares a geographic range with Bothrops jararaca 
and is likely to be a prey item of several South American vipers (Macrini 2004, Voss 
2013). It has also been rarely described to eat snakes, though species were not specified 
(Streilein 1982). It is therefore possible that Monodelphis domestica represents an 
independent instance of rapid evolution of vWF among opossum species. Examining the 
physiology of CTL resistance among additional didelphid speices (Figure 3.4) could be a 
fruitful avenue for future research.  
Though changes on vWF in this clade indicate that rapid adaptation may be 
shaping this gene, it is possible that these are artifacts of another unknown selection 
pressure unrelated to venom. Therefore, an alternative interpretation of this data may be 
that CTL-resistant vWF is the ancestral state for all opossums and may have facilitated a 
dietary adaptation (snake eating) in Didelphini. This initial disabling of venom CTL 
function may have disrupted coagulopathy enough to allow differential survival, which 
subsequently may have allowed these species to evolve additional mechanisms of venom 
resistance such as metalloproteinase and phospholipase inhibitors that are well known for 
this group (Voss and Jansa 2012). Whether this type of pre-existing resistance to CTLs 
would be effective for all opossums regardless of body size is unknown. Given that most 
members of Didelphini are large bodied compared to the remainder of Didelphidae, the 
combination of a large body size which is able to dilute venom dosage in addition to a 
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pre-adapted vWF may have combined to facilitate the evolution of whole venom 
resistance via metalloproteinase and phospholipase inhibitors in this group.  
Though vWF resistance likely does not confer organismal venom resistance, it 
may be indicative of unexamined partial or complete organismal venom resistance. The 
results reported here suggest that the long-held assumption that M. domestica and 
potentially other related smaller bodied opossums are venom sensitive may need re-
evaluation. Though analyses of positive selection which motivated this work are robust in 
detecting signals of persistent diversifying selection, they are poor at detecting selection 
in which a few advantageous nonsynonymous mutations are either quickly reaching 
fixation or toggling back and forth between states- as might be expected in the case of 
rapid directional selection or trench warfare coevolution (Yang and Reis 2011, Nuismer 
et al. 2007). Because of this, while tests of positive selection are a useful tool in directing 
attention to potential adaptive function, they should be followed up through examination 
of the functional effects of observed genotypes (Yokoyama et al. 2008). Although our 
results isolate the vWF-platelet-CTL interaction as the likely source of disruption of 
botrocetin/aspercetin coagulopathic response in opossums, further investigation is 
required to understand the underlying mechanism of CTL resistance conferred 
specifically by amino acid changes in vWF both in Didelphini and their more distant 
relatives. Identification of the molecular mechanism(s) of resistance and the ability to 
survey this function across more species in Didelphidae would help to better discern 
whether loss of aggregation response in these opossums is ancestral to all Didelphidae or 
is convergently derived as an antipredatory adaptation (in small bodied opossums) and as 
a dietary adaptation (in large bodied opossum).  
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CHAPTER 4. EVIDENCE FOR COEVOLUTION AND CRYPTIC 
CONVERGENCE BETWEEN OPOSSUMS AND PIT-VIPERS 
Introduction 
 Coevolution is a process that has been central to evolutionary biology since its 
beginnings, when biologists and naturalists began to recognize that patterns of adaptation 
and counter adaptation produce reciprocal changes in phenotypes (Priestley 1764, Darwin 
1859, 1862, and 1895, Müller 1873, Smith 1887, Andrews 1891, Kellogg 1896, von 
Ihering 1902).  The best studied examples of these interactions include obligate 
mutualisms, host-pathogen models, and some predator-prey systems (Ehrlich and Raven 
1964, Janzen 1966, Anderson and May 1979, Anderson and May 1982, Hanfin et al. 
2008, Scanlan et al. 2011). However, Janzen (1980) argued that though we observe 
coevolution as matched phenotypes in the present day, the inability to observe the history 
of interactions among ancestral species renders us unable to distinguish the role that 
coevolutionary processes played in shaping modern species interactions.  For example, 
predators may be able to eat novel toxic prey because they already carry detoxifying 
abilities attained through some other process.  Such pre-adaptations may make a new 
predator-prey interaction possible, but the interaction did not result from trophic 
coevolution. 
 The study of coevolution in natural systems via large scale phenotypic and 
phylogenetic associations (using these as proxies for co-adaptive change) has been 
successful at demonstrating reciprocity through co-speciation and counter-adaptations 
(Langamore et al. 2003, Currie et al. 2003, Janzen 1980, Lawton and Hassel 1981, 
Klassen 1992).  However, these approaches are limited to very recent and fast changing 
interactions that can be observed in contemporary species. However, distinguishing pre-
adaptation from coevolution may be possible at deeper time scales if we can examine the 
pattern of evolution of ancestral phenotypes in interacting species.  For example, 
coevolving species observed in present-day interactions may appear to have phenotypes 
which are tightly matched; however, examination of their ancestral phenotypes may show 
that they each already possessed their phenotypes before coming into contact with one 
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another, with no subsequent change. As coevolution is characterized by reciprocal 
evolutionary change in interacting partners, a pattern of unchanged phenotypes across 
ancestral forms in each species would exclude coevolution as the underlying process 
producing matched phenotypes, and instead would suggest that pre-adaptation is 
responsible for this observation.  
Different models of the coevolutionary process make predictions about how 
ancestral phenotypes should change as a result of long-term reciprocal interactions 
between species.  For example, arms-race coevolution — where antagonists evolve 
increasing defense/attack phenotypes perpetually escalating their trait values — has been 
described as the dominant model of antagonistic coevolution (Abrams 1986, Dawkins 
and Krebs 1979).  A simple example of this model is predator speed versus prey speed. 
Arms-race coevolution would dictate escalating unidirectional selection for faster 
phenotypes in both interacting species. Thus, ancestral phenotypes in arms-race 
coevolution are expected to show unidirectional evolution of trait values (in this example, 
slow to fast) across the history of this interaction.   
An alternative model of coevolution, where phenotypes change by alternating 
their ability to match one another, has been described as ‘trench warfare’, or ‘phenotype 
matching’ coevolution (Gomulkiewicz et al. 2000, Ridenhour and Nuismer 2007), by 
virtue of its characteristic reciprocal retaliation (Axelrod and Hamilton 1981). This model 
invokes a distinct process of cyclic fluctuating selection which generates traits that flip 
back and forth between trait values (Thompson 1994, Jokela et al. 2000). The best 
examples of this kind of coevolution include protein-matching models where a predator 
or disease must ‘match’ or identify a host in order to exploit it. Ancestral phenotypes in 
this type of coevolution would instead be expected to be changing in a non-unidirectional 
fashion, toggling between trait values over time.  
 These two models of coevolution are difficult to assess empirically without 
access to observations on ancestral interactions.  These observations can come from 
analysis of the fossil record (e.g. Kelley 1992, Grossnickle and Polly 2013), from studies 
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of experimental evolution (Brockhurst and Kokella 2013), or from engineering ancestral 
proteins involved in a potential coevolutionary interaction (Golding and Dean 1998). 
This latter approach — sometimes termed the ‘functional synthesis’— places 
emphasis on testing the function of ancestral proteins to examine the plausibility of 
hypothesized evolutionary scenarios (Golding and Dean 1998). This approach uses 
models of sequence evolution to detect selection and reconstruct ancestral sequences, as 
well as in-vitro expression and functional assays to empirically test hypotheses of 
adaptive function in extant and ancestral proteins.  Studies applying this approach have 
provided important new insights into the relative roles that additional complexities such 
as constraint, epistasis, and permissive mutations play in molecular evolution (Dean and 
Thornton 2007, Bridgham et al. 2009, Harms and Thornton 2013). However, the 
functional synthesis has primarily been applied to understanding adaptive evolution to 
abiotic selection pressure and has yet to be used to elucidate the history of protein 
evolution for coevolving molecules, including whether this history is consistent with an 
arms-race model or a trench warfare model of coevolution.  
Ideally, the functional synthesis approach would be applied to both proteins 
involved in a coevolutionary interaction, but this goal has remained elusive due to the 
difficulty of reconstructing the evolutionary history of both participants within a 
coevolutionary interaction. Nevertheless, empirical ancestral phenotype data for just one 
of the interacting partners can still address predictions of different models of coevolution 
(Figure 4.1). For example, if interacting proteins are not coevolving, but rather are pre-
adapted for their current interaction, then we might expect to see patterns of ancestral 
protein evolution consistent with pre-adaptation (Figure 4.1A) or a single adaptive event 
early in the clade’s history (Figure 4.1B).  Alternatively, if the protein shows evidence of 
rapid evolution in the clade of interest — consistent with expectations of ongoing 
coevolution — then different patterns of ancestral protein evolution would imply either 
arms-race coevolution (Figure 4.1C) or trench warfare coevolution (Figure 4.1D).   
We apply this approach to examine the evolution of a blood protein (vWF or 
vonWillebrand Factor) that has apparently evolved to confer resistance to the 
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coagulopathic effects of snake venoms in some species of South American opossums.  
Prior research (Jansa and Voss 2011) discovered that vWF is evolving rapidly in a group 
of opossums known to be resistant to snake venoms.  This finding suggests that vWF and 
its snake-venom agonist – the C-type lectin (CTL), botrocetin – might be involved in a 
co-evolutionary arms-race.  However, to test this idea, we require evidence that snake 
venom proteins can no longer bind vWF to induce coagulopathy in resistant opossum 
species.  Further, we require an understanding of how ancestral vWF proteins interact 
with these venom agonists.  To elucidate these interactions, we use a functional synthetic 
approach to engineer modern and ancestral vWF proteins and assay their sensitivity to 
venom agonists in order to assess both the contemporary and ancestral interaction of 
vWF and venom CTLs. These data address the contemporary function of vWF, whether 
phenotype evolution of this protein in opossums is consistent with a coevolutionary 
process, and if so, which dynamic— arms-race dynamic or trench warfare coevolution—
best describes this interaction.  
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Figure 3.1- Figure showing four evolutionary histories of traits hypothesized to be coevolving because of a 
matched phenotype with an interacting partner. In each panel the evolutionary history is indicated by 
colored arrows with inner arrows representing ancestral phenotypes. In this case only the phenotype in 
green is known for ancestral forms. The evolutionary history for this single green trait is mapped onto a 
phylogenetic tree to show what the expected pattern of ancestral phenotype evolution would be given each 
of these histories. Panel A and B show expected pattern of phenotype evolution for histories which are not 
consistent with coevolution. Panel C shows an expected pattern of phenotype evolution given either arms 
race coevolution also consistent with gradual adaptive evolution towards an unchanging selection pressure. 
Panel D shows the expected pattern of phenotype evolution given trench warfare coevolution also 
consistent with adaptive evolution towards and changing selection pressure.  
The Study System: Opossums and Pitvipers 
Snake venoms are a complex cocktail of proteins which include both enzymatic 
tissue-destroying proteins (e.g. metalloproteinases, phospholipases), as well as integrin-
like proteins (e.g. α-neurotoxins, C-type lectins), which target receptors involved in 
maintaining physiological processes (Markland 1998). Some venom C-type lectins 
(CTLs) are specialized to target vWF, causing disruption of normal blood coagulation. 
vWF is a multidomain protein (15 domains), whose main function is to initiate 
coagulation by binding to platelets in response to endothelial damage (Cruz et al. 2000). 
Botrocetin, a vWF-targeting CTL, functions by first binding tightly to the A1 domain of 
vWF, then inducing vWF to bind the platelet-associated glycoprotein GP1Bɑ, and finally 
binding to GP1Bɑ itself (Fukuda et al. 2005). This tri-molecular complex (botrocetin-
vWF- GP1Bɑ) is the ultimate source of coagulopathy, preventing vWF and platelets from 
functioning normally (Maita et al. 2003).  A second venom CTL, aspercetin, has been 
shown to induce coagulopathy via vWF, though the specific vWF domain(s) and platelet 
binding site it targets is unknown (Rucavado et al. 2001). Both botrocetin and aspercetin 
are derived from South American vipers (Bothrops jararaca and Bothrops asper, 
respectively), species that are known to be both prey and predators of various opossums 
(Oliveira and Santori 1999, Voss and Jansa 2012). A third vWF binding CTL, bitiscetin, 
is derived from an African viper (Bitis arietans) and is structurally and functionally 
similar to botrocetin (Hamako et al. 1996, Maita et al. 2003). Though many more vWF 
targeting CTLs likely exist within the genus Bothrops these are the only three that have 
been formally described to date (Read et al. 1979) 
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Some members of the South American opossum Tribe Didelphini (Voss et al. 
2009) are resistant to snake venom and are known to prey upon venomous snakes in the 
genus Bothrops including Bothrops jararaca (Vellard 1945, Wood 1954, Fitch 1960, 
Perales et al. 1986, Melo and Suarez-Kurtz 1988, Sazima 1992, Jared et al. 1998,  
Oliveira and Santori 1999, Almedia-Santos et al. 2000). Several species in this group are  
known to possess multiple mechanisms which render them resistant to venom, including 
specific inhibitors which neutralize enzymatic venom components such as 
metalloproteinases and phospholipases (Kilmon 1976, Werner and Vick 1977, Werner 
and Faith 1978, Mousattche et al. 1978, 1979, Perez et al. 1979,  Menchaca and Perez 
1981, Soto et al. 1988, Moussatche and Perales 1989, Catanese and Kress 1993, Perales 
et al. 1994, Lovo-Farah et al. 1996, Voss and Jansa 2012). In addition, the A1 subunit of 
vWF has been shown to be evolving under positive selection at sites associated with 
botrocetin binding in species within Didelphini (Jansa and Voss 2011). Physiological 
assays have further shown that opossum platelets from two species of Didelphini have 
lost almost all aggregation response to botrocetin, aspercetin, and bitiscetin (a third CTL 
from an African viper) (Chapter 3). However, this loss of platelet aggregation response 
was also recovered in a species of opossum outside Didelphini (Monodelphis domestica), 
suggesting either that resistance to vWF-binding CTLs might be a shared ancestral trait 
for all Didelphids, or that it has arisen multiple times during opossum evolutionary 
history (Chapter 3).  
Though tests of selection indicate that the vWF protein is rapidly evolving in 
Didelphini, these tests do not explicitly show that the causal selection pressure is indeed 
botrocetin, or that vWF has lost binding affinity for botrocetin. Furthermore, amino acids 
at the botrocetin-binding sites under positive selection in vWF differ among species in 
this clade, making it impossible to identify clear loss-of-function mutations by examining 
sequences alone, and indicating that there is likely functional variation among species. 
Therefore, testing the affinity of opossum vWF for venom CTLs is an important next step 
towards understanding the functional consequences of vWF evolution (Jansa and Voss 
2011, Chapter 3).  Moreover, synthesizing ancestral vWF proteins and assaying their 
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affinity for C-type lectins will extend our understanding of how coevolution may be 
shaping the interaction between these proteins. 
Materials and Methods 
Study Design. 
 We estimated the binding affinity between vWF A1 and venom CTLs 
(botrocetin, bitiscetin, and aspercetin) for several extant species from the tribe Didelphini, 
as well as species outside this clade, to assess the binding function of vWF across 
Didelphidae (Figure 4.2 Panel B). Species of Didelphini, and its sister taxon Metachirus 
nudicaudatus were chosen based on Jansa and Voss (2011). Though subsequent work has 
resulted in some species splits (Voss et al. 2018). Species within Didelphini are expected 
to be venom resistant based on several behavioral and experimental studies (Voss and 
Jansa 2012, Chapter 1), with the exception of Chironectes minimus, for which venom 
resistance status is unknown. Metachirus nudicaudatus was shown to be susceptible to 
venom injections from Bothrops jararaca, as two individuals tested died at 2x LD50 for 
mice, and has thus been assumed to be venom sensitive (Perales et al.1994). Other 
species outside Didelphini such as Monodelphis spp are assumed to be venom sensitive 
as they are small-bodied and common prey of Bothrops spp (Voss 2013). Monodelphis 
domestica was used, because it does not exhibit platelet aggregation in the presence of 
venom CTLs (Drabeck et al., in prep.), even though it is unknown it if is susceptible to 
pit-viper venom. We also included another species from this genus - Monodelphis emiliae 
– because we have observational evidence that pit-vipers attack and eat this species in the 
wild (Voss 2013).  The genus Monodelphis has several unique changes in vWF 
botrocetin-binding sites which may disrupt the interaction between the two molecules, 
but this has never been tested. Though we attempted to express species from other genera 
of Didelphidae (e.g. Gracilinanus) these did not successfully express in E. coli. Human 
vWF was also chosen for expression as its affinity for botrocetin and bitiscetin (a third 
venom CTL from an African viper Bitis arietans) has previously been shown, and thus 
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served as a gauge for venom and binding assay function (Hamako et al. 1998, Fukuda et 
al. 2005). 
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Figure 4.2- Panel A: Pruned time-calibrated tree from Jansa et al. (In Prep) used for reconstructing 
ancestral vWF sequences. Tribe Didelphini is highlighted in salmon. We refer to Didelphini as defined by 
Jansa and Voss (2011) for this work, with the updated taxon designation for a specimen previously 
identified as Philander frenatus, which is now Philander quica (Voss et al. 2018). In yellow are species 
whose vWF was selected for overexpression outside Didelphini (human not pictured). Panel B: Topology 
of Didelphini and other opossums whose vWF was selected for overexpression. Nodes are numbered with 
reference to the larger phylogeny shown in Panel A; only node numbers for nodes selected for 
overexpression are shown.  
 
 Finally, to investigate the how the venom CTL-vWF binding interaction may 
have changed during opossum evolution, we inferred several ancestral opossum vWF 
sequences, expressed them, and quantified their binding affinity for various venom CTLs 
(Figure 4.2).  
vWF Sequencing. 
 To express opossum vWF A1 protein, the entire sequence of the region used for 
previous expression studies on human vWF (residues 475-709) was required (Cruz et al. 
2000, numbering scheme Maita et al. 2003). vWF sequences from species within and 
outside Didelphini were used from a previous study (Jansa and Voss 2011); however, the 
N-terminal region (~207bp) of the vWF-A1 region (residues 475-543) was missing from 
these individuals. We therefore sequenced this upstream region and assembled it with 
existing sequences using a ~50 bp overlapping region. The vWF-A1 region was newly 
sequenced for three species, either because ambiguities existed in the original sequence, 
or because the sequence was not available (Appendix Table 4.1). Sequences for human 
and Monodelphis domestica were downloaded from whole genome sequences available 
from NCBI (Appendix Table 4.1).  
 Polymerase Chain Reactions (PCRs) were carried out in a 25 l reaction using 
0.5 l of 10 mM dNTPs, 15 l ddH20, 5 l 5X Phire reaction buffer (Thermo-Scientific), 
1 l each of 10 mM primer solution of forward and reverse primers, 0.5 l of Phire 
polymerase (Thermo-Scientific), and 2 l of template DNA. Primers DvWF_F1 and 
DvWF_R1 were used for the partial upstream sequence, DvWF_F1 and DvWF_R6 was 
used for sequencing the complete vWF region (covering residues 475-543) (Appendix 
Table 4.2). Reactions included a 30 second 98° C activation step, after which 35 cycles 
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were programmed as follows; 98° C for 5 seconds, 65° C for 5 seconds, and 72° C for 15 
seconds. Amplified PCR product was sequenced at the University of Minnesota 
Genomics Center for all species except Didelphis aurita, which was sequenced at the 
Instituto Butantan Laboratorio Especial de Toxinologia Aplicada (LETA). Permission for 
the capture and sampling of D. aurita was granted by SISBIO (permit #64934-1). 
Resulting sequences were edited and assembled in Geneious version 7.1.8. Upstream 
sequences were accessioned as amendments to the original sequence accession, and new 
sequences were accessioned separately (Appendix Table 4.1).  
 
Ancestral Sequence Reconstruction. 
 We used a codon model for maximum likelihood reconstruction of ancestral 
sequences. To infer ancestral sequences and compare alternative models of selection in a 
likelihood framework, we used the codon model (CODEML) implemented in PAMLx 
version 1.3.1, PAML version 4.9 (Xu and Yang 2013, Yang 2007, Randall et al. 2016). 
These analyses require two components; (1) vWF sequences from extant taxa, and (2) a 
tree with branch lengths for all species included (Xu and Yang 2013, Yang 2007). 
Complete vWF sequences described above (Appendix Table 4.1, excluding human and 
Didelphis aurita) as well as 28 additional opossum vWF DNA sequences (covering 
residues 543-709) from a previous study (Jansa and Voss 2011) were used to make a 39 
taxon vWF alignment in Geneious version 7.1.8 using MUSCLE (Edgar 2004) 
(Appendix Material 4.1- DidvWFAlign1.phy). An unpublished tree (Jansa et al., in prep.) 
resulting from Bayesian analysis of 6 genes (CYTB, BRCA, IRBP, and 3 nuclear introns) 
and 121 taxa with the same calibrations points as Jansa and Voss (2014) was pruned 
down to this same set of 39 species using R-package ape (Appendix Material 4.2 
DidvWFtree1.tre) (Paradis and Schliep 2018).  
 We used a likelihood ratio test to compare maximum likelihood models of 
selection in PAMLx version 1.3.1, PAML version 4.9 (Xu and Yang 2013, Yang 2007). 
Specifically, we compared the  distribution models M8 and M7 to test whether a model 
(M8) that allows for positive selection (dN/dS >1) was a significantly better fit than a 
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model that only allows for neutral or purifying selection (M7). We the M7/M8 
comparison as it is unconstrained by a priori designation of branches under positive 
selection, though Jansa and Voss (2012) used such a model (the branch-site test) to show 
positive selection in Didelphini. Subsequent data (Chapter 3) indicates that rapid 
evolution may be present throughout Didelphidae, and that species outside Didelphini 
may also be venom resistant. The relative fit of the two models was measured by the 
natural log of the likelihood ratio (), where -2[] under the null hypothesis was 
assumed to follow a χ2 distribution with two degree of freedom (Yang 2006).  
 Nine ancestral sequences generated under the best fit model (M8) were selected 
for expression in E.coli. These included all nodes within Didelphini as well as the most 
recent common ancestor of Didelphini with its sister taxa Metachirus nuducadatus 
(Figure 4.2).  We used parsimony to reconstruct a deletion at the N-terminal end of 
ancestral sequences as well as a single deletion event mid-sequence on the branch leading 
to Metachirus nudicaudatus (Appendix Figure 4.1). Maximum likelihood sequence 
inference was originally conducted using an alignment of 39 species based on sequence 
availability of vWF (Appendix Material 4.1 DidvWFAlign1.phy). Sequences of 
Didelphis aurita were subsequently generated for expression and added to the alignment 
(Appendix Material 4.3 DidvWFAlign2.phy). Re-estimation of ancestral sequences with 
the addition Didelphis aurita resulted in one amino change in one ancestor (node 70). 
This alternative ancestral sequence was not subsequently cloned and used for in-vitro 
expression. 
Gene Synthesis. 
 Extant and ancestral vWF sequences were edited in Geneious version 7.1.8 to 
contain N-terminal leader BamHI (5’- CACGGTAGC-3’) and C-terminal HinDIII (5’- 
TAACAAGCTTAA-3’) cut sites, optimized for E.coli codon usage, and submitted for 
gene synthesis by GenScript (Piscataway, NJ). Several sequences were identical at the 
protein level, and therefore synthesized only once: (Node 74, Philander mcilhennyi and 
Philander opossum), (Nodes 72 and 75), and (Node 76, 77 and D. marsupialis). A 
complete list of unique extant and ancestral constructs can be found in Appendix 
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(Material 4.5 Constructs.phy). Constructs were received inserted in a pUC57 backbone 
plasmid (Tai et al. 2013). 
 
Vector Construction. 
 A pQE9 plasmid vector containing an N-terminal 6-Histidine tagged Human 
vWFA1 fragment (residues 475-710) was kindly provided by Dr Miguel Cruz (Baylor 
College of Medicine). This plasmid was used for expression of human vWF and 
subsequently modified for expression of extant and ancestral opossum vWF (Cruz et at 
2000, Appendix Figure 4.1). Extant and ancestral opossum sequences were excised from 
pUC57 via BamHI/HinDIII restriction digest and ligated into purified pQE9 from which 
human vWF had been excised by the same digestion (Appendix Figure 4.1). pQE9 at this 
site has been engineered such that a ligated product will be placed directly downstream 
from a start codon and a 6-Histidine tag (Appendix Figure 4.1). For efficiency, a pQE9 
plasmid for Didelphis aurita was constructed by site-directed mutagenesis PCR on the 
Didelphis marsupialis pQE9 construct. Two protein coding differences at the binding site 
exist between these two species and were altered accordingly via Golden Gate Assembly 
(Engler et al. 2008). A single protein coding difference 4 residues from the N-terminus 
and outside the botrocetin binding site was not altered.  
 To isolate mutant plasmids, ligation product was transformed into chemically 
competent M15 cells and allowed to recover in LB media at 37° C for 1 hour before 
being plated on LB-ampicillin plates (50 μg/mL) and grown at 37° C overnight. Single 
colonies were picked, grown overnight in liquid LB with 100 μg/ml ampicillin, and 
plasmids were isolated via a QIAprep Spin Miniprep Kit (QIAGEN, Hilden, Germany). 
Isolated plasmids were checked for correct insert sequence by PCR amplification using 1 
μl each of a 10mM primer solution of PQE9 Insert F1 and PQE9 insert R3 0.5 μl 10mM 
dNTPs, 15 l ddH20, 0.5 l Phire polymerase, and 5 l 5X Phire buffer (Thermo-
Scientific) (Appendix Table 4.2). Reactions were run on a thermocycler using a 30 
second 98° C activation step, and 35 cycles as follows: 98° C for 5 seconds, 65° C for 5 
seconds, and 72° C for 15 seconds. PCR products were Sanger sequenced at the 
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University of Minnesota Genomics Center with the same primers. Sequences were edited 
and assembled in Geneious version 7.1.8; multi-species sequence alignments were 
created using MUSCLE (Edgar 2004). Vectors containing the correct inserted sequences 
were stored at -20° C for use in overexpression. A complete list of vWF constructs for 
extant and ancestral species can be found in Appendix (Materials 4.5 Constructs.phy).  
 
vWF Expression and Purification. 
 To produce active vWF protein capable of binding to venom CTLs in vitro, 
plasmid constructs were overexpressed and purified. Overexpression and purification was 
carried out as described previously (Cruz et al. 2000), with the following modifications. 
After addition of DNase, cell lysate was subjected to 3 minutes of sonication with a 6mm 
microtip (Q500, Qsonica), (5 seconds on, 5 seconds off) with a 50% duty cycle. 
Purification was carried out as described previously (Cruz et al. 2000). Briefly, sonicated 
lysate was centrifuged, and supernatant was discarded. Remaining inclusion body 
proteins were unfolded in 6M Guanidium-HCL, filtered, and refolded by dilution. Diluent 
containing refolded protein was applied to a 15 mL nickel column (GE Life Sciences) 
overnight and fractions containing vWF were eluted at 350 mM imidazole. While Cruz et 
al. (2000) use a heparin column for further purification, the heparin binding site in human 
vWF A1 is not conserved in opossums, thus we used an altered protocol to ensure a 
folded monomeric product. Once eluted off nickel column, fractions were dialyzed into 
100 mM Tris-HCl, 400 mM NaCl, 1 mM EDTA, pH 7.4 and applied to a 10 mL 
Thiopropyl Sepharose 6B column (GE Life Sciences). Folded protein was collected in the 
flow-through (Miura et al. 2000). Flow-through was then dialyzed in 10 mM Tris-HCL, 
100 mM NaCl pH 7.5 at 4° C overnight, and concentrated to 5 mL or less via 
ultrafiltration in a Vivispin 15 10,000 molecular weight cut off spin column (Sartorius, 
Goettingen, Germany). This concentrated sample was applied to a size exclusion column 
(16/600 200 pg Superdex, GE Life Sciences) and the final peak was collected as 
monomeric folded vWF A1. Product was concentrated via ultrafiltration, checked for size 
and purity on a Tris-glycine gel, quantified by absorbance at 280 nm (NanoDrop model 
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2000, Thermo-Scientific), aliquoted, and frozen at -80 until use. Purification was done for 
each protein separately on an ATKA FPLC (GE Healthcare). Purified vWF protein for 
each species/node were stored in separate freezer boxes and labeled individually 
throughout to avoid cross-contamination. 
 Sequences inferred from ancestral-state reconstruction were transformed and 
overexpressed months apart from each other (with the exception of nodes 72 and 73 
which were expressed on the same day) to reduce the possibility of samples being 
accidentally switched. As a control, vWF from Monodelphis domestica and Philander 
quica were expressed twice, months apart from one another. Resulting affinity 
measurements were comparable (Appendix Table 4.1).  
Venom Purification. 
 Aspercetin was purified as previously described (Rucavado et al. 2001), 
reconstituted and dialyzed into TBS (25mM Tris-HCL, 150nM NaCl pH7.4). Two 
isoforms of botrocetin were utilized.  One (‘botrocetin A’) was kindly gifted by Dr 
Robert Andrews, Monash University, and was among the batches used for the first 
studies of botrocetin structure and function (e.g. Dong et al. 2001). A second (botrocetin 
B) was purified from Bothrops jararaca venom as previously described (Chapter 3). Both 
samples botrocetin A and botrocetin B were the same isoforms used in Chapter 3.   
 Bitiscetin, a third vWF targeting CTL, is derived from the venom of a distantly 
related African viper (Bitis arietans) and has been shown to bind the vWF A1 domain 
and platelet receptor GB1Bɑ in a perpendicular conformation to botrocetin with several 
overlapping binding sites (Maita et al. 2003, Miura et al. 2000). Because bitiscetin is not 
proposed to be co-evolving with Didelphini, and is known to bind vWF A1 in humans, it 
was used as a positive control for assay function. Bitiscetin was purified as previously 
described and used to confirm that E. coli-expressed and refolded vWF A1 was capable 
of binding a venom CTL in the assay conditions described below (Chapter 3, Hamako et 
al. 1996). 
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Binding Assays. 
 Binding affinities for vWF and venom proteins were measured using a white 
light interferometry system, BLItz (ForteBio, Pall Corporation). Experimental design was 
optimized according to manufacturer recommendations (Sultana et al. 2015). The BLItz 
design was chosen as it allows for data collection of each binding interaction with 
extremely small volumes of venom protein (4 μl/curve), and therefore extended the 
ability to collect data given very limited sample volumes. Each binding curve is obtained 
by first immobilizing vWF (the ligand) to a surface, and then exposing it to a venom CTL 
(the analyte). Association and dissociation of analyte is observed in nearly continuous 
time, resulting in a directly observed binding curve (association and dissociation). 
Because curves from multiple concentrations of an analyte are required for accurate 
equilibrium estimation of binding affinity, each assay used 4-7 concentrations of analyte 
(CTL), resulting in 4-7 binding curves for each vWF-CTL pair (Shah and Duncan 2016). 
Where possible, replicate assays were run. However, because of limited sample volume 
for venom proteins, replicate assays for all species of vWF were not possible. Where 
replicate assays were possible, variation of resulting binding affinity was low in both 
tight and loose binders (Figure 4.3). Additional measures of assay accuracy are described 
below.  Samples of venom and vWF were stored in separate boxes before and after data 
collection, and Human vWF A1 was used to spot-check venom protein activity 
periodically throughout data collection. A complete list of data collected for each vWF 
and venom protein pair by date can be found in the Appendix (Appendix Table 4.3).  
  Venom proteins (botrocetin A, botrocetin B, aspercetin, and bitiscetin) and vWF 
A1 aliquots were thawed from -80° C storage on ice and all samples were stored on ice 
until immediately prior to use. Both vWF and venom proteins were diluted into a buffer 
containing 25 mM Tris, 150 mM NaCl 1% BSA, 0.05% Tween 20, pH 7.4. vWF was 
diluted into test buffer to an approximate concentration of 200 nM for loading on to the 
chip. Venom proteins were serially diluted into concentration series which were 
appropriate to each KD, as low concentrations series are required for tight binders, and 
higher concentrations series are required for loose binders. Binding affinity was measured 
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on a BLItz instrument (ForteBio, Pall Corporation). Both HS1K (anti-histidine antibody) 
and NiNTA (Nickel) chip tips were used to immobilize vWF A1 onto the chip surface. 
This was done because HS1K chips loaded with vWF recovered tight binding to 
botrocetin and aspercetin, however, they loaded some forms of vWF poorly. NiNTA 
chips loaded all vWF forms well, and recovered tight binding with bitiscetin, but a 
reduced binding to botrocetin and aspercetin when compared to the same assays done on 
HS1K chips. As bitiscetin binds vWF at the same sites as botrocetin but in a 
perpendicular conformation, this difference is likely due to conformational differences of 
vWF when it is immobilized on each chip (Maita et al. 2003). To recover binding for 
vWFs which bound better to NiNTA than HS1K or vice versa, both chips were used. To 
compensate for KD differences between chips, KD for human samples (tight binders) were 
compared between chips and the derived ratio was used to scale binding data between 
data gathered on different chips. Botrocetin B NiNTA results (KD, ka, and kd) were 
divided by 7.59, bitiscetin HS1K results (KD, ka, and kd) were divided by 7.78.  
 Per manufacturer recommendations, biosensors were incubated in buffer for ten 
minutes prior to each test. Kinetic data collection was performed with a 30 second buffer 
baseline, followed by a 120 second loading step in which 4 μl of vWF A1 was exposed to 
the biosensor chip surface. This was followed by a second baseline for 30 seconds, an 
association phase of 60-120 seconds in which 4 μl of various concentrations of venom 
protein were allowed to associate to the chip, and a disassociation phase of the same 
length (either 60 or 120 seconds) where the biosensor was returned to buffer. A sample 
containing no venom protein was used to calibrate machine noise and subtracted from all 
curves, as is standard (Sultana et al. 2015). Association and disassociation times were 
chosen as sufficient time for the CTL to reach equilibrium association to vWF, as well as 
disassociation of more than 50% (Sultana et al. 2015). Nonspecific binding assays were 
performed by using a blank buffer for loading, and a sample containing the venom 
protein at up to the second highest concentration used for each curve series on each chip. 
Nonspecific binding was visually observed as a flat line for each CTL on each chip type, 
confirming no nonspecific binding, and not further analyzed (Sultana et al. 2015)  
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Data Analysis. 
 Raw kinetics data were globally fit to a 1:1 binding model using the BLItz Pro 
software v1.2.1.3. This software optimizes the observed association constant (kon), 
dissociation constant (koff), and Rmax (the maximum binding of the venom protein, given 
the amount of vWF on the biosensor surface) over multiple curves (serial dilutions). 
BLItz Pro software then uses these optimized values to calculate an equilibrium constant 
KD, where KD for a given Analyte (A) and Ligand (L) is 
[𝐴][𝐿]
[𝐴𝐿]
=
koff
kon
 = KD,  given a 1:1 
binding model. A 1:1 binding model was used as both botrocetin and bitiscetin have been 
shown to bind in a 1:1 conformation with vWF A1 (Maita et al. 2003, Fukuda et al. 
2005). For a full description of curve fitting and affinity calculations see Appendix 
Materials 4.6. Curve sets were optimized by local fitting first, and curves which both had 
extremely low R2 values and significantly changed the globally calculated KD and R
2 
were excluded per recommendation by the manufacturer (ForteBio, Pall Corporation). All 
resulting kinetics estimates were extrapolated from a minimum of 3 curves 
(concentrations of CTLs).  All data estimated from the global fit for each curve set (vWF-
venom protein pair) were exported into a CSV file for further analysis.   
 Summary statistics and subsequent analyses of binding curve data extracted from 
BLItz software were calculated in JMP Pro version 14.0.0 (SAS Institute). Variance in 
KD is right skewed as larger numbers (higher KD) will have associated larger error. A 
standard least squares regression was used to assess the assumption that error (variance) 
will increase with weaker binding, and identify data points that exhibited variance which 
was higher than expected (outside a 95% CI), above the regression curve. These data 
points are further addressed in the results. Because of the skewness of this data, KD was 
log10 transformed for subsequent analyses. Log transformed KD was also regressed 
against variance to determine resolution of skewness. As each exported assay has an 
associated KD and R
2 value, R2 was regressed with KD to determine if goodness of fit (R
2) 
reduced with increasing KD, which would indicate systemic poor fit for high KD values.  
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 To test how differences in on-rates (Kon) and off-rates (Koff) influence binding 
loss, data were grouped into binders (1 to 
1
3
 human binding), and non-binders (< 
1
3
 human 
binding). We chose this value because a 3 fold error is the reported expectation for error 
between BLItz measurements, though our standard error between KD measures were 
much lower that this. A 3 fold change in binding therefore represents the smallest binding 
change which could not feasibly be due to measurement error, and is therefore likely to 
be biologically relevant. Non-parametric Wilcoxon tests were used on log-transformed 
Kon and Koff to assess differences between these groups (binders and non-binders).  
Parsimony Reconstruction of Binding Phenotypes. 
 Estimates of ancestral phenotypes can be quite misleading when processes of 
molecular evolution are not adequately accounted for.  To assess whether inferred 
ancestral binding affinity differed from actual measured affinity of expressed proteins, we 
estimated phenotypes (binding capacity) for the same nodes used for in-vitro expression 
for botrocetin A, botrocetin B, and aspercetin using phylogenetic inference of whole trait 
reconstruction. Binding capacity of extant vWF from biophysical assays was divided by 
human binding capacity for the same protein to generate a relative binding capacity and 
was used to generate predictions of ancestral node relative binding. Because relative 
binding spans values from 0.17-10000X, binding loss was coded by binning relative 
binding loss by increments of 5x binding loss: (1) 0-5x, (2) 6-10x, (3) 11-15x, (4) 16-20x, 
(5)>20x, and (6) no detectable binding (NDB) and treated as a discrete ordered trait. The 
same 121 taxon tree with branch lengths was pruned down to include only species within 
Didelphini and sister taxon Metachirus nudicaudata with the function drop.tip in 
Phytools (version 0.6-60). As Philander mchilhennyi had an identical vWF A1 protein 
sequence (and therefore phenotype) as Philander opossum, it was also pruned collapsing 
these two species into one, and collapsing their identical ancestral nodes (73 and 74) 
similarly into one node. We used several methods to reconstruct node states (parsimony 
and maximum likelihood) which all yielded similar results. Here we present results for 
squared change parsimony trait reconstruction done in the R package castor (function 
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asr_squared_change_parsimony, version 1.3.6) with unweighted transition costs 
(weighted= FALSE) (Maddison 1991, Louca and Doebeli 2017).  
 
Results 
Reconstruction of Ancestral vWF Sequences. 
 Consistent with previous work, an M8 model that allows a proportion of 
positively selected sites (with a dN/dS >1) was a significantly better fit than an M7 model 
that does not (Jansa and Voss 2011). This was true for both analyses with Didelphis 
aurita (-2·ln[] =114.5, d.f. = 2), and without Didelphis aurita (-2·ln[] =112.8, d.f. = 2) 
(Yang 2000, Jansa and Voss 2011). Inferred ancestral sequences from this model for 
nodes 69-77 were selected for expression (Figure 4.2). A total of 5 ancestral sequences 
were reconstructed representing 9 nodes, all of which had high marginal likelihood 
(<90%) for sites within and surrounding botrocetin binding regions (Appendix Material 
4.5 Constructs.phy). Referring to node labeling in Figure 1, nodes 72 and 75 were 
identical to each other, node 76 and 77 were identical to Didelphis marsupialis, and node 
74 was identical to both P. mcilhennyi and P.opossum. The addition of Didelphis aurita 
to the maximum likelihood reconstruction resulted in one amino acid difference in node 
70 at a single botrocetin binding site (Site 636 L→ R): this alternative ancestor was not 
subsequently engineered or expressed.  
 
Assessment of Kinetic Data Reliability   
Extant Data Assessment  
 As synthetic refolded protein is not guaranteed to be recovered in an active 
conformation, Bitiscetin was used as a control to assess the ability of synthetic and 
refolded vWF (from inclusion bodies) to bind normally,. Normal binding curves were 
observed for vWF of all species with bitiscetin except Philander opossum, and thus is the 
only species for which loss of binding may be due to the expression/purification process 
(Figure 4.3). Separately expressed batches of M. domestica and P. quica were used for 
bitiscetin (batch 1) and botrocetin B (batch 2) assays and produced comparable binding 
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affinities (Figure 4.3). As is expected for kinetics data, measurement error increases with 
the magnitude of KD. When average KD is regressed with standard error a linear 
relationship is recovered (R2= .90, P<0.0001). The only standard error value which falls 
above the 95% CI of this linear relationship is Monodelphis emiliae (for botrocetin B), 
though the range of this variation does not change the broad interpretation of binding loss 
relative to human (Figure 4.3). Mean Log-transformed KD regressed with variance 
showed no relationship (R2=0.03, p=0.48). Individual Log10 (KD) regressed with its 
associated R2 generated by BLItz model fitting also showed no significant correlation 
(R2=0.03, p=0.12), indicating that log transformed data for both tight and loose binders 
are robust, including data which surpass the 1 μM limit of detection for BLItz. 
 The level of binding loss with respect to human vWF for botrocetin B across 
Didelphini is much less than that of botrocetin A.  Between these samples we know that 
human platelets aggregate with botrocetin A, and its KD for human vWF is 766 nM, 
whereas Didelphis virginiana platelets do not aggregate when exposed to botrocetin A 
and its vWF has a KD for it of 25800 nM. For botrocetin B we know that human platelets 
aggregate in response to it, and it has a KD of 50nM with its vWF. Whereas botrocetin B 
does not aggregate Didelphis aurita platelets and it binds to its vWF with a KD of 428nM. 
This suggests that botrocetin A can induce aggregation even when binding fairly loosely 
to vWF (with a 766 nM KD), while botrocetin B cannot  as it fails to aggregate at 428nM, 
and requires a much tighter interaction to induce binding (50nM KD).  
 Previously reported KD derived from radiolabeling assays report a KD for 
botrocetin and human vWF at 23 nM (Miura et al. 2000), though this assay was 
performed with an immobilized C-type Lectin, whereas our design immobilized vWF A1, 
which may account for differences in binding results. We recovered equilibrium 
constants for botrocetin B as 55.15 nM (SE±3.74 nM), quite similar to previously 
reported KD, and botrocetin A as 766 nM (SE± 5.84 nM), a much higher KD than 
previously reported.  The low binding observed for botrocetin A could be considered 
suspect because the sample provided from the Andrews lab was at least several years old 
(Dr Robert Andrews Pers Comm) and could have experienced some degree of 
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degradation. However, if this was the case, the botrocetin A sample should have 
exhibited at least some observable reduction in ability to aggregate human platelets, 
which was not observed (Chapter 3).  
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Figure 4.3- Log10 KD [M] for vWF A1 against four venom proteins A. botrocetin A, B. botrocetin B C. 
aspercetin D. bitiscetin. Binding loss above -4, indicated by grey circles are data with no detectable binding 
curves (flat lines) and represent an arbitrarily low binding affinity. All other data points are derived from 
binding curve data. Data points with low R2 values (0.91-0.95) are indicated by empty circles. As an R2 
value of >0.96 is generally used as a rule of thumb for acceptable data, KD measurements with R2 values of 
0.96 or greater are indicated by black circles. Standard quantile box plots show a line at the median and 
enclose the 25th and 50th quantiles of the distribution. The line extending across each graph represents 
mean Human Log10 KD. All graphs scales are identical.  
 
 
Ancestral Data Assessment  
 Because all synthesized ancestral proteins produced measurable binding (some 
quite substantial) for at least one venom protein, all were presumed to be functionally 
folded. The sole function of bitiscetin in these assays was to confirm the ability to bind to 
the chip and produce measurable binding data (qualities of being functionally folded), 
therefore no bitiscetin data were not gathered. Variation among replicates was similar to 
data from extant proteins (Figure 4.4), with the exception of node 72 for aspercetin which 
had no detectable binding in one replicate and very little binding in a second replicate, 
with a notably low R2 (0.94). This likely indicates that this protein is a weaker binder than 
is indicated by parameters estimated from the poor curve fit, and is on the border of 
detectable binding (50-200μM). However, the range of this variation does not change 
interpretation of a large binding loss relative to human. Similar to results from proteins 
representing extant species, several data points exceeded the detection limit of 1μM, but 
exhibited low variance and high R2 in for globally fit binding curves. 
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Figure 4.4- Log10 KD for ancestral vWF A1 nodes against venom proteins. Panel A- botrocetin A, Panel B- 
botrocetin B, Panel C- aspercetin.  Binding loss above -4, indicated by grey circles are data with no 
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detectable binding curves (flat lines) and represent an arbitrarily low binding affinity. All other data points 
are derived from binding curve data. Data points with low R2 values (0.91-0.95) are indicated by empty 
circles. Data with R2 values of 0.96 or greater are indicated by black circles). Standard quantile box plots 
show a line at the median and enclose the 25th and 50th quantile of the distribution. The line extending 
across each graph represents mean extant Human Log10(KD) for reference.  
 
Kinetics Results for Extant Taxa.  
  We report average KD values for human vWF A1 for botrocetin B as 55.15 nM 
(SE±3.74 nM), botrocetin A as 766 nM (SE± 5.84 nM), bitiscetin as 19.2 nM (± 0.337 
nM), and aspercetin as 2180 nM (SE± 485 nM). These results, as well as estimated KD 
values for opossum species, are summarized in Figure 4.3.    
 Several species of vWF exhibited no binding curves i.e. flat lines, when 
challenged with a CTL. This lack of response indicates either a complete lack of binding, 
or a binding constant which is higher than our capacity to measure it given CTL 
concentrations and/or system detection limits. Flat lines or binding curves which were too 
small to be meaningfully fit to a binding model were therefore assigned a KD value of 
200 μM, in order to be included in analyses. This value is 4 times the largest KD we were 
able to measure and one order of magnitude larger than expected machine error (3X KD). 
Thus, this number represents the tightest KD that could have been present but undetected 
as a result of the machine detection limitations of BLItz.  
 Binding loss for venom CTLs relative to human was observed both for species 
within and outside of clade Didelphini (Figure 4.5). All opossums showed binding loss 
when compared with human for both isoforms of botrocetin and bitiscetin (Figure 4.5). 
All but two species showed binding loss for aspercetin (Figure 4.5). All species known to 
exhibit total physiological resistance via loss of aggregation response for a botrocetin (A 
or B) and bitiscetin showed vWF-CTL binding loss between 8-36 fold (Figure 4.5). 
Didelphis aurita vWF A1 bound to botrocetin B with an 8 fold lower affinity than human 
vWF, but is known to have no aggregation response when its blood is exposed to this 
venom protein (Chapter 3). Because we know this species has a complete loss of 
physiological response given an 8-fold loss of binding we can surmise that an 8-fold 
binding loss is sufficient to abolish aggregation response. Using this as a benchmark, we 
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can interpret that the remaining species which have greater than 8-fold binding loss 
would not exhibit aggregation in response to botrocetin, bitiscetin, or aspercetin (though 
two species show tight binding to aspercetin).Two species’ vWF A1 that bound to 
aspercetin showed binding tighter than that of human vWF A1 (Figure 4.5).  
 
Figure 4.5 - Relative binding loss across the clade Didelphini and outgroup species. Binding loss is 
expressed as a multiple of loss from human binding (divided by human KD). Heat map reflects the range of 
binding loss in increments of 5x up to 20x. This same 6 category classification is used for ancestral state 
reconstruction in Figure 4.6. NDB indicates no detectable binding. (*) species whose platelets have not 
aggregated in the presence of the venom protein indicated, and (Ϯ) have shown partial aggregation when 
compared to human samples, which aggregate completely (Chapter 2).  
Kinetics Results for Ancestral vWF.  
 Kinetic data for proteins representing ancestral nodes was collected for 
botrocetin A, botrocetin B, and aspercetin. Relative binding loss of ancestors mapped to 
their location on a topology of Didelphini shows a remarkable pattern of repeated loss 
and gain of binding for botrocetin A and botrocetin B (Figure 4.6). This contrasts with 
the parsimony reconstruction of phenotype states (binding vs. non-binding) predicted 
from extant species (Figure 4.6). Large magnitude transitions in binding for these two 
proteins occur 4 times across internal nodes, and 4 times convergently in branches 
leading to extant taxa. Notably, this pattern is nearly in perfect opposition between the 
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two isoforms of botrocetin; as a reconstructed protein loses affinity for one isoform, it 
gains it for another. Switches from gain to loss are seen for aspercetin a total of 2 times 
across nodes, with convergent loss of binding in 5 branches leading to terminal taxa 
(Figure 4.6). Nearly all ancestral opossums bind strongly to aspercetin, while all extant 
taxa except Didelphis virginiana don’t bind it at all. Only reconstructed ancestors of the 
genus Didelphis have lost binding in a way that matches extant taxa in a similar pattern to 
the parsimony reconstruction for this genus, and show that D. virginiana has regained 
binding for aspercetin (Figure 4.6).  
 
   
 
Figure 4.6- Relative binding of ancestral nodes of vWF A1 mapped onto a species topology. On left is the 
actual binding capacity of each node measured via biophysical assays of heterologously expressed ancestral 
protein. On right is the predicted phenotypes of the nodes based on a squared change parsimony 
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reconstruction of phenotypes given the binding data from tips. Asterisks indicated identical protein 
sequences Philander opossum and Philander mcilhennyi collapsed as one tip taxa, subsequent nodes (node 
73 and 74) from Figure 1 are also identical and collapsed into one node. Panel A- botrocetin A, panel B- 
botrocetin B, C- aspercetin. Heat map indicates loss of binding with darkening shades, with increments of 
0-5x, 6-10x, 11-15x, 16-20x, >20x, and NDB, identical to Figure 4.4. Number at each node indicates actual 
multiple of binding loss relative to human (KD divided by human KD). NDB at tips and N at nodes indicates 
no detectable binding.  Extant relative binding is shown at the tips for reference. Node numbers correspond 
to Figure 4.2 and are labeled under each node’s relative binding. 
Influence of Kon and Koff.  
 To assess the influence of on and off-rates in binding loss we grouped all 
botrocetin A, botrocetin B, and aspercetin extant and ancestral data for which complete 
binding curves could be estimated. Species and ancestors were grouped as binders if they 
bound at 0.1-3 fold human binding loss (n=17), and grouped as non-binders if they 
exhibited binding loss greater than 3 fold (n=68). This value was chosen as a cut-off as a 
3 fold maximum expected error between replicates for BLItz measurements, though our 
error between replicates was never this high. A three-fold difference in binding likely is 
the smallest binding change which is not expected to be recovered from measurement 
error alone. Binders did not have significantly faster on-rates from non-binders (p=0.07, 
χ2=5.2, df= 2). However, binders did have significantly slower off-rates when compared 
to non-binders (p=0.0007, χ2= 14.5, df= 2). 
 
Analysis of Sequence and Functional Data  
 Seven sites within the botrocetin binding pocket exhibit independent changes 
across Didelphini, while 18 sites exhibit convergent changes across this clade, making it 
difficult to discern which are vital to functional binding loss by examination of sequence 
alone (Jansa and Voss 2011). Though sites evolving under positive selection narrow this 
pool, they cannot identify specific amino acid changes responsible for binding loss (Jansa 
and Voss 2011). The addition of functional data from reconstructed ancestral proteins 
allowed us to identify branches that exhibited extreme loss of binding (>10 fold binding 
loss) either between nodes or from nodes to tips (Table 4.1).  
 Using this approach we identified six branches exhibiting such loss for botrocetin 
A, 3 for botrocetin B, and 5 for aspercetin. Among these branches, multiple instances of 
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site convergence were observed (Table 4.1, Figure 4.7). The sites repeatedly associated 
with >10 fold loss of binding are summarized in Table 4.1. One site exhibited an 
additional level of convergence, having the same amino acid change multiple times at the 
same site (Table 4.1). Eight sites in total were associated with >10 fold loss of binding of 
venom proteins, and overlapped closely but not entirely with either botrocetin binding 
sites, or sites identified to be evolving under positive selection (Figure 4.7) (Jansa and 
Voss 2011).  
 
Figure 4.7- Protein alignment of Didelphini. vWF sites associated with multiple independent instances of  
>10 fold binding loss are enclosed in boxes, venom protein(s) for which binding loss is associated is 
denoted above the box. A- botrocetin A, B- botrocetin B, C- aspercetin. Known botrocetin binding sites are 
marked with a circle, and sites evolving under positive selection per Jansa and Voss et al. (2011), are 
denoted with an asterisk. Region 624-677 is shown as it encompasses the two botrocetin binding pockets 
(624-645), and (655-677) highlighted in blue. Majority amino acids are in grey, and variants are denoted in 
black.  
 
 
Site Change Branch Binding loss for  
628* 
deletion node 69→Me. nudicaudatus botrocetin A 
L→F node 76→D. albiventus botrocetin A 
630 
M→I node 71→ L. crassicaudata botrocetin A, aspercetin 
M→K node 69→Me. Nudicaudatus botrocetin A, aspercetin 
631 
A→G node 71→ L. crassicaudata botrocetin A, aspercetin 
A→G node 73→P. quica botrocetin A, aspercetin 
A→D node 69→ Me. nudicaudatus botrocetin A, aspercetin 
633* 
S→L node 69→Me. nudicaudatus botrocetin A 
S→G node69→node 70 botrocetin A 
635* 
D→E node 70→C. minimus botrocetin B, aspercetin 
D→G node 70→ Node 71 botrocetin B, aspercetin 
636* 
R→H node 77→ D. aurita botrocetin A 
R→L node 69→node 70 botrocetin A 
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639* 
Q→R node 70→ C. minimus aspercetin 
Q→H node 69→ Me. nudicaudatus aspercetin 
668 
Q→K node 69→node 71 botrocetin A 
E→A Node 71→ node 72 botrocetin A 
Table 4.1- Sites which are associated with >10 fold binding loss at least twice (on two branches 
independently) within Didelphini + Metachirus nudicaudata. Sites in bold are known botrocetin binding 
sites, and sites with asterisks are evolving under positive selection per Jansa and Voss (2011). Changes 
with the exact same amino acid changes are colored in grey.  
 
Discussion 
Ancestral reconstruction and in-vitro testing of vWF A1 phenotypes show the 
capacity for large losses and gains of binding capacity in single steps, repeated loss and 
gains of function across ancestors, and convergent loss of function across species. 
Though vWF A1-CTL binding loss was expected to be found exclusively in the Tribe 
Didelphini, it was instead found to be more widespread across the family Didelphidae. 
These results suggest that both trench warfare coevolution and convergent evolution have 
played important roles in the evolution of resistance to venom CTLs in opossums.  
 
How Ancestral Binding Results Inform Coevolution.  
 Kinetic testing of ancestral vWF A1 shows a pattern of repeated loss and gains 
of function across nodes. This pattern diverges from the expectation of phenotype 
evolution under a simple parsimony reconstruction of binding affinity (Figure 4.6). While 
surprising, results from Jansa and Voss (2011) showing strong positive selection suggest 
that coevolution may be working on vWF A1. Data from ancestral binding reveal that 
trench warfare rather than arms race coevolution is likely the dominant process at work in 
this system. Ancestral binding results also reveal several cases of unexpected—cryptic—
convergent evolution.  
 The mismatch between observed in vitro reconstruction and trait reconstruction 
in this study likely stems partially from an overly simplified model of trait change which 
is not meant to handle traits with complex genotype-phenotype interactions like protein 
binding which can jump between states not represented in tip taxa in a saltatorial manner 
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(Webster and Purvis 2002, Wiens et al. 2006). Secondarily, assumptions of these models 
do not account for more complex evolutionary dynamics such as coevolution. Though 
ancestral sequences expressed in vitro also used models of evolution to predict ancestral 
states, they differ as they rely on models of codon evolution which do not make broad 
assumptions about the basis and mode of complex whole-trait evolution (Yang 2006, 
Dean and Thornton 2007, Randall et al. 2012, Harms and Thornton 2013). Thus, this 
method is more capable of recovering unusual tempo and mode which are not allowed in 
models of whole-trait evolution (Dean and Thornton 2007, Randall et al. 2012, Harms 
and Thornton 2013).  
 Data presented here show a departure from expectations commonly assumed in 
models of trait evolution (gradual evolution) and stress the importance of ancestral 
reconstruction and testing in uncovering otherwise hidden evolutionary histories. Models 
of trait evolution in this case would likely never recover the pattern seen in in vitro 
testing as vWF A1 binding capacity varies in a continuous manner, but is capable of large 
jumps in trait values in single steps.  Though increased taxon sampling may result in 
increased resolution of change in deeper nodes (and may in fact be more gradual), at least 
one set of sister taxa (Didelphis aurita and Didelphis marsupialis) differ by two changes 
at the binding site which abolishes binding of botrocetin A. This demonstrates that at 
least to some degree few changes of large effect can abolish binding and suggests that 
saltatorial change is important in the evolution of this interaction.  
 These data also exhibit a trajectory uncharacteristic of simple adaptive evolution. 
While adaptive evolution for an unchanging selection pressure would predict states 
evolving unidirectionally (Figure 4.1 Panel B and C), actual ancestral trait data here show 
a distinct pattern of loss and gain across nodes, with repeated convergence between 
species (Figure 4.6). Such losses and gains (as well as repeated convergence) are 
expected in models of trench warfare coevolution, referred to as phenotype matching 
coevolution in Nuismer (2007) (Figure 4.1 Panel D). This pattern of functional flipping is 
strongest for the botrocetin isoforms, and less so for aspercetin, which may be a further 
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reflection of either its flexibility in target (A2, or A3) or the GP1Bɑ site being a more 
important player in the latter interaction. 
 Utilizing the framework of the functional synthesis, we have reconstructed the 
pattern of evolution in one interacting gene and uncovered a cryptic evolutionary mode 
(convergence and repeated loss and gain of function) which is consistent with that 
predicted by trench warfare coevolution (Thompson 1994, Jokela et al. 2000). Though 
these data add to previous evidence that opossums and pit-vipers may be coevolving, the 
pattern recovered here could also be explained by intermittent selection for binding loss, 
where very high cost drives reversals when selection is not present. This pattern may also 
be consistent with opossums expanding their diet to multiple species of Bothrops with 
differing CTLs, essentially mimicking reciprocal venom changes via prey-switches. 
Ultimately, further work reconstructing the history of venom vWF-binding CTLs and 
testing ancestral botrocetins in vitro would be necessary to confirm the assertions that 
venom CTLs are in fact evolving reciprocally with opossum vWF. With recent advances 
in snake venom genomics and venomics (Holding et al. 2018, Amazonas et al. 2018) as 
well as recent work in developing an in vitro expression system for botrocetin (Matsui et 
al. 2017), this system in uniquely poised to characterize reciprocal functional and 
molecular changes in ancestors for both interacting partners in a natural system; a goal 
that has remained elusive in coevolutionary work thus far (Lovell and Robertson 2010, 
Scanlan et al. 2011). 
   
The Role of vWF in Venom CTL Resistance 
Botrocetin: 
 Here we show that vWF A1 from the majority of opossums within and outside 
Didelphini have lost binding to two isoforms of botrocetin. All species that were 
previously shown to have near complete loss of platelet aggregation response for 
botrocetin showed a substantial loss of vWF A1 binding by botrocetin, suggesting that 
this protein interaction plays an important role in the observed physiological resistance to 
this venom protein (Chapter 3).  
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 The threshold of binding needed for aggregation loss seems to be much higher 
for botrocetin A compared to botrocetin B, suggesting that these proteins may differ 
substantially both in underlying amino acid sequence and functional potency. Given that 
botrocetin A did not show reduced aggregation response, and that binding in ancestral 
vWF differed between these isoforms not just by magnitude but in pattern (botrocetin A 
bound ancestors that botrocetin B did not), we assume that differences between 
botrocetin A and B are due to variation in the amino acid sequence, as opposed to 
preparation quality or degradation. This kind of functional diversification is consistent 
with rapid evolution in response to a constantly changing, coevolving target. Future work 
using broader taxon sampling of Botrocetin-like CTLs and population level studies of 
CTL diversity may shed light on the sequence and functional variation of Botrocetin like 
CTLs in the genus Bothrops.  
 Though previous workers have observed variation in botrocetin activity by batch 
(R. Andrews, pers. comm.), our work is the first to report variation in KD. Between these 
samples a 36-fold vWF binding loss appears to protect Didelphis virginiana from 
botrocetin A- induced aggregation, whereas an 8-fold loss of vWF binding appears to 
protect Didelphis aurita from botrocetin B. A possible explanation for this may be in the 
tertiary complex of vWF-botrocetin-GB1bα, as botrocetin must first bind to vWF and 
then bind efficiently and persistently with GP1Bα in order to initiate an aggregation 
response. Botrocetin A may retain its potency even with relatively low affinity for vWF, 
as long as it retains its ability to bind tightly with GP1bα and initiate aggregation. 
Similarly, botrocetin B may bind as tightly or even more tightly to vWF but may have a 
reduced ability to bind to GP1Bα, raising the threshold of vWF binding loss required for 
a loss of aggregation response in in vitro assays. These suggest that a secondary mode of 
resistance (GP1Bɑ binding) is likely playing a supporting role in botrocetin B resistance. 
However, confirmation of amino acid differences between these two isoforms in needed 
to confirm this result.  
 
Bitiscetin: 
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              Bitiscetin has been previously reported to have a KD for human vWF A1 of 2 
nM, a value obtained by surface plasmon resonance, with no associated replicate number 
or error estimates (Maita et al. 2003). While we report a KD nearly ten times this value 
via our immobilized vWF assay, our assay showed high replicability and low error. 
Bitiscetin also bound nearly every species of vWF (except P. opossum), though all 
species showed significant binding loss relative to human vWF. This is likely a result of 
the overlap in binding sites shared between these two venom proteins. Of 15 known 
bitiscetin binding sites, 13 are within the botrocetin binding pocket, 5 directly overlap 
with botrocetin binding sites, and another 5 are directly adjacent to a botrocetin binding 
site (Maita et al. 2003). Given this, it is not surprising that we saw a greatly reduced 
affinity (though still larger than botrocetin A, and very similar to botrocetin B) for 
bitiscetin in nearly all species tested with respect to human (Figure 4.4). Furthermore, 
previous work has shown that Didelphis virginiana platelets do not aggregate in response 
to bitiscetin, consistent with these data (Chapter 3).  
 
Aspercetin: 
 Aspercetin bound with the lowest affinity for human vWF A1 (2180 nM), 
though it has been shown to exhibit vWF specific aggregation (Rucavado et al. 2001). 
These data suggest that aspercetin may not primarily target vWF A1, but may target vWF 
flexibly via the A2 or A3 domains, similar to bitiscetin (Hirotsu et al. 2001). While 
binding loss for aspercetin was nearly ubiquitous in opossums, vWF from two species 
(Didelphis virginiana, and Monodelphis emiliae) bound aspercetin more tightly than 
human vWF. Puzzlingly, though Didelphis virginiana exhibit partial (though variable) 
loss of aggregation response to aspercetin, it bound nearly 6 times more tightly than 
human vWF A1 (Chapter 3, Figure 4.4). Another species, Didelphis aurita, showed 
complete binding loss for aspercetin as well as complete physiological resistance (no 
aggregation response; Chapter 3). These data further suggest either that aspercetin may 
not primarily target vWF A1, or that the tertiary interactor (GP1Bα) may be a more 
important factor in resistance to aspercetin, or both. Further work examining aspercetin’s 
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capacity to bind vWF A1, A2, A3, and GB1Bα across taxa would serve to distinguish 
these hypotheses.  
 
vWF Resistance Outside Didelphini.  
 Chapter 3 showed that Monodelphis domestica exhibits physiological resistance 
to botrocetin measured in lack of platelet aggregation response. Kinetics data reported 
here from botrocetin are consistent with the results of Chapter 3, and further suggest that 
Metachirus nudicaudatus and Monodelphis emiliae likely also exhibit physiological 
resistance to botrocetins. If we use the 8-fold loss of binding seen in D. aurita as a 
threshold for protection for all venom CTLs, we can predict that all species tested in this 
work are resistant to all CTLs except D. virginiana and M. emiliae for aspercetin. The 
general agreement of physiological data from previous work and kinetics data reported 
here strongly suggest that all opossums tested in this work either within or outside 
Didelphini enjoy physiological resistance to multiple isoforms of botrocetin.  
 Though this result was expected for species within Didelphini (particularly 
species for which organismal venom resistance has been demonstrated), it was not 
expected for species outside this group. Previous work has reported Metachirus 
nudicaudatus as venom sensitive, however, this assertion relies on a single study in 
which 2 individuals died after an injected dose of Bothrops jararaca venom (at 2X LD50 
for mice) (Perales et al. 1994). Though these data certainly indicate that M. nudicaudatus 
whole venom resistance is less than that of species that survive higher doses of the same 
venom, it not necessarily inconsistent with the existence of venom CTL resistant vWF in 
this species. While resistant vWF alone would likely not confer organismal resistance to 
whole venom, it may suggest that partial venom resistance for B. jararaca venom, or the 
venom of a closely related viper, may be important in this species.  
 While the ecological selection pressure driving venom resistance within 
Didelphini appears to be a dietary adaptation that enabled large bodied opossums to 
exploit venomous snakes as a food source (Wood 1954, Fitch 1960, Jared et al. 1998, 
Sazima 1992, Voss and Jansa 2012, Voss 2013), opossums outside this clade are smaller 
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bodied and more likely prey of Bothrops spp. (Voss 2013). While Monodelphis 
domestica has been reported to eat snakes, specific species are not reported, and known 
instances of predation on Monodelphis spp by Bothrops spp are more common (Streilein 
1982, Voss 2013). Other species known to have evolved venom resistance as a dietary 
adaptation include mammals that exhibit exceptionally strong and generalized antivenom 
competence (e.g. Hedgehogs, Mongoose, Grasshopper mice) (Barchan et al. 1995, Rowe 
et al. 2013). By contrast, species known to have evolved venom resistance as a predator 
defense generally show weaker venom resistance that is highly variable by species and 
geographic range (Holding et al. 2016a, Pomento et al. 2016). While CTL resistant vWF 
does not by itself appear to confer resistance to whole venom, it may be indicative of 
selection pressures for partial or local resistance for species outside Didelphini which 
experience heavy predation by Bothrops spp. 
 Given that at least 3 species outside Didelphini exhibit loss of aggregations 
response to botrocetins (Chapter 3), it is possible that venom resistance at vWF A1 is 
ancestral for all opossums and is rapidly evolving only in species (Didelphini) who have 
engaged in a coevolutionary relationship with vipers via a dietary adaptation. However, 
examination of ancestral nodes shows repeated convergent evolution of CTL binding 
loss, with several ancestral nodes that are sensitive to CTLs at levels comparable to 
human vWF A1. Similarly, if we examine rates of vWF A1 evolution from Jansa and 
Voss (2011), several additional branches leading to species of Monodelphis and Marmosa 
are as long if not longer than the branch leading to Didelphini. This suggests that these 
lineages also have accelerated evolutionary rates on vWF A1 and indicate that possible 
repeated convergent evolution for vWF CTL resistance in opossums was missed because 
branch-site rate tests require an a priori designation of branches under selection.  Below, 
we examine how repeated loss of function recovered in this work may inform the extent 
of venom CTL resistance across the remaining species in the family Didelphidae.    
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Repeated Loss of Function.  
 Changes within the botrocetin binding pockets (624-645, 655-677; Figure 4.7) 
indicate that both convergent and independent changes may be important for vWF-CTL 
resistance in Didelphini (Jansa and Voss 2011).  Previous work using alanine-scanning 
mutagenesis has shown that single alanine mutants at 629, 632, 636, and 667 each result 
in >60% loss of binding (Matsushita et al. 2000). Of these 629 and 632 also disrupt 
binding to GP1Bα (Matsushita and Sadler 1995, Matsushita et al. 2000). Though most 
mutations in vWF observed in Didelphini seem to be working via steric hindrance or 
charge disruption rather than elimination of amino acids with essential side-chains (as 
alanine scanning does) we similarly recover sites 632, and 636 as essential for binding 
loss. However, we find two additional sites adjacent to those previously identified, 628 (a 
known botrocetin binding site) and 630 a site not identified previously, which seem to be 
repeatedly associated with large degrees of binding loss (Table 4.1). Alanine scans have 
also shown that tandem mutations at the lysine stretch 642-645, disrupt botrocetin 
binding (Matsushita and Sadler 1995, Matsushita et al. 2000). While we do see a loss of 
two of these lysines from node 71 to 72 in Didelphini, this branch only shows significant 
loss of binding for botrocetin A and aspercetin, indicating that it may contribute to 
binding loss (as an important independent change), but may not be as vital to opossum 
vWF-botrocetin B binding loss. As these changes are only present once in this clade, the 
effect of these mutations would need to be tested via direct mutagenesis to decipher their 
specific effect on CTL binding. Previous work has also shown that a stretch outside the 
binding pocket 613-616 induces loss of binding for botrocetin only for tandem mutants 
(when more than one site is replaced with A) (Matsushita and Sadler 1995, Matsushita et 
al. 2000). However, this stretch is conserved between humans in almost all opossums; M. 
emiliae has one lysine in this region, and M. robinsoni has a phenylalanine in this stretch. 
Though these differ from alanine and could disrupt binding more efficiency, previous 
work suggests that single mutations in this region have little effect on binding 
(Matsushita et al. 2000).  
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 Using the sites and changes in Table 4.1, we examined the protein sequence of the 
remaining species outside Didelphini used for this work (Figure 4.1, Appendix Material 
4.1 DidvWFAlign1.phy). Several species exhibit many of the same amino acids found in 
Table 4.1 at these sites, as well as different amino acid changes at the same sites (Table 
4.2). In particular, Glironia venusta, several species of Monodelphis and Marmosa had 3 
or more changes which are associated with >10 fold binding loss for several venom CTLs 
(Table 4.2). Marmosa rubra showed the highest number of changes (8) repeatedly 
associated with >10 fold binding loss (Table 4.2). 
 
  Parallel Changes  Divergent Changes  Total 
Caluromys philander 635  2 
Caluromys lanatus 628 635 2 
Gilronia venusta 628 635, 639 3 
Metachirus nudicaudatus   635 1 
Gracilinanus agilis  635 1 
Gracilinanus microtarsus  635 1 
Gracilinanus aceramarcae  635 1 
Gracilinanus emliliae  635 1 
Thylamys venustus 635 628 2 
Thylamys pallidior 635  1 
Thylamys macrurus 635 628 2 
Thylamys pusillus 635 628 2 
Marmosops incanus  635 1 
Marmosops noctivagus  635 1 
Marmosops spGalves  635, 639 2 
Marmosops pinheiroi  635 1 
Marmosops parvidens  635 1 
Tlacuatzin canescens  635 1 
Monodelphis scalops  635 1 
Monodelphis emiliae 635, 636, 668 631, 633 5 
Monodelphis pervuviana 635  1 
Monodelphis brevicaudata  628, 630, 631, 635 4 
Monodelphis domestica  628, 630, 631, 635 4 
Marmosa rubra 628, 630, 635, 636, 668 633, 639 8 
Marmosa robinsoni  630, 631, 635 3 
Marmosa mexicana  630, 631, 635 3 
Marmosa murina  628, 631, 635 3 
Marmosa lepida  635 1 
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Marmosa rutteri 628 630, 631, 635 4 
Marmosa paraguayana  635 1 
Marmosa demerarae  635 1 
    
Table 4.2- Species outside of Didelphini that have parallel changes (the same amino acid replacement) 
associated with >10 fold binding loss for venom proteins seen in Table 4.1, and divergent changes at the 
same site. Sites associated with loss of binding by venom protein are: botrocetin A [628, 630, 631, 633, 
636, 668], botrocetin B [635], aspercetin [630, 631, 639]. One site highlighted in grey (635) indicates that 
every species had a change from the known binding state (D-Aspartic Acid) at this site. Rows of species 
that have associated vWF A1 affinity data are highlighted in grey.  
 
   Sites associated with loss of function identified in this work represent a subset 
of known botrocetin binding and adjacent sites, and further narrow down our ability to 
identify additional taxa which may be venom resistant, and potentially coevolving with 
venomous snakes (Table 4.2). Future work should focus on examining the physiological 
resistance of species in Table 4.2 with exceptionally high numbers of changes at sites 
associated with binding loss (CTL resistance), as these may represent species which are 
convergently evolving venom resistance.  
 Additionally, further work examining the ability of vWF from species with very 
few changes (Table 4.2), as well as species with slower evolutionary rates of vWF shown 
in Jansa and Voss (2011) should be examined to assess if these species are in fact 
botrocetin binders. These data will be vital to deciphering if all species of Didelphid 
opossums exhibit some degree of venom resistance, or if this is observed only in species 
with accelerated rates of evolution on vWF (convergently). Though sites identified here 
are associated with repeated loss of function, site directed mutagenesis on extant 
opossums for single mutations (one by one) identified to promote binding in ancestral 
forms would ultimately quantify the exact extent to which each of the mutations seen in 
extant taxa is responsible for binding loss.  
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Future Directions 
 While coevolution with resistant prey has been cited as a major driver of venom 
evolution (Casewell et al. 2012b), this study is the first to report a potentially coevolving 
molecular mechanism of venom resistance across several species of both prey items and 
predators of venomous snakes. This work also highlights that the role of the invasion and 
radiation of a generalist predator (Viperids) may be an important driver of adaptive 
evolution for all South American opossums, not just those who have evolved as specialist 
snake predators. South American opossums are unique in exhibiting a high extinction 
fraction, and an unusual period of net-zero lineage accumulation mid-Miocene, 
suggesting a mass extinction event unique to Didelphidae (Jansa et al. 2014).  It has been 
suggested that the invasion of Viperids to South America ~23 mya played a role this 
extinction event (Jansa et al. 2014). If surviving opossum lineages are in fact coevolving 
with vipers, this may be the driver of the high variation in botrocetin binding sites and 
sites associated with botrocetin binding loss across all Didelphids found in this study 
(Jansa and Voss 2011). Evidence presented here of loss of venom CTL binding 
associated with loss of aggregation function across several extant members of 
Didelphidae (not seen in several other placental mammals Read et al. 1983), as well as a 
pattern which suggests trench warfar coevolution add credence to this assertion and argue 
for the merit of further study of the diversity, physiology, and ecology of this 
evolutionary relationship.  
THE INFLUENCE OF CONVERGENCE AND COEVOLUTION IN THE 
EVOLUTION OF VENOM RESISTANCE IN MAMMALS 
This dissertation examines the role of convergent evolution and coevolution in the 
evolution of venom resistance in mammals. In Chapter 1 I outlined and reviewed how 
mammalian resistance to snake venom can be used to elucidate evolutionary tempo and 
mode of complex potentially coevolving adaptations. In Chapter 2 I examined convergent 
evolution of resistance to α-neurotoxins across mammals, and found strong evidence that 
resistance has evolved at least 4 times across mammals via two distinct biophysical 
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mechanisms. In Chapter 3 I demonstrated the function of a molecule previously 
hypothesized to confer resistance to a class of venom CTLs, and discover that this 
resistance is present more broadly across opossums than expected. In Chapter 4 I 
developed an experimental model to test the specific function of vWF, the protein 
hypothesized to confer CTL resistance. In this work I demonstrate lack of binding 
broadly across opossums and use ancestral reconstruction to identify mutations relevant 
to binding. By testing the function of vWF A1 ancestors with modern CTLs we find that 
the mode of vWF evolution is non-linear and departs from expectations of adaptive 
evolution towards an unchanging selection pressure, or arms race coevolution. Rather, we 
find that vWF A1 evolution is consistent with expectations of tit-for tat coevolution 
(though this pattern does not exclude other non-linear histories). These results revealed 
repeated convergence which is otherwise not predicted by models of trait evolution and 
show that vWF evolutionary tempo is saltatorial.  
These results indicate that the evolution of venom resistance may be an important 
driver of adaptive evolution across species which are both prey and predators of 
venomous snakes. Chapter 4 demonstrates of the need to reconstruct and empirically test 
ancestral states to determine if traits hypothesized to be coevolving conform to a mode 
which is expected for a coevolving trait. Chapter 4 also demonstrates the untapped 
potential to apply a functional synthesis framework to other cases of hypothesized 
coevolution, in order to explicitly test for the presence of this dynamic in one or both 
interacting partners. This work presents a case study in examining convergence and 
coevolution in the molecular basis of ecologically-relevant traits in a natural system. 
Chapters 3 and 4 establish an experimental system in which it is possible to explicitly test 
the tempo and directionality of traits hypothesized to be coevolving. My goal was to lay 
the groundwork for establishing an experimental system which could eventually be 
developed (over the course of a career) to explicitly test the functional and molecular 
evolution of both interacting partners in a coevolutionary relationship. This elusive but 
important goal is necessary to test long held assumptions of how coevolution plays out in 
natural systems.  
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Further work utilizing site-directed mutagenesis to explicitly identify the 
functional effect of each site identified in chapter 4 is needed to further our understanding 
of the biophysical interaction between vWF and CTLs. Establishing the same robust time 
-calibrated species and genes trees for Bothrops and CTLs respectively are the next steps 
in facilitating the development of this system to include botrocetin ancestors and test 
whether snake venom is indeed evolving reciprocally in response to mammalian venom 
resistance.   
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APPENDIX 1. SUPPLEMENTARY MATERIAL FOR CHAPTER 1. 
Appendix Table 1.1. Potentially coevolving venom and venom resistant proteins within 
mammals which meet conditions outlined for evolutionary studies involving phylogenetic and 
functional reconstruction as described in the text. 
Resistant 
Protein 
Venom 
component 
Heterologous 
expression 
system 
developed 
previously 
R V 
 
Resistant Species 
V  
Citations for 
heterologous 
expression 
systems 
R  
Citations for 
heterologous 
expression 
systems 
Citations 
for 
Resistance 
muscular 
nAChR 
alpha 
neurotoxins 
Y Y 
Herpestes ichneumon, 
Erinaceus concolor, 
Erinaceus europus, 
Mellivora capensis, 
Sus scrofa 
Lyukmanova et 
al. 2007, 
(Botes 1971, 
Utkin 2012, 
Ogawa et al. 
2004, Tsetlin 
1999, Kini and 
Doley 2010) 
Barchan et al. 
1992, Utkin et 
al. 2001 
Barchan et 
al. 1992, 
Barchan et 
al. 1995, 
Takacs et 
al. 2004, 
Drabeck et 
al. 2015 
vWF botrocetin Y Y* 
Didelphis virginiana, 
Didelphis albiventris, 
Didelphis 
marsupialis, 
Philander mcilhennyi, 
Philander opossum, 
Philander frenatus, 
Lutreolina 
crassicaudata, 
Chironectes minimus 
Yamamoto-
Susuki et al. 
2012 
Cruz et al. 
1993, Schulte  
am Esch II et 
al. 2007, 
Emsley et al. 
1998 
Jansa and 
Voss 2011 
SVMPIs 
(e.g.: oprin, 
DM43, 
DM40, 
Erinacin) 
SVMPs N** Y*** 
Didelphis virginiana, 
Didelphis 
marsupialis, 
Didelphis albiventris, 
Lutreolina 
crassicaudata, 
Philander frenatus, 
Erinaceus europus, 
Otospermophilus 
beecheyi, Ictidomys 
mexicanus, Neotoma 
micropus, Sigmodon 
hispidus, Herpestes 
edwardsii, 
None  
***Shimokaw
a et al. 1993, 
Zhu et al. 
2010, Ramos 
et al. 2003, 
Assakura et al. 
2003, Wang 
and Huang 
2002, Wu et al. 
2001, Selistre-
de-Araujo et 
al. 2000 
For a 
review see: 
Sanchez 
and 
Rodriguez-
Aucosta 
2008 
Nav1.8/ 
Nav1.7 
Unnamed 
toxin/ 
CvIV4 
Y N 
Onychomys torridus, 
Onychomys arenicola 
None 
Rowe et al. 
2013, Dib-Hajj 
et al. 2010 
Rowe and 
Rowe 2008, 
Rowe et al. 
2013 
* botrocetin-2, a similar but altered version of botrocetin has been expressed in mammalian cells 
(Yamamoto-Susuki et al. 2012). Native botrocetin is commercially available as E.coli expressed 
product, however, only as individual monomers. To our knowledge, the heterodimeric form is not 
commercially available, and has not been experimentally expressed in E.coli. Several other venom 
CTLs have been successfully expressed ex: Kassab et al. 2004  
** Though not completed, partial expression of opossum SVMPIs (DM43) is being undertaken at San 
Jose State University by Dr Claire Komives as a part of a project aimed at improving antivenom 
technology (Komives et al. Poster 2016) 
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*** This is a diverse set of proteins, however, many researchers have developed expression systems to 
study this class of protein, far too many to list here. 
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APPENDIX 2. SUPPLEMENTARY MATERIAL FOR CHAPTER 2. 
Appendix Table 2.1- Species and acccession numbers for CHRNA1 sequences that were 
obtained from public databases and used in this report. 
Species Genbank/EnsEMBL accession 
Canis lupus familiaris chromosome:CanFam3.1:36:18726243:18742505:1 
Cavia porcellus scaffold:cavPor3:scaffold 3:15383510:15398211:1 
Ceratotherium simum simum Genbank Accession XM 004426644 
Condylura cristata Genbank Accession XM 004674514 
Crocidura russula Genbank Accession U17006 
Dasypus novemcinctus genescaffold:dasNov2:GeneScaffold 3470:18400:33825:1 
Echinops telfairi genescaffold:TENREC:GeneScaffold 4122:3564:109793:1 
Equus caballus chromosome:EquCab2:18:53455099:53470210:1 
Erinaceus concolor Genbank Accession U17016 
Erinaceus europaeus genescaffold:HEDGEHOG:GeneScaffold 4250:14792:92863:1 
Felis catus chromosome:Felis catus 6.2:C1:163017266:163029388:1 
Gorilla gorilla gorilla chromosome:gorGor3.1:2b:62651955:62669340:1 
Herpestes ichneumon Genbank Accession M93639 
Heterocephalus glaber Genbank Accession XM 004908522 
Homo sapiens chromosome:GRCh37:2:175612320:175629200:1 
Ictidomys tridecemlineatus scaffold:spetri2:JH393319.1:4453205:4465194:1 
Jaculus jaculus Genbank Accession XM 004660327 
Loxodonta africana supercontig:loxAfr3:scaffold 3:52617234:52634961:1 
Macaca mulatta chromosome:MMUL 1:12:38373466:38390438:1 
Microcebus murinus genescaffold:micMur1:GeneScaffold 2120:3839:19770:1 
Monodelphis domestica chromosome:BROADO5:4:185745550:185772251:1 
Mus musculus chromosome:GRCm38:2:73563215:73580338:1 
Mustela putorius furo scaffold:MusPutFur1.0:GL897095.1:951737:970798:1 
Myotis lucifugus scaffold:Myoluc2.0:GL429772:8136691:8152800:1 
Nomascus leucogenys supercontig:Nleu1.0:GL397263.1:18550090:18569431:1 
Ochotona princeps genescaffold:pika:GeneScaffold 2413:62892:79747:1 
Odobenus rosmarus  Genbank Accession XM 004408997 
Orcinus orca Genbank Accession XM 004267331 
Otolemur garnettii scaffold:OtoGar3:GL873567.1:11514795:11524631:1 
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Ovis aries Genbank Accession XM 004004575 
Pan paniscus Genbank Accession XM 003824235 
Pan troglodytes chromosome:CHIMP2.1.4:2B:179204218:179221621:1 
Papio anubis Genbank Accession XM 003907633 
Pongo abelii chromosome:PPYG2:2b:64841691:64858791:1 
Procavia capensis genescaffold:proCap1:GeneScaffold 3561:16616:35113:1 
Pteropus vampyrus genescaffold:pteVam1:GeneScaffold 1768:18325:32806:1 
Rattus norvegicus chromosome:Rnor 5.0:3:66925970:66940958:1 
Sarcophilus harrisii scaffold:DEVIL7.0:GL849635.1:349074:365803:1 
Sorex araneus Genbank Accession XM 004601170 
Sus scrofa chromosome:Sscrofa10.2:15:89889110:89903466:1 
Tarsius syrichta genescaffold:tarSyr1:GeneScaffold 3989:3074:23223:1 
Trichechus manatus  Genbank Accession XM 004375490 
Tupaia belangeri genescaffold:TREESHREW:GeneScaffold 2670:43101:54292:1 
Tursiops truncatus genescaffold:turTru1:GeneScaffold 1529:17744:33028:1 
Vicugna pacos genescaffold:vicPac1:GeneScaffold 980:219012:234612:1 
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Appendix Figure 2.1- Part of the amino acid alignment for the region of the nicotinic 
acetylcholine receptor (CHRNA1) used for this study and others (Barchan et al. 1992, 1995). On 
the left is the evolutionary tree of mammals that have been sequenced for the α1 subunit of the 
nicotinic acetylcholine receptor gene (CHRNA1). The α-bungarotoxin-binding region of nAChR 
(Barchan et al. 1995) is outlined with a square. The consensus sequence is shown at the top, and 
dots indicate sequence identity with this reference sequence. 
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             Monodelphis domestica Response to aspercetin 
 
Appendix Figure 3.1- Percent aggregation of Monodelphis domestica samples from failed ADP control for 
high and low concentrations of aspercetin. Grey diamonds are Monodelphis domestica, black rectangles are 
Didelphis virginiana, and black circles are Human. All tests are in PRP, and error bars are the standard 
error of the mean (%Transmittance as %Aggregation). All samples of M. domestica are from an individual 
who failed to aggregate in response to ADP. M. domestica samples contained botrocein which failed to 
aggregate platelets, after which aspercetin was added to the same samples and results above were recorded.  
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                          Intraspecific Variation in Aggregation Response 
Species Ind ID N tests ChiSquare DF P-Value 
Didelphis virginiana F1 9 4.0319 2 0.1332 
Didelphis virginiana M1 5    
Didelphis virginiana M2 10    
 
Appendix Table 3.1- Kruskal-Wallis rank sums test of aggregation between individuals. N tests is number 
of tests including high and low concentrations and all test types (PRP and washed assay). DF- degrees of 
freedom. Ind ID- Individual identification. 
 
High versus Low Concentration PRP Tests 
Venom Species N high N low ChiSquare DF P-Value Corrected P 
aspercetin Didelphis aurita 2 1 0 1 1 1 
aspercetin Didelphis virginiana 4 7 3.74 1 0.053* 0.265 
aspercetin  Human 4 2 0.2143 1 0.6434 1 
botrocetin Didelphis virginiana 11 2 0.3939 1 0.5302 1 
botrocetin Human 12 2 0.3033 1 0.5818 1 
 
Appendix Table 3.2- One-way Wilcoxin tests of differences in percent aggregation in PRP between high 
and low concentrations of venom proteins used for botrocetin and aspercetin. DF- degrees of freedom N 
high- number of tests using a high concentration, N low- number of tests using a low concentration. 
Bonferroni corrected P values are multiplied by the number of tests and reported as 1 if >1. Asterisk 
indicate significance at ɑ=0.05.  
 
Comparison of aspercetin Aggregation Response of Monodelphis domestica  
Agonist [C] Species Species Difference Std Err Dif Lower CL Upper CL p-Value 
 Human M. domestica 92.65 24.74003 23.5756 161.7244 0.0115* 
Low Human D. virginiana 81.36429 13.86956 42.6403 120.0882 0.0006* 
 D. virginiana M. domestica 11.28571 23.656 54.7621 77.3335 0.8836 
 Human D. virginiana 63.25 6.898369 40.8037 85.69635 0.0006* 
High Human M. domestica 43.5 7.965551 17.5812 69.41881 0.0065* 
 M. domestica D. virginiana 19.75 6.898369 -2.6963 42.19635 0.0767 
 
Appendix Table 3.3- Tukey-Kramer HSD comparison of percent aggregation of Monodelphis domestica 
PRP samples from failed ADP control in response to high (100ug/ml) and low (<51ug/ml) concentrations 
of aspercetin. Responses are compared to both D. virginiana and Human PRP aggregation to the same 
aspercetin concentrations.  M. domestica samples contained both Botrocein which failed to aggregate 
platelets, after which aspercetin was added to the same samples and results were recorded.  Asterisk 
indicate significance at ɑ=0.05.  
 
PRP versus Washed Platelet Tests 
Agonist Species N WP N PRP ChiSquare DF P-Value Corrected P 
ADP Didelphis virginiana 6 7 1.317 1 0.2511 1 
aspercetin Didelphis virginiana 13 11 0.2245 1 0.6356 1 
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bitiscetin Didelphis virginiana 9 12 1.9106 1 0.1669 1 
botrocetin Didelphis virginiana 8 13 1.2923 1 0.2556 1 
ristocetin Didelphis virginiana 2 4 1.4205 1 0.2333 1 
bitiscetin Human 2 2 3 1 0.0833 0.5831 
ristocetin Human 5 5 0.1756 1 0.6752 1 
 
Appendix Table 3.4- One-way Wilcoxin tests of differences in percent aggregation between tests run in 
PRP versus washed assays. DF- degrees of freedom, N WP- number of tests done in washed platelets, N 
PRP- number of tests done in PRP. Bonferroni corrected P values are multiplied by the number of tests and 
reported as 1 if >1. 
 
High versus Low Concentration Tests in Washed Assays 
Venom Species N high N low ChiSquare DF P-Value  Corrected P 
aspercetin Didelphis virginiana 10 3 0.1895 1 0.6633 1 
botrocetin Didelphis virginiana 2 6 0 1 1 1 
 
Appendix Table 3.5- One-way Wilcoxin tests of differences in percent aggregation between low and high 
concentrations in washed assays. DF- degrees of freedom, N high- number of tests done in high 
concentrations of agonist, N low- number of tests done in low concentrations of agonist. Bonferroni 
corrected P values are multiplied by the number of tests and reported as 1 if >1. 
 
 
 
 
 
Comparison of Source of vWF in Washed Assays 
Agonist Species N PPP N pvWF ChiSquare DF P-Value Corrected P 
aspercetin Didelphis virginiana 9 4 8.1866 1 0.0042* 0.021* 
bitiscetin Didelphis virginiana 8 1 0.125 1 0.7237 1 
botrocetin Didelphis virginiana 7 1 0 1 1 1 
ristocetin Didelphis virginiana 1 1 1 1 0.3173 1 
ristocetin Human 1 3 3.2 2 0.2019 1 
 
Appendix Table 3.6- One-way Wilcoxin tests of differences in percent aggregation between washed 
assays which used 10% v/v PPP or cleaned up concentrated vWF as a source of vWF for washed assays. 
DF- degrees of freedom, N PPP- number of tests using 10% v/v PPP, N pvWF- number of tests using 
cleaned up vWF from size exclusion chromatography. Bonferroni corrected P values are multiplied by the 
number of tests and reported as 1 if >1. Asterisk indicate significance at ɑ=0.05.  
 
List of Platelet Rich Plasma Assays 
TestID Test Material Agonist [C] units %Trasmittance Species Ind ID 
21 PRP ADP 850 μg/ml 61 Human CM 
22 PRP ADP 850 μg/ml 72 Human CM 
23 PRP ADP 850 μg/ml 63 Human CM 
35 PRP ADP 850 μg/ml 68 Human DD 
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TestID Test Material Agonist [C] units %Trasmittance Species Ind ID 
36 PRP ADP 850 μg/ml 76 Human DD 
89 PRP ADP 850 μg/ml 79 Human CM 
90 PRP ADP 850 μg/ml 79 Human CM 
19 PRP ADP 850 μg/ml 70 Didelphis virginiana M2 
20 PRP ADP 850 μg/ml 69 Didelphis virginiana M2 
24 PRP ADP 850 μg/ml 72 Didelphis virginiana F1 
28 PRP ADP 850 μg/ml 59 Didelphis virginiana M1 
31 PRP ADP 850 μg/ml 50 Didelphis virginiana M1 
33 PRP ADP 850 μg/ml 70 Didelphis virginiana F1 
102 PRP ADP 850 μg/ml 60 Didelphis virginiana F1 
160c PRP ADP 10 μM 78 Didelphis aurita DE001 
161 PRP ADP 10 μM 68.9 Human EHZ 
170 PRP ADP 10 μM 52.5 Didelphis aurita DE003 
171 PRP ADP 10 μM 72 Human PC 
172 PRP ADP 10 μM 72 Human PC 
182 PRP ADP 10 μM 55 Didelphis aurita DE006 
185 PRP ADP 10 μM 74 Didelphis aurita DE005 
195 PRP ADP 850 μg/ml 45 Monodelphis domestica MdomA 
196 PRP ADP 850 μg/ml 45 Monodelphis domestica MdomA 
154 PRP aspercetin 20 μg/ml 100 Human NZ 
3 PRP aspercetin 20 μg/ml 99 Human DD 
93 PRP aspercetin 100 μg/ml 85 Human CM 
94 PRP aspercetin 100 μg/ml 95 Human CM 
85 PRP aspercetin 100 μg/ml 30 Didelphis virginiana M2 
86 PRP aspercetin 100 μg/ml 38 Didelphis virginiana M2 
106 PRP aspercetin 100 μg/ml 20 Didelphis virginiana F1 
107 PRP aspercetin 100 μg/ml 19 Didelphis virginiana F1 
156 PRP aspercetin 20 μg/ml 0 Didelphis virginiana F1 
9a PRP aspercetin 20 μg/ml 5 Didelphis virginiana F1 
12a PRP aspercetin 20 μg/ml 0 Didelphis virginiana M1 
25 PRP aspercetin 20 μg/ml 3 Didelphis virginiana F1 
12b PRP aspercetin 36.36 μg/ml 0 Didelphis virginiana M1 
9b PRP aspercetin 36.3 μg/ml 71 Didelphis virginiana F1 
12c PRP aspercetin 50 μg/ml 0 Didelphis virginiana M1 
162 PRP aspercetin 20 μg/ml 81.6 Human EHZ 
168 PRP aspercetin 20 μg/ml 0 Didelphis aurita DE003 
173 PRP aspercetin 20 μg/ml 90 Human PC 
178 PRP aspercetin 20 μg/ml 0 Didelphis aurita DE006 
186 PRP aspercetin 20 μg/ml 0 Didelphis aurita DE005 
91 PRP bitiscetin 12.75 μg/ml 85 Human CM 
92 PRP bitiscetin 12.75 μg/ml 85 Human CM 
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TestID Test Material Agonist [C] units %Trasmittance Species Ind ID 
76a PRP bitiscetin 12.75 μg/ml 0 Didelphis virginiana M1 
80 PRP bitiscetin 12.75 μg/ml 0 Didelphis virginiana M2 
81 PRP bitiscetin 12.75 μg/ml 0 Didelphis virginiana M2 
82 PRP bitiscetin 12.75 μg/ml 0 Didelphis virginiana M2 
100 PRP bitiscetin 12.75 μg/ml 0 Didelphis virginiana M2 
101 PRP bitiscetin 12.75 μg/ml 0 Didelphis virginiana F1 
108 PRP bitiscetin 12.75 μg/ml 0 Didelphis virginiana F1 
145 PRP bitiscetin 12.75 μg/ml 5 Didelphis virginiana F1 
146a PRP bitiscetin 12.75 μg/ml 6 Didelphis virginiana F1 
146b PRP bitiscetin 11.59 μg/ml 1 Didelphis virginiana F1 
146c PRP bitiscetin 10.625 μg/ml 1 Didelphis virginiana F1 
147 PRP bitiscetin 12.75 μg/ml 3 Didelphis virginiana F1 
153 PRP botrocetin 2 μg/ml 75 Human NZ 
2 PRP botrocetin 2 μg/ml 75 Human DD 
5 PRP botrocetin 4 μg/ml 90 Human DD 
17 PRP botrocetin 4 μg/ml 0 Didelphis virginiana M2 
18 PRP botrocetin 4 μg/ml 2 Didelphis virginiana M2 
8c PRP botrocetin 10 μg/ml 0 Didelphis virginiana F1 
11c PRP botrocetin 10 μg/ml 0 Didelphis virginiana M1 
8d PRP botrocetin 12.3 μg/ml 0 Didelphis virginiana F1 
11d PRP botrocetin 12.3 μg/ml 0 Didelphis virginiana M1 
14 PRP botrocetin 20 μg/ml 5 Didelphis virginiana M1 
155 PRP botrocetin 2 μg/ml 0 Didelphis virginiana F1 
159 PRP botrocetin 2 μg/ml 0 Didelphis virginiana M1 
8a PRP botrocetin 4 μg/ml 0 Didelphis virginiana F1 
11a PRP botrocetin 4 μg/ml 0 Didelphis virginiana M1 
8b PRP botrocetin 7.27 μg/ml 0 Didelphis virginiana F1 
11b PRP botrocetin 7.27 μg/ml 0 Didelphis virginiana M1 
160a PRP botrocetin 4 μg/ml 0 Didelphis aurita DE001 
160b PRP botrocetin 10 μg/ml 0 Didelphis aurita DE001 
163 PRP botrocetin 10 μg/ml 66.8 Human EHZ 
164 PRP botrocetin 10 μg/ml 69.5 Human EHZ 
165 PRP botrocetin 4 μg/ml 71 Human EHZ 
166 PRP botrocetin 4 μg/ml 70.6 Human EHZ 
167 PRP botrocetin 4 μg/ml 0 Didelphis aurita DE003 
169 PRP botrocetin 10 μg/ml 0 Didelphis aurita DE003 
174 PRP botrocetin 10 μg/ml 75 Human PC 
175 PRP botrocetin 4 μg/ml 79 Human PC 
176 PRP botrocetin 10 μg/ml 78 Human PC 
177 PRP botrocetin 4 μg/ml 82 Human PC 
179 PRP botrocetin 10 μg/ml 0 Didelphis aurita DE006 
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TestID Test Material Agonist [C] units %Trasmittance Species Ind ID 
180 PRP botrocetin 4 μg/ml 0 Didelphis aurita DE006 
181 PRP botrocetin 4 μg/ml 0 Didelphis aurita DE006 
181a PRP botrocetin 10 μg/ml 0 Didelphis aurita DE006 
183 PRP botrocetin 4 μg/ml 0 Didelphis aurita DE005 
183a PRP botrocetin 10 μg/ml 0 Didelphis aurita DE005 
184 PRP botrocetin 4 μg/ml 0 Didelphis aurita DE005 
184a PRP botrocetin 10 μg/ml 0 Didelphis aurita DE005 
187 PRP botrocetin 10 μg/ml 80 Human MW 
188 PRP botrocetin 10 μg/ml 78 Human MW 
189 PRP botrocetin 10 μg/ml 81 Human MW 
194 PRP botrocetin 10 μg/ml 0 Monodelphis domestica MdomA 
194b PRP botrocetin 17 μg/ml 0 Monodelphis domestica MdomA 
194c PRP botrocetin 71 μg/ml 0 Monodelphis domestica MdomA 
152 PRP ristocetin 1.5 mg/ml 90 Human NZ 
1 PRP ristocetin 1.5 mg/ml 84 Human DD 
4 PRP ristocetin 1.5 mg/ml 89 Human DD 
48 PRP ristocetin 1.5 mg/ml 68 Human JD 
49 PRP ristocetin 1.5 mg/ml 67 Human JD 
155 PRP ristocetin 1.5 mg/ml 0 Didelphis virginiana F1 
6a PRP ristocetin 1.5 mg/ml 0 Didelphis virginiana F1 
6b PRP ristocetin 2.72 mg/ml 2 Didelphis virginiana F1 
6c PRP ristocetin 3.75 mg/ml -10 Didelphis virginiana F1 
 
Appendix Table 3.7- List of all PRP assays. Individual ID corresponds to a single unique organism. Test 
ID is each 450μl Test. When test ID is a subset a,b,c this indicates that this test was a continuation of a 
previous test (the same 450μl PRP sample). Sections highlighted in grey denote a different venom protein 
(for visual ease).  
 
 
List of Washed Platelet Assays 
TestID Test Material vWF source reagent [C] units %Transmittance Species Ind ID 
66 Washed Platelets PPP opossum ADP 850 μg/ml 82 Didelphis virginiana M2 
77 Washed Platelets PPP opossum ADP 850 μg/ml 65 Didelphis virginiana M1 
110 Washed Platelets PPP opossum ADP 850 μg/ml 49 Didelphis virginiana F1 
110 Washed Platelets PPP opossum ADP 850 μg/ml 49 Didelphis virginiana F1 
116c Washed Platelets PPP opossum ADP 850 μg/ml 50 Didelphis virginiana F1 
120 Washed Platelets PPP opossum ADP 850 μg/ml 65 Didelphis virginiana M1 
141 Washed Platelets PPP opossum ADP 850 μg/ml 20 Didelphis virginiana F1 
64 Washed Platelets PPP opossum aspercetin 20 μg/ml 10 Didelphis virginiana M2 
68 Washed Platelets PPP opossum aspercetin 20 μg/ml 10 Didelphis virginiana M2 
74 Washed Platelets PPP opossum aspercetin 100 μg/ml 5 Didelphis virginiana M1 
78 Washed Platelets PPP opossum aspercetin 100 μg/ml 3 Didelphis virginiana M1 
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TestID Test Material vWF source reagent [C] units %Transmittance Species Ind ID 
115a Washed Platelets PPP opossum aspercetin 100 μg/ml 40 Didelphis virginiana F1 
150a Washed Platelets PPP opossum aspercetin 100 μg/ml 5 Didelphis virginiana F1 
127 Washed Platelets PPP opossum aspercetin 100 μg/ml 10 Didelphis virginiana M2 
128 Washed Platelets PPP opossum aspercetin 100 μg/ml 10 Didelphis virginiana M2 
129 Washed Platelets PPP opossum aspercetin 100 μg/ml 9 Didelphis virginiana M2 
65 Washed Platelets purified opossum aspercetin 20 μg/ml 0 Didelphis virginiana M2 
96 Washed Platelets purified opossum aspercetin 100 μg/ml 0 Didelphis virginiana M2 
99 Washed Platelets purified opossum aspercetin 100 μg/ml 0 Didelphis virginiana M2 
111 Washed Platelets purified opossum aspercetin 100 μg/ml 0 Didelphis virginiana F1 
73 Washed Platelets PPP human bitiscetin 12.75 μg/ml 90 Human SJ 
73 Washed Platelets PPP human bitiscetin 12.75 μg/ml 90 Human SJ 
75 Washed Platelets PPP opossum bitiscetin 12.75 μg/ml 0 Didelphis virginiana M1 
79 Washed Platelets PPP opossum bitiscetin 12.75 μg/ml 0 Didelphis virginiana M1 
109 Washed Platelets PPP opossum bitiscetin 12.75 μg/ml 0 Didelphis virginiana F1 
116a Washed Platelets PPP opossum bitiscetin 12.75 μg/ml 0 Didelphis virginiana F1 
121 Washed Platelets PPP opossum bitiscetin 12.75 μg/ml 0 Didelphis virginiana M1 
122 Washed Platelets PPP opossum bitiscetin 12.75 μg/ml 0 Didelphis virginiana M1 
123 Washed Platelets PPP opossum bitiscetin 12.75 μg/ml 0 Didelphis virginiana M1 
148 Washed Platelets PPP opossum bitiscetin 12.75 μg/ml 5 Didelphis virginiana F1 
98 Washed Platelets purified opossum bitiscetin 12.75 μg/ml 0 Didelphis virginiana M2 
61 Washed Platelets PPP opossum botrocetin 2 μg/ml 0 Didelphis virginiana M1 
124 Washed Platelets PPP opossum botrocetin 2 μg/ml 0 Didelphis virginiana M2 
125 Washed Platelets PPP opossum botrocetin 2 μg/ml 0 Didelphis virginiana M2 
126 Washed Platelets PPP opossum botrocetin 2 μg/ml 0 Didelphis virginiana M2 
140 Washed Platelets PPP opossum botrocetin 10 μg/ml 0 Didelphis virginiana F1 
143a Washed Platelets PPP opossum botrocetin 2 μg/ml 0 Didelphis virginiana F1 
143b Washed Platelets PPP opossum botrocetin 10 μg/ml 0 Didelphis virginiana F1 
62 Washed Platelets purified opossum botrocetin 2 μg/ml 0 Didelphis virginiana M1 
54 Washed Platelets PPP Human ristocetin 1.5 mg/ml 68 Human CM 
55 Washed Platelets purified human ristocetin 1.5 mg/ml 78 Human CM 
56 Washed Platelets purified human ristocetin 1.5 mg/ml 86 Human CM 
57 Washed Platelets purified human ristocetin 1.5 mg/ml 80 Human CM 
69 Washed Platelets purified human ristocetin 1.5 mg/ml 73 Human SJ 
58 Washed Platelets PPP opossum ristocetin 2 mg/ml -10 Didelphis virginiana M2 
59 Washed Platelets purified opossum ristocetin 2 mg/ml -8 Didelphis virginiana M2 
 
Appendix Table 3.8- List of all washed platelet assays. Individual ID corresponds to a single unique 
organism. Test ID is each 450μl Test. When test ID is a subset a,b,c this indicates that this test was a 
continuation of a previous test (the same 450μl WP sample). Sections highlighted in grey denote a different 
venom protein (for visual ease).  
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APPENDIX 4. SUPPLEMENTARY MATERIAL FOR CHAPTER 4. 
 
 
Appendix Figure 4.1- Parsimony reconstruction of N-terminal sequence gaps for clade Didelphini. 
Didelphini is defined as the clade beginning at node 70.  Node labels are arbitrarily designated by the 
program PAML and are used for reference in ancestral reconstruction. Ancestral reconstruction identifies 
nodes/ species identical at the proteins level as nodes (72,75), (76, D. marsupialis), (74, P. mcilhennyi, 
P.opossum). An additional node generated by the addition of D. aurita as sister to D. marsupialis (not 
shown) is identical to D. marsupialis.  
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Appendix Figure 4.2- Cartoon depiction of the pQE9 vector with the vWF insert pictured. Zoom shows 
the exact sequences of the leader and terminating sequence. Not all features shown.  
 
 
 
 
 
Species NCBI Accession # 
Chironectes minimus FJ159330.1* 
Didelphis virginiana FJ159335.1* 
Lutreolina crassicaudata FJ159342.1* 
Philander quica FJ159362.1* 
Philander mcilhennyi ######### 
Philander opossum FJ159364.1* 
Metachirus nudicaudata FJ159353.1* 
Didelphis marsupialis ######### 
Homo sapiens AAB39987.1 
Monodelphis domestica NW_001582018.1 
Monodelphis emiliae FJ159358.1* 
Didelphis aurita ######### 
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Appendix Table 4.1- List of specimens used for vWF constructs. GenBank accession numbers with 
asterisks were amended with the newly sequenced upstream portion of vWF for this work. Accession 
numbers in bold were novel and accessioned uniquely, sequences with hash marks will be accessioned 
upon publication. Sequences not in bold were used directly from GenBank and not re-sequenced.  
 
Primer name Primer Sequence 
DvWF_F1 5’- TCACTGTGATGGTGTGAACTT-3’ 
DvWF_R6 5’- GTCTGAGCCTTCTAGCACAAA-3’ 
DvWF_R1 5'-ACATTGAACTGAAAGATCGGAAGC-3' 
PQE9 Insert F1  5’- CACAGAATTCATTAAAGAGGAGA-3’ 
PQE9 insert R3 5’-CTGAGGTCATTACTGGATCTATCAACAGGA-3’ 
 
Appendix Table 4.2- List of primers used.  
 
date molecule chip species KD [M] ka kd Rmax R equilibrium R2 
9/14/2016 bitiscetin NiNTA Human 1.97E-08 2.07E+04 4.07E-04 5.32E-01 5.28E-01 0.9882 
9/14/2016 bitiscetin NiNTA Didelphis virginiana 1.81E-07 2.95E+04 5.35E-03 3.69E-01 3.22E-01 0.9776 
11/1/2016 bitiscetin NiNTA Human 1.03E-08 1.02E+05 1.05E-03 4.22E-01 4.16E-01 0.9841 
11/1/2016 bitiscetin NiNTA Human 1.77E-08 9.83E+04 1.74E-03 2.69E-01 2.57E-01 0.9835 
11/2/2016 bitiscetin NiNTA Didelphis virginiana 8.47E-08 7.06E+04 5.98E-03 5.44E-01 4.88E-01 0.9832 
11/3/2016 bitiscetin NiNTA Didelphis virginiana 9.52E-08 4.63E+04 4.41E-03 4.30E-01 3.81E-01 0.9863 
11/12/2016 
bitiscetin NiNTA Human 1.39E-08 8.01E+04 1.12E-03 7.65E-01 7.51E-01 0.9941 
11/15/2016 
bitiscetin NiNTA Human 1.92E-08 8.74E+04 1.67E-03 1.15E+00 1.10E+00 0.9963 
11/15/2016 
bitiscetin NiNTA Didelphis virginiana 9.90E-08 1.19E+05 1.18E-02 7.71E-01 6.80E-01 0.9842 
12/9/2016 botrocetin A HS1K Didelphis virginiana 3.00E-05 2.11E+03 6.33E-02 1.76E+00 1.73E-01 0.9905 
12/13/2016 botrocetin A HS1K Human 6.50E-07 7.23E+03 4.70E-03 5.34E-01 4.45E-01 0.9794 
1/2/2017 botrocetin A HS1K Human 6.47E-07 7.41E+03 4.80E-03 3.31E-01 2.37E-01 0.9838 
1/2/2017 botrocetin A HS1K Didelphis virginiana 2.16E-05 3.61E+03 7.78E-02 1.72E+00 1.21E-01 0.9835 
5/15/2017 bitiscetin HS1K Chironectes minimus  2.03E-06 6.79E+04 1.38E-01 4.30E-01 2.38E-01 0.9745 
5/18/2017 botrocetin A HS1K Human 7.69E-07 9.48E+03 7.29E-03 4.50E-01 3.64E-01 0.9896 
5/18/2017 botrocetin A HS1K Monodelphis domestica 2.00E-04 na na na na na 
5/24/2017 aspercetin HS1K Human 1.92E-06 2.49E+04 4.78E-02 4.14E-01 3.47E-01 0.9944 
5/24/2017 aspercetin HS1K Metachirus nudicaudatus  2.00E-04 na na na na na 
5/25/2017 aspercetin HS1K Lutreolina crassicaudata 2.00E-04 na na na na na 
5/25/2017 botrocetin A HS1K Metachirus nudicaudatus  2.00E-04 na na na na na 
5/25/2017 botrocetin A HS1K Lutreolina crassicaudata 2.00E-04 na na na na na 
5/25/2017 botrocetin A HS1K Philander quica  2.00E-04 na na na na na 
5/25/2017 botrocetin A HS1K Didelphis albiventris 2.00E-04 na na na na na 
5/30/2017 bitiscetin HS1K Didelphis marsupialis 9.36E-07 2.27E+04 2.12E-02 9.00E-01 6.55E-01 0.9591 
5/30/2017 bitiscetin HS1K Chironectes minimus  6.03E-06 1.89E+04 1.14E-01 1.07E+00 3.13E-01 0.9846 
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date molecule chip species KD [M] ka kd Rmax R equilibrium R2 
5/30/2017 botrocetin A HS1K Chironectes minimus  2.00E-04 na na na na na 
5/30/2017 botrocetin A HS1K Didelphis marsupialis 6.03E-06 3.03E+04 1.83E-01 3.71E-01 1.30E-01 0.9509 
6/1/2017 aspercetin HS1K Chironectes minimus  2.00E-04 na na na na na 
6/1/2017 aspercetin HS1K Didelphis virginiana 3.64E-07 4.42E+03 1.61E-03 3.59E-01 3.46E-01 0.9865 
6/1/2017 bitiscetin NiNTA Human 3.44E-08 2.76E+04 9.51E-04 6.71E-01 6.62E-01 0.997 
6/1/2017 bitiscetin NiNTA Didelphis virginiana 4.80E-07 1.90E+04 9.10E-03 1.46E+00 1.23E+00 0.9948 
6/2/2017 aspercetin HS1K Human 1.50E-06 3.08E+04 4.63E-02 4.09E-01 3.56E-01 0.9941 
6/2/2017 aspercetin HS1K Human 3.12E-06 2.01E+04 6.25E-02 3.73E-01 2.84E-01 0.9901 
6/2/2017 aspercetin HS1K Monodelphis domestica 2.00E-04 na na na na na 
6/2/2017 aspercetin HS1K Didelphis marsupialis 2.00E-04 na na na na na 
6/2/2017 aspercetin HS1K Didelphis albiventris 2.00E-04 na na na na na 
6/19/2017 aspercetin HS1K Philander quica  2.00E-04 na na na na na 
6/19/2017 aspercetin NiNTA Philander opossum   2.00E-04 na na na na na 
6/19/2017 botrocetin A NiNTA Philander opossum   2.00E-04 na na na na na 
6/27/2017 bitiscetin NiNTA Didelphis albiventris 9.77E-07 9.09E+03 8.89E-03 3.17E+00 2.28E+00 0.9947 
6/27/2017 bitiscetin NiNTA Didelphis marsupialis 7.91E-07 7.82E+03 6.18E-03 3.99E+00 3.03E+00 0.9973 
6/27/2017 bitiscetin NiNTA Monodelphis domestica 5.70E-07 1.85E+04 1.06E-02 1.27E+00 1.03E+00 0.9928 
6/27/2017 bitiscetin NiNTA Metachirus nudicaudatus  3.10E-06 3.80E+03 1.18E-02 3.56E-01 1.59E-01 0.9141 
2/23/2018 botrocetin A HS1K Human 7.99E-07 8.51E+03 6.81E-03 4.04E-01 3.25E-01 0.9608 
2/23/2018 botrocetin A HS1K Node 69 9.79E-07 1.13E+04 1.11E-02 5.53E-01 4.25E-01 0.9721 
2/23/2018 botrocetin A HS1K Monodelphis emiliae 2.00E-04 na na na na na 
2/24/2018 bitiscetin NiNTA Monodelphis emiliae 1.96E-06 9.50E+03 1.87E-02 2.31E+00 1.29E+00 0.9977 
2/24/2018 bitiscetin NiNTA Node 69 3.03E-07 1.80E+04 5.45E-03 1.16E+00 1.04E+00 0.9934 
2/25/2018 aspercetin HS1K Node 69 2.67E-06 1.97E+04 5.26E-02 3.21E-01 2.54E-01 0.9769 
3/27/2018 bitiscetin NiNTA Lutreolina crassicaudata 2.11E-07 1.64E+04 3.47E-03 6.91E-01 6.37E-01 0.9921 
3/27/2018 bitiscetin NiNTA Lutreolina crassicaudata 3.74E-07 1.31E+04 4.89E-03 8.68E-01 7.55E-01 0.9938 
3/28/2018 bitiscetin NiNTA Philander quica  6.95E-07 1.49E+04 1.04E-02 5.88E-01 4.60E-01 0.9925 
3/28/2018 bitiscetin NiNTA Philander quica  1.33E-06 1.05E+04 1.39E-02 5.05E-01 3.30E-01 0.9768 
3/28/2018 bitiscetin NiNTA Philander opossum   2.00E-04 na na na na na 
3/29/2018 botrocetin A HS1K Philander quica  2.00E-04 na na na na na 
3/29/2018 botrocetin A HS1K Didelphis marsupialis 6.48E-06 7.31E+03 4.74E-02 7.37E-01 2.46E-01 0.9807 
7/16/2018 botrocetin B HS1K Human 5.09E-08 5.20E+05 2.65E-02 2.39E-01 2.38E-01 0.9699 
12/13/2018 
botrocetin A HS1K Node 70 2.00E-04 na na na na na 
12/13/2018 
botrocetin A HS1K Node 71 2.87E-06 3.05E+04 8.75E-02 3.85E-01 2.05E-01 0.9788 
12/13/2018 
botrocetin A HS1K Node 72 2.00E-04 na na na na na 
12/13/2018 
botrocetin A HS1K Node 73 2.00E-04 na na na na na 
12/16/2018 
botrocetin B HS1K Didelphis marsupialis 7.49E-07 2.22E+05 1.66E-01 1.56E-01 1.13E-01 0.9569 
12/16/2018 
botrocetin B HS1K Lutreolina crassicaudata 1.39E-06 9.69E+04 1.35E-01 2.42E-01 2.23E-01 0.9645 
12/16/2018 
botrocetin B HS1K Lutreolina crassicaudata 3.00E-06 6.24E+04 1.87E-01 1.30E+02 3.26E+01 0.9394 
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12/17/2018 
botrocetin B NiNTA Chironectes minimus 2.78E-05 3.14E+03 8.73E-02 5.38E-01 1.97E-01 0.9377 
12/17/2018 
botrocetin B HS1K Didelphis virginiana 1.66E-06 1.51E+05 2.51E-01 4.67E-01 4.23E-01 0.9841 
12/18/2018 
botrocetin B HS1K Didelphis albiventris 2.63E-06 1.39E+05 3.64E-01 4.61E-01 3.47E-01 0.9784 
12/18/2018 
botrocetin B NiNTA Didelphis albiventris 1.06E-05 4.24E+04 4.50E-01 9.04E-01 7.78E-02 0.9917 
1/8/2019 botrocetin B NiNTA Human 4.99E-07 3.85E+04 1.92E-02 1.39E+00 1.31E+00 0.9812 
1/8/2019 botrocetin B NiNTA Human 3.72E-07 7.28E+04 2.71E-02 6.10E-01 5.97E-01 0.9892 
1/9/2019 botrocetin B NiNTA Didelphis virginiana 1.33E-05 2.19E+04 2.90E-01 4.71E-01 6.18E-02 0.9626 
1/9/2019 botrocetin B NiNTA Human 4.18E-07 7.11E+04 2.97E-02 7.67E-01 7.29E-01 0.9895 
1/10/2019 botrocetin B NiNTA Didelphis albiventris 6.91E-06 4.05E+04 2.79E-01 2.26E+00 1.58E+00 0.9928 
1/10/2019 botrocetin B NiNTA Didelphis albiventris 8.16E-06 3.71E+04 3.03E-01 2.64E+00 1.75E+00 0.9916 
1/10/2019 botrocetin B NiNTA Didelphis marsupialis 6.16E-06 2.73E+04 1.68E-01 3.11E+00 2.25E+00 0.9921 
1/10/2019 botrocetin B NiNTA Didelphis marsupialis 6.96E-06 3.85E+04 2.68E-01 3.07E+00 2.14E+00 0.9797 
1/10/2019 botrocetin B NiNTA Chironectes minimus 1.76E-05 1.89E+04 3.32E-01 2.12E-01 1.01E-01 0.9416 
1/10/2019 botrocetin B NiNTA Didelphis virginiana 6.19E-06 3.28E+04 2.03E-01 1.31E+00 9.45E-01 0.9974 
1/10/2019 botrocetin B NiNTA Didelphis virginiana 7.65E-06 3.52E+04 2.70E-01 1.58E+00 1.07E+00 0.9965 
1/10/2019 botrocetin B NiNTA Philander opossum 2.00E-04 na na na na na 
1/15/2019 botrocetin B NiNTA Didelphis aurita 3.87E-06 5.71E+04 2.21E-01 2.37E-01 1.91E-01 0.9829 
1/15/2019 botrocetin B NiNTA Didelphis aurita 2.64E-06 5.10E+04 1.35E-01 2.63E-01 2.25E-01 0.9843 
1/15/2019 botrocetin B NiNTA Metachirus nudicaudatus  2.00E-04 na na na na na 
1/15/2019 botrocetin B NiNTA Metachirus nudicaudatus  2.00E-04 na na na na na 
1/15/2019 botrocetin B NiNTA Monodelphis emiliae 4.92E-05 1.27E+04 6.23E-01 2.09E+00 5.13E-01 0.9954 
1/15/2019 botrocetin B NiNTA Monodelphis emiliae 1.30E-05 3.47E+04 4.51E-01 8.88E-01 4.90E-01 0.9938 
1/18/2019 aspercetin HS1K Node 72 2.00E-04 na na na na na 
1/18/2019 botrocetin B NiNTA Node 69 6.77E-06 2.83E+04 1.91E-01 1.03E+00 7.21E-01 0.9924 
1/18/2019 botrocetin B NiNTA Node 71 9.14E-06 2.29E+04 2.09E-01 2.79E+00 1.78E+00 0.9978 
1/18/2019 botrocetin B NiNTA Node 71 9.52E-06 2.35E+04 2.24E-01 3.41E+00 1.56E+00 0.9937 
1/18/2019 botrocetin B NiNTA Node 72 8.45E-06 2.14E+04 1.81E-01 4.06E+00 2.66E+00 0.9947 
1/18/2019 botrocetin B NiNTA Node 69 1.25E-05 2.16E+04 2.69E-01 1.77E+00 9.92E-01 0.9965 
1/21/2019 botrocetin B NiNTA Node 69 3.62E-05 7.76E+03 2.81E-01 2.24E+00 6.86E-01 0.9773 
3/3/2019 botrocetin B NiNTA Monodelphis domestica* 1.55E-05 2.32E+04 3.60E-01 1.07E+00 5.46E-01 0.9905 
3/3/2019 botrocetin B NiNTA Monodelphis domestica* 1.36E-05 2.73E+04 3.72E-01 7.30E-01 3.94E-01 0.9968 
3/3/2019 botrocetin B NiNTA Node 69 2.19E-05 1.17E+04 2.57E-01 1.82E+00 7.66E-01 0.9955 
3/3/2019 botrocetin B NiNTA Node 70 8.39E-07 5.59E+04 4.69E-02 1.14E-01 1.03E-01 0.9823 
3/3/2019 botrocetin B NiNTA Node 70 2.41E-06 4.71E+04 1.14E-01 1.55E-01 1.35E-01 0.9418 
3/3/2019 botrocetin B NiNTA Philander quica* 1.39E-05 2.52E+04 3.51E-01 1.62E+00 5.91E-01 0.9974 
3/3/2019 botrocetin B NiNTA Philander quica* 8.65E-06 3.58E+04 3.10E-01 1.16E+00 5.57E-01 0.9966 
3/4/2019 aspercetin HS1K Monodelphis emiliae 2.69E-07 1.03E+05 2.76E-02 2.64E-01 2.08E-01 0.9758 
3/4/2019 aspercetin HS1K Node 71 3.71E-07 1.77E+04 6.58E-03 1.35E-01 1.30E-01 0.9616 
3/4/2019 aspercetin HS1K Node 73 9.59E-07 1.40E+04 1.34E-02 1.68E-01 1.54E-01 0.9595 
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3/4/2019 aspercetin HS1K Node 70 1.83E-06 4.47E+04 8.17E-02 9.06E-02 7.66E-02 0.9719 
3/4/2019 aspercetin HS1K Node 72 1.77E-05 1.73E+04 3.06E-01 3.83E-01 1.38E-01 0.9418 
3/4/2019 aspercetin HS1K Didelphis aurita 2.00E-04 na na na na na 
3/4/2019 botrocetin B NiNTA Node 73 5.71E-06 2.65E+04 1.52E-01 2.61E+00 1.92E+00 0.9949 
3/4/2019 botrocetin B NiNTA Node 73 1.05E-05 1.85E+04 1.95E-01 5.33E+00 4.63E-01 0.9973 
3/20/2019 bitiscetin NiNTA Didelphis aurita 2.15E-07 3.34E+04 7.20E-03 4.08E-01 3.48E-01 0.9777 
3/20/2019 bitiscetin NiNTA Didelphis aurita 6.40E-07 1.77E+04 1.13E-02 5.62E-01 4.47E-01 0.9842 
3/21/2019 botrocetin A HS1K Human 9.65E-07 7.10E+03 6.85E-03 4.61E-01 3.56E-01 0.98250 
3/22/2019 botrocetin A HS1K Didelphis aurita  2.00E-04 na na na na na 
Appendix Table 4.3- All data collection for curve sets by date from oldest to newest. Table is color coded 
by venom protein. All data is from a globally fit 1:1 binding model performed in BLItz Pro software. Date 
is the date the assay was performed. Chip types are Nickel coated (NiNTA) or pentahistidine tagged 
(HS1K). Molecular indicates the venom protein used. Species indicates the species (or node) of vWF used. 
KD is given here in [M] units. Off rates (ka) is 1/Ms, and off rates (kd) are in 1/s (seconds). Rmax is the 
maximum response determined from the fit of the binding data (nm), R equilibrium is the calculated 
response (nm) at equilibrium resulting from globally fit binding data. R2 is a measure of goodness of fit of 
globally fit binding data.  KD, ka, and kd between chips are scaled --for botrocetin B NiNTA results are 
divided by 7.59, bitiscetin HS1K results are divided by 7.79. Separately expressed bactches of M. 
domestica and P. quica are indicated with an asterisk.  
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Caluromys_lanatus   --------------------------------------------------------------------------------------------
-------------------------------------------------------
AAGCTGTCAGAGGCTGAATTTGAAGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAAGCGCATCCGGGTGGCCGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGAGACCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGTGCTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTTTGACAGCCAGTGAGGAGCCCTTTCCCATGGCTAAGTCTATAGCTCTCTATGT
CCAACGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTGGGGCCCCATGC
TAGCCTCAAGCAGATTCATATCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTTTG
TGACCTGGTACCTGATATTCCTGCTCCTACCATCCCCTCC 
Caluromys_philander   -----------------------------------------------------------------------------------------
----------------------------------------------------------
AAGCTGTCAGAGGCTGAATTTGAAGTGCTGAAGGCTTTTGTCGTAAGTGTGATGGAG
CGTTTACACATCTCTCAAAGGCGCATCCGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGAGACCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGTGCTGAAG
136 
 
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTTTGACAGCCAATGAGGAGCCCCTTCCCATGGCTAAGTCTATAGGTCGCTATGT
CCAAAATCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTGGGGCCCCATGC
TAGCCTCAAGCAGATTCATTTAATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGACCTGGTGCCTGATATTCCTGCTCCTACCATCCCCTCC 
Chironectes_minimus   CAGAAG------
GATCAGAAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATACTTGGAG
GAAACCCCTGAGCCGCCCCTGCATAGCTTCCACTGTAGCAAGATATTGGACTTGGCT
TTCCTGTTGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTT
TTGTCGTAGGTGTGATGGAGCGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTG
TGGTGGAATACCATGATGGCTGCCACTCCTACATTCAAYTGAAAGATCGGAAGCGGC
CCTCAGAGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAATATGGCAT
CCACCAGTGAGGTATTGAAGTTTGCCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCC
TGAAGCATCTCGGATTGCCTTGCTTCTGACGGCCAATGAGGAGCCCCTTCCCATGGCT
AAGGGTATAGAACTCTATGCCCGAGGTCTGAAGAAGAAGAAGGTCATTGTGATTCCA
GTGGGCTTAGGGCCCCATGCTAGCCTTAAGCAGATTCGTCTCATTGAGCAGAAGGCA
CCTGAAAACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGAT
GACATCTTGGACTACTTCTGTGACCTGGTTCCTGATATTCCTGCTCCTACCATCCCCTC
C 
Didelphis_albiventris   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCACCTCTGCATAACTTCCACTGTAGCAAGATATTGGACTTGGCTTTCCTAT
TGGATGGCTCATCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGATGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAAAATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGACGGCCAGTGGGGAGCCCTTTCCCATGGCTAGGAAT
ATAGGTCGCTATGCCCAAAGTCTGAGCGAGAAGAAGGTCACTGTGATTCCAGTGGGC
TTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGTGGCACGCGAA
AACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATC
TTGGGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Didelphis_marsupialis   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCGCCTCTGCATAACTTCCACTGTAGCAAGATATTGGACTTGGCTTTCCTAT
TGGATGGCTCATCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGATGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAAAATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGACGGCCAGTGGGGAGCCCTTGCCCATGGCTAGGAA
TATAGGTCGCTATGCCCAAAGTCTGAGCGAGAAGAAGGTCACTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGTGGCACGTGA
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AAACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGGGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Didelphis_virginiana   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCGCCTCTGCATAACTTCCACTGTAGCAAGATATTGGACTTGGCTTTCCTAT
TGGATGGCTCCTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGATGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAAAATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGACGGCCAGTGGGGAGCCCTTGCCCATGGCTAGGAA
TATAGGTCGCTATGCCCAAAGTCTGAGCCAGAAGAAGGTCACTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGCGGCACGCGA
AAACAAGCCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGAGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Glironia_venusta   ----------------------------------------------------------------------------------------------
-----------------------------------------------------
AAGCTGTCAGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAR
CGCTTACACATCTCTCAGAGGCGCATCCGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGYAAGATGGCATCCACCAGTGAGGCGCTGAAG
TTTACCCTTTTCCACATCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCTTTCCCATGGCTAGGTCTATAGCTCGCTTTGT
CAAAGGTCTAAATAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTCATACCATTGAGGAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGCATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTATCTCTG
TGACTTGGTACCTGATATTCCTGCTCCTACCCTCCCCTCC 
Gracilinanus_aceramarcae   -----------------------------------------------------------------------------------
----------------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAAGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTTTGGTGGAATACCATGATGGT
TCCCATTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCGCTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCACCC
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCCAAGTCTATAGCTCGCTATA
CCCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATG
CTAGCCTCAAGCAGATTCGTCTCATCGAGAAGCAGGCACCAGAAAACAAGGCCTTTT
TGCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCAGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATGTTCCTGCTCCCACCATCCCCTCC 
Gracilinanus_agilis   --------------------------------------------------------------------------------------------
-------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTCGAGGTGCTGAAGGCTTTTGTCGTGGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCGGAGCTTCGTCGGATT
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GCCAGTTCTGTGAGGTATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCGCTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCACCT
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCCAAGTCTATAGCTCGCTATG
CCCAAGGTCTGAAGAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCAT
GCTAGCCTCAAGCAGATTCGTCTCATCGAGAAGCAGGCACCAGAAAACAAGGCCTTT
TTGCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTC
TGTGACCTGGTACCTGATATTCCTGCTCCTACCGTCCCCTCC 
Gracilinanus_emiliae   -----------------------------------------------------------------------------------------
----------------------------------------------------------
AAGCTGTCGGAGGCTGAATTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCGGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCGCTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCACCT
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCCAAGTCTATAGCTCGCTATG
CCCAAGGTCTGAAGAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCAT
GCTAGCCTCAAGCAGATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTT
TTGCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTC
TGTGACCTGGTACCTGACATTCCTGCTCCTACCATCCCCTCC 
Gracilinanus_microtarsus   ------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
------------------
CAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGTTCCCACTCCTACATT
GAACTGAAAGATCGGAAGCGGCCTTCGGAGCTTCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCGCTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCACCTTGCTTCTGACGGCC
AGTGAGGAGCCCCTTCCCATGGCCAAGTCTATAGCTCGCTATGCCCAAGGTCTGAAG
AAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCATGCTAGCCTCAAGCAG
ATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTTGCTTAGTGGCGTG
AATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCT
GATATTCCTGCTCCTACCATCCCCTCC 
Lutreolina_crassicaudata   CAGGAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCGCCCCTGCATAGCTTCCACTGTAGCAAGATGTTGGACTTGGCTTTCCTGT
TGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTGCACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGATGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAAAATGGCATCCATCA
GTGAGGTATTGAAGTTTGCCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGACAGCCAGTGGGGAGCCCTTGCCCATAGGTAGGAA
TATAGGTCGCTATGCCCAAAGTCTGAAGAAGAAGAAGGTCATTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGAGGCACGCGA
AAACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGAGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTATCATCCCCTCC 
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Marmosa_demerarae   ------------------------------------------------------------------------------------------
---------------------------------------------------------
AAGTTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGACCTGAAGCATCTCGGATTACCT
TGCTTCTGACAGCCAGTGAGGAGCCCTATCCCATGGCTAAGTCTATAGCTCGCTATA
CCCACGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATG
CTAGCCTCAAGCAGATTAGTACCATTGAGGAGGCGGCACCAGAAAACAAGGCCTTTT
TGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATATTCCTGCTCCTACTATCCCCTCC 
Marmosa_lepida   -----------------------------------------------------------------------------------------------
----------------------------------------------------
AGGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGCGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACAGACCTGAAGCATCTCGGATTGCCT
TGCTTCTGACAGCCAGTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGCTCGCTATAC
CCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
CAGCCTCAAGCAGATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCAGGATGACATCTTGGGCTACCTCTG
TGACCTGGTACCTGATATTCCTGCTCCTACTATCCCCTCC 
Marmosa_mexicana   -------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
-----------
CAGAGGCGCATCAGGGTGGCGGTGATGGAATACCATGATGGCTCCCACTCCTACATT
GAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGTAAGATGGCATCCACCAGCGAGGCACTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGACCTGAAGCATCTCGGATTGCCTTGCTTCTGACAGCC
AGTGAGGAGCCCCTTCCCAGATCTAAGTCTATAGTTCGCTATGCCCAAGGTCTGAAG
AAGAAGAAGATCATTGTGATCCCAGTGGGCATAGGGCCCCATGTTAGCCTCAAGCAG
ATTCAAGTCATTGAGAATCAGGCACCAGAAAACAAGGCCTTTTTGCTTAGTGGTGTG
AATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCT
GATATTCCTGCTCCTACCATCCCCTCC 
Marmosa_murina   ----------------------------------------------------------------------------------------------
-----------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTTGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGACCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCATTCCCATGTCTAAGTCTATACCTCGCTATGC
140 
 
CCAAAGTCTGAAGAAGAAGAAGGTCATTGTGATCCCGGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTCATCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGACCTGGTACCTGATATTCCTGCTCCTACTATCCCCTCC 
Marmosa_paraguayana   ---------------------------------------------------------------------------------------
------------------------------------------------------------
AAGTTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGACCTGAAGCATCTCGGATTACYT
TGCTTCTGACAGCCAGTGAGGAGCCCTTTCCCATGGCTAAGTCTATAGCTCGCTATAC
CCACGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTAGTACCATTGAGGAGGCGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGACCTGGTACCTGATATTCCTGCTCCTACTATCCCCTCC 
Marmosa_robinsoni   -------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
-----------
CAGAGGCGCATCAGGGTGGCGGTGATGGAGTACCATGATGGCTCCCACTCCTACATT
GAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGTAAGATGGCATCCACCAGTGAGGCACTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGACCTGAAGCATTTCGGATTGCCTTGCTTCTGACAGCCA
GTGAGGAGCCCCTTCCCACATCTAAGTCTATAATTCGCTATGCCCAAGGTCTGAAGA
AGAAGAAGGTCATTGTGATCCCAGTGGGCATAGGGCCCCATGCTAGCCTCAGGCAG
ATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTTGCTTAGTGGTGTG
AATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCT
GATATTCCTGCTCCTACCATCCCYTCC 
Marmosa_rubra   ------------------------------------------------------------------------------------------------
---------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
TGCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATAGCATCTATCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGACTGACCGACCTGAAGCATCTCGGATTGCCT
TGCTTCTGACAGCCAGTAAGGAGCCCTTTCGTACGGCTAAGAATATAGGTCACTATG
CCGGAAATCTGAAGAAGAAGAATATCATTGTGATCCCAGTGGGCTTAGGGCCCCGTG
CTAACCTCCAGCAAATTGATCACATTGTGACGAAGGCACCAGAAAACAAGGCCTTTT
TGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATATTCCTGCTCCTACCATCCCCTCC 
Marmosa_rutteri   -----------------------------------------------------------------------------------------------
----------------------------------------------------
AAGTTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTTGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAAGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
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TCCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCATCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGTTGACCGACCTGAAGCATCTCGGATTACCT
TGCTTCTGACGGCCAGTGAGGAGCCCTTTCCCGTGACTAAGACTATAGCTCGCTATA
CCCAAGGTCTGAAAAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATG
CTAGCCTCAAGTACATTCGTCTCATTGAGAAGCAGGCACCAGTAAACAAGGCCTTTT
TGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATATTCCTGCTCCTACTATCCCCTCC 
Marmosops_incanus   ------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
------------
CAGAGGCGCATCAGAGTGGCTGTGGTGGAATACCATGATGGTTCCCACTCCTACATT
GAACTGAAAGATCGGAAGCGGCCCTCAGAGCTCCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGCAAGATGGCATCCATCAGTGAGGCACTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGCCCTGAAGCTTCTCGGATTGCCTTGCTTCTGATGGCCA
GTGAGGAGCCCTTACCCATGGCTAAGTCTATAGCTCGCTATACCCAAGGTCTGAAGA
AGAAGAAGGTCATTGTGATCCCAGTGGGCTTGGGGCCCCATGCTAGCCTCAAGCAGA
TTCATCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTTGCTGAGTGGTGTGA
ATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTG
ATGTTCCTGCTCCTACCATCCCCTCC 
Marmosops_noctivagus   --------------------------------------------------------------------------------------
-------------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTTGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGACGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGACCCTCAGAGCTCCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCTTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTCTAACAGCCAGTGAGGAGCCCCTTCCCATGGCCAGATCTATACCTCGCTATGC
CCWAGCGCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTGGGGCCCCATG
CTAGCCTCAGGCAKATTCGTCTCATTGAGAAACAGGCACCAGAAAACAAGGCCTTTT
TGCTGAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATGTTCCTGCTCCTACCATCCCCTCC 
Marmosops_parvidens   ----------------------------------------------------------------------------------------
-----------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCCCAGAGGCGCATCAGGGTGGCAGTGGTGGAATACCATGATGGT
TCTCACTCCTACATTGAACTGAAAGCTCGGAAGCGGCCCTCAGAGCTCCGCCGGATT
GCTAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGCTCGCTATAC
CCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGATCTGGTACCTGATGTTCCTGCTCCTACCATCCCCTCC 
142 
 
Marmosops_pinheiroi   -----------------------------------------------------------------------------------------
----------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTTGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCAGTGGTGGAATACCATGATGGT
TCTCACTCCTACATTGAACTGAAAGCTCGGAAGCGGCCCTCAGAGCTCCGCCGGATT
GCTAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCATCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGCTCGCTATAC
CCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAACGGCGGGATGACATCTTGGGCTACCTCTG
TGATCTGGTACCTGATGTTCCTGCTCCTACCATCCCCTCC 
Marmosops_spGalvez   ----------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
--------------
CAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGTTCCCACTCCTACATT
GAACTGAAAGATCGGAAGCGACCTTCAGAGCTCCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCCCTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCTTGCTTCTAACGGCCA
GTGAGGAGCCCCTTCCCATGGCTAAGTCTATACCTCGCTATGCCCTAGGGCTGAAGA
AGAAGAAGGTCATTGTGATCCCAGTGGGCTTGGGGCCCCATGCTAGCCTCAGGCAGA
TTCGTCTCATTGAGAAACAGGCACCAGAAAACAAGGCCTTTTTGCTGAGTGGTGTGA
ATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTG
ATGTTCCTGCTCCTACCATCCCCCCC 
Metachirus_nudicaudatus   CAGAAGCCATGG---------
TTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATACCTGGAGGAAACCCCT
GAGCCACCCCTGGATAGTTTCCACTGCAGCAAGATATTGGACTTGGCTTTCCTGTTGG
ATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTTGTAG
ATATGATGGAGCGTTTGCACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAAT
ACCATGAGGGTTCCCACTCGTACATTGAACTAAAAGATCGGAAGCGGCCCTCAGAGC
TTCGTCGKATTGCCAGTTCTGTGAGATATCCTGGCAGCAAGATAGCATCTACCAGTG
AGGCGCTGAAATTTGCCCTTTTCCATATCTTTGGCAAGGCTGACCGTCCTGAAGCATC
TCGGATCGCCTTGCTTCTGACAGCCAGTGAGGAACCC------
AAGGATAAGCTTATAGCTCGCTACTCCCACAGTCTGAAGAAGAAGAAGGTCATTGTG
ATCCCAGTGGGCTTAGGGCCCCATGCTAGCCTCAAGCAGATTCGACTCATTGAGAAG
CAGGCACCAGAAAACAAAGCCTTTTTGCTTAGTGGTGTGAATGAGCTACAGCAAAGG
CGTGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTGATATTCCTGCTCCTACAA
AACCCTCC 
Monodelphis_domestica   
CAGAAGCCAGGGGACCTGCAGTTGTCCCCATCATTTACGACTGTTGCCCCAACCGCA
GAATACCTGGAGGAAACCCCTGAGCCACCCCTGCATAGCTTCTACTGTAGCAAGATG
TTGGACTTGGCTTTCCTGTTGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGG
TGCTGAAGGCTTTTGTCGTAGGTGTGATGGAGCGTTTACACATCTCTCAGAGGCGCA
TCAGGGTGGCTTTGGTGGAATACCATGAGGGCTCCCACTCCTACATTGAACTGAAGG
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ATCGGAAGCGGCCCTCAGAGCTTCGTCGGATTGCCAGTTCTGTAAGATATCCTGGAA
GCAAGATGGCATCCACCAGCGAGGTACTGAAGTTTACCCTTTTCCATGTCTTTGGCA
AGGTTGACCGTCCTGAAGCATCTCGGATTGCCTTGCTTCTGACGGCCAGTGAGGAGC
CCCGTCCCACGTCTAAGTCTATAGCTCGCTATTCCCAAGATCTGATGGAGAAGAAGG
TCATTGTGATCCCAGTGGGCTTAGGGCCCCATGCTAGCCTCAGGCAGATTCGTCTCAT
TGAGAAGCAGGCACCAGAAAACAAGGCCTTTTTGCTTAGTGGTGTGAATGAGCTAGA
GCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTGATAGTCCTGC
TCCTACCATTCCCTCC 
Monodelphis_brevicaudata   ----------------------------------------------------------------------------------
-----------------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGATCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTACGATATCCTGGAAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGTCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCGTCCCACGTCTAAGTCTATAGCTCGCTATTC
CCAAGGTCTGGCGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAGGCAGATTCATCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGACCTGGTACCTGATAGTCCTGCTCCTACCATTCCCTCC 
Monodelphis_emiliae   -----------------------------------------------------------------------------------------
----------------------------------------------------------
AAGCTGTCAGAGTCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGATCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTAAGATATCCTGGCAGCAAGATGGCATCCATCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGTCCTAAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAAGAGCCCCTTCGCATGACTAAGTTTATAGGTCACTATG
CCCAAAGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATG
CTAGCCTCAAGCATATTCGTCTCATTGAGAACAAGGCACCAGAAAACAAGGCCTTTT
TGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATATTCCTGCTCCTACCATTCCCTCC 
Monodelphis_peruviana   --------------------------------------------------------------------------------------
-------------------------------------------------------------
AAACTGTCGGAGTCTGAGTTTGAGGTGCTGAAGGCTTTTGTYGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGC
TCCCACTCTTACATTGAACTGAAGGATCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTAAGATATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGTCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCTAGTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGGTCGCTATAC
CCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTCGTCTCATCGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAACTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGACCTGGTACCTGATATTCCTGCTCCTACCATTCCCTCC 
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Monodelphis_scalops   -----------------------------------------------------------------------------------------
----------------------------------------------------------
AAGCTGTCAGAGTCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGTATCAGGGTGGCTGTGGTGGAATACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGATCGGAAACGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTAAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGTCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGCTCGCTACA
CCCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATG
CTAGCCTCAAGCAGATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTT
TGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATATTCCTGCTCCTACCATTCCCTCC 
Philander_mcilhennyi   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCGCCTCTGCATAACTTCCACTGTAGCAAGATATTGGACTTGGTTTTCCTGT
TGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGAGGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAATATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTAAACGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGAYGGCCAGTGGGGAGCCCTTGCCCATGGCTAGGAA
TATAGTTCGCTATGCCCAAAGTCTGAGCGAGAAGAAGGTCACTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGCGGCACGCGA
AAACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGGGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Philander_opossum   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCGCCTCTGCATAACTTCCACTGTAGCAAGATATTGGACTTGGTTTTCCTGT
TGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGAGGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAATATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTAAACGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGACGGCCAGTGGGGAGCCCTTGCCCATGGCTAGGAA
TATAGTTCGCTATGCCCAAAGTCTGAGCGAGAAGAAGGTCACTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGCGGCACGCGA
AAACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGGGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Philander_quica   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACTACAGCATATGTGGAGGAAACC
CCTGAGCCGCCTCTGTATAACTTCCACTGCAGCAAGCTATTGGACTTGGTTTTCCTGT
TGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGATGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
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AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCGAAATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGATGGCCAGTGGGGAGCCCTTGCCCATGGGTAGGAA
TATAGGTCACTATGCCCAAAGTCTGAGCGAGAAGAAGGTCACTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGCGTCACGTGA
AAACAAGCCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGGGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Thylamys_macrurus   ------------------------------------------------------------------------------------------
---------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCCTCCCATGGCTAAGTCTATAGGTCGCTATG
CCCAAGGTCTGAAGAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCAT
GCTAGCCTCAAGCAGATCCGTATCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTT
TTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTC
TGTGACCTGGTACCTGATATTCCTGCTCCTACCATCCCCTCC 
Thylamys_pallidior   -------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
--------------------------
GTGGCTGTGGTGGAATACCATGATGGTTCCCACTCCTACATTGAACTGAAAGATCGG
AAGCGGCCTTCAGAGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAAG
ATGGCATCCACCAGTGAGGCACTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTG
ACCGCCCTGAAGCATCTCGGATCGCCTTGCTTCTGACGGCCAGTGAGGAGCCCCTTC
CCATGGCTAAGTCTATAGGTCGCTATGCCCAAGGTCTGAAGAAGAAGAAGGTCATCG
TGATCCCAGTGGGCTTAGGGCCCCATGCTAGCCTCAAGCAGATCCGTATCATTGAGA
AGCAGGCACCAGAAAACAAGGCCTTTTTGCTCAGTGGCGTGAATGAGCTAGAGCAA
AGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTGATATTCCTGCTCCTA
CCATCCCCTCC 
Thylamys_pusillus   --------------------------------------------------------------------------------------------
-------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCCTCCCATGGCTAAGTCTATAGGTCGCTATG
CCCAAGGTCTGAAGAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCAT
GCTAGCCTCAAGCAGATCCGTATCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTT
TTGCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTC
TGTGACCTGGTACCTGATATTCCTGCTCCTACCRTCCCCTCC 
146 
 
Thylamys_venustus   -------------------------------------------------------------------------------------------
--------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCCTCCCATGGCTAAGTCTATAGGTCGCTATG
CCCAAGGTCTGAAGAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCAT
GCTAGCCTCAAGCAGATCCGTATCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTT
TTGCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTC
TGTGACCTGGTACCTGATATTCCTGCTCCTACCATCCCCTCC 
Tlacuatzin_canescens   -----------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
-------------
CAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGATCCCACTCCTACATT
GAACTGAAGGATCGGAAGCGGCCCTCGGAGCTTCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCTTTGCTTCTGACGGCCA
GTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGCTCGCTTTACCCAAGGTCTGAAGA
AGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGCTAGCCTCAAGCAGA
TTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTTGCTTAGTGGTGTGA
ATGAGCTAGAGCAAAGGCAGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTG
ATGTTCCTGCTCCTACCATCCCCTCC 
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((((((((((Marmosa_demerarae:2.765345451,Marmosa_paraguayana:2.765345451):1.273905464,
Marmosa_rutteri:4.039250914):4.807878906,Marmosa_lepida:8.847129821):0.6181647349,Mar
mosa_murina:9.465294557):2.563326222,((Marmosa_mexicana:6.095467925,Marmosa_robinso
ni:6.095467925):4.271309193,Marmosa_rubra:10.36677712):1.661843661):6.811332203,((((Mo
nodelphis_domestica:1.910844392,Monodelphis_brevicaudata:1.910844392):5.417041016,Mono
delphis_peruviana:7.32788541):0.5183117649,Monodelphis_emiliae:7.846197173):0.754799745
2,Monodelphis_scalops:8.600996918):10.23895606):1.563429229,Tlacuatzin_canescens:20.4033
8221):4.157254367,((((Marmosops_parvidens:4.419065303,Marmosops_pinheiroi:4.419065303)
:9.729347487,((Marmosops_spGalvez:3.685183951,Marmosops_noctivagus:3.685183951):7.422
23026,Marmosops_incanus:11.10741421):3.040998578):4.907926781,((((Thylamys_pusillus:1.6
91742116,Thylamys_macrurus:1.691742116):0.5182666689,Thylamys_pallidior:2.210008785):0
.317471128,Thylamys_venustus:2.527479913):9.042200902,(Gracilinanus_emiliae:7.154086816
,(Gracilinanus_aceramarcae:4.776400484,(Gracilinanus_microtarsus:4.134707034,Gracilinanus_
agilis:4.134707034):0.6416934509):2.377686333):4.415593998):7.486658755):4.257517681,((((
((Philander_opossum:0.5543911959,Philander_mcilhennyi:0.5543911959):2.69796657,Philander
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_quica:3.252357766):1.647067035,((Didelphis_marsupialis:2.148514431,Didelphis_albiventris:2
.148514431):0.9146554021,Didelphis_virginiana:3.063169833):1.836254969):2.661929493,Lutr
eolina_crassicaudata:7.561354295):3.428728553,Chironectes_minimus:10.99008285):9.1381667
44,Metachirus_nudicaudatus:20.12824959):3.18560766):1.246779326):6.533314423,Glironia_ve
nusta:31.093951):1.445331938,(Caluromys_lanatus:4.708844969,Caluromys_philander:4.70884
4959):27.83043798); 
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Caluromys_lanatus   --------------------------------------------------------------------------------------------
-------------------------------------------------------
AAGCTGTCAGAGGCTGAATTTGAAGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAAGCGCATCCGGGTGGCCGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGAGACCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGTGCTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTTTGACAGCCAGTGAGGAGCCCTTTCCCATGGCTAAGTCTATAGCTCTCTATGT
CCAACGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTGGGGCCCCATGC
TAGCCTCAAGCAGATTCATATCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTTTG
TGACCTGGTACCTGATATTCCTGCTCCTACCATCCCCTCC 
Caluromys_philander   -----------------------------------------------------------------------------------------
----------------------------------------------------------
AAGCTGTCAGAGGCTGAATTTGAAGTGCTGAAGGCTTTTGTCGTAAGTGTGATGGAG
CGTTTACACATCTCTCAAAGGCGCATCCGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGAGACCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGTGCTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTTTGACAGCCAATGAGGAGCCCCTTCCCATGGCTAAGTCTATAGGTCGCTATGT
CCAAAATCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTGGGGCCCCATGC
TAGCCTCAAGCAGATTCATTTAATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGACCTGGTGCCTGATATTCCTGCTCCTACCATCCCCTCC 
Chironectes_minimus   CAGAAG------
GATCAGAAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATACTTGGAG
GAAACCCCTGAGCCGCCCCTGCATAGCTTCCACTGTAGCAAGATATTGGACTTGGCT
TTCCTGTTGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTT
TTGTCGTAGGTGTGATGGAGCGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTG
TGGTGGAATACCATGATGGCTGCCACTCCTACATTCAAYTGAAAGATCGGAAGCGGC
CCTCAGAGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAATATGGCAT
CCACCAGTGAGGTATTGAAGTTTGCCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCC
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TGAAGCATCTCGGATTGCCTTGCTTCTGACGGCCAATGAGGAGCCCCTTCCCATGGCT
AAGGGTATAGAACTCTATGCCCGAGGTCTGAAGAAGAAGAAGGTCATTGTGATTCCA
GTGGGCTTAGGGCCCCATGCTAGCCTTAAGCAGATTCGTCTCATTGAGCAGAAGGCA
CCTGAAAACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGAT
GACATCTTGGACTACTTCTGTGACCTGGTTCCTGATATTCCTGCTCCTACCATCCCCTC
C 
Didelphis_albiventris   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCACCTCTGCATAACTTCCACTGTAGCAAGATATTGGACTTGGCTTTCCTAT
TGGATGGCTCATCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGATGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAAAATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGACGGCCAGTGGGGAGCCCTTTCCCATGGCTAGGAAT
ATAGGTCGCTATGCCCAAAGTCTGAGCGAGAAGAAGGTCACTGTGATTCCAGTGGGC
TTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGTGGCACGCGAA
AACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATC
TTGGGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Didelphis_aurita   CAGAAG------------
CAGTCGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCTCCTCTGCATAACTTCCACTGTAGCAAGATATTGGACTTGGCTTTCCTAT
TGGATGGCTCATCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGATGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAAAATGGCATCCATAA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGACGGCCAGTGGGGAGCCCTTGCCCATGGGTAGGAA
TATAGGTCACTATGCCCAAAGTCTGAGCGAGAAGAAGGTCACTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGTGGCACGCGA
AAACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGGGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Didelphis_marsupialis   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCGCCTCTGCATAACTTCCACTGTAGCAAGATATTGGACTTGGCTTTCCTAT
TGGATGGCTCATCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGATGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAAAATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGACGGCCAGTGGGGAGCCCTTGCCCATGGCTAGGAA
TATAGGTCGCTATGCCCAAAGTCTGAGCGAGAAGAAGGTCACTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGTGGCACGTGA
149 
 
AAACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGGGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Didelphis_virginiana   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCGCCTCTGCATAACTTCCACTGTAGCAAGATATTGGACTTGGCTTTCCTAT
TGGATGGCTCCTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGATGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAAAATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGACGGCCAGTGGGGAGCCCTTGCCCATGGCTAGGAA
TATAGGTCGCTATGCCCAAAGTCTGAGCCAGAAGAAGGTCACTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGCGGCACGCGA
AAACAAGCCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGAGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Glironia_venusta   ----------------------------------------------------------------------------------------------
-----------------------------------------------------
AAGCTGTCAGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAR
CGCTTACACATCTCTCAGAGGCGCATCCGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGYAAGATGGCATCCACCAGTGAGGCGCTGAAG
TTTACCCTTTTCCACATCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCTTTCCCATGGCTAGGTCTATAGCTCGCTTTGT
CAAAGGTCTAAATAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTCATACCATTGAGGAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGCATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTATCTCTG
TGACTTGGTACCTGATATTCCTGCTCCTACCCTCCCCTCC 
Gracilinanus_aceramarcae   -----------------------------------------------------------------------------------
----------------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAAGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTTTGGTGGAATACCATGATGGT
TCCCATTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCGCTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCACCC
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCCAAGTCTATAGCTCGCTATA
CCCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATG
CTAGCCTCAAGCAGATTCGTCTCATCGAGAAGCAGGCACCAGAAAACAAGGCCTTTT
TGCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCAGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATGTTCCTGCTCCCACCATCCCCTCC 
Gracilinanus_agilis   --------------------------------------------------------------------------------------------
-------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTCGAGGTGCTGAAGGCTTTTGTCGTGGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCGGAGCTTCGTCGGATT
150 
 
GCCAGTTCTGTGAGGTATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCGCTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCACCT
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCCAAGTCTATAGCTCGCTATG
CCCAAGGTCTGAAGAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCAT
GCTAGCCTCAAGCAGATTCGTCTCATCGAGAAGCAGGCACCAGAAAACAAGGCCTTT
TTGCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTC
TGTGACCTGGTACCTGATATTCCTGCTCCTACCGTCCCCTCC 
Gracilinanus_emiliae   -----------------------------------------------------------------------------------------
----------------------------------------------------------
AAGCTGTCGGAGGCTGAATTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCGGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCGCTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCACCT
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCCAAGTCTATAGCTCGCTATG
CCCAAGGTCTGAAGAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCAT
GCTAGCCTCAAGCAGATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTT
TTGCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTC
TGTGACCTGGTACCTGACATTCCTGCTCCTACCATCCCCTCC 
Gracilinanus_microtarsus   ------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
------------------
CAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGTTCCCACTCCTACATT
GAACTGAAAGATCGGAAGCGGCCTTCGGAGCTTCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCGCTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCACCTTGCTTCTGACGGCC
AGTGAGGAGCCCCTTCCCATGGCCAAGTCTATAGCTCGCTATGCCCAAGGTCTGAAG
AAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCATGCTAGCCTCAAGCAG
ATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTTGCTTAGTGGCGTG
AATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCT
GATATTCCTGCTCCTACCATCCCCTCC 
Lutreolina_crassicaudata   CAGGAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCGCCCCTGCATAGCTTCCACTGTAGCAAGATGTTGGACTTGGCTTTCCTGT
TGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTGCACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGATGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAAAATGGCATCCATCA
GTGAGGTATTGAAGTTTGCCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGACAGCCAGTGGGGAGCCCTTGCCCATAGGTAGGAA
TATAGGTCGCTATGCCCAAAGTCTGAAGAAGAAGAAGGTCATTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGAGGCACGCGA
AAACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGAGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTATCATCCCCTCC 
151 
 
Marmosa_demerarae   ------------------------------------------------------------------------------------------
---------------------------------------------------------
AAGTTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGACCTGAAGCATCTCGGATTACCT
TGCTTCTGACAGCCAGTGAGGAGCCCTATCCCATGGCTAAGTCTATAGCTCGCTATA
CCCACGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATG
CTAGCCTCAAGCAGATTAGTACCATTGAGGAGGCGGCACCAGAAAACAAGGCCTTTT
TGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATATTCCTGCTCCTACTATCCCCTCC 
Marmosa_lepida   -----------------------------------------------------------------------------------------------
----------------------------------------------------
AGGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGCGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACAGACCTGAAGCATCTCGGATTGCCT
TGCTTCTGACAGCCAGTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGCTCGCTATAC
CCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
CAGCCTCAAGCAGATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCAGGATGACATCTTGGGCTACCTCTG
TGACCTGGTACCTGATATTCCTGCTCCTACTATCCCCTCC 
Marmosa_mexicana   -------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
-----------
CAGAGGCGCATCAGGGTGGCGGTGATGGAATACCATGATGGCTCCCACTCCTACATT
GAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGTAAGATGGCATCCACCAGCGAGGCACTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGACCTGAAGCATCTCGGATTGCCTTGCTTCTGACAGCC
AGTGAGGAGCCCCTTCCCAGATCTAAGTCTATAGTTCGCTATGCCCAAGGTCTGAAG
AAGAAGAAGATCATTGTGATCCCAGTGGGCATAGGGCCCCATGTTAGCCTCAAGCAG
ATTCAAGTCATTGAGAATCAGGCACCAGAAAACAAGGCCTTTTTGCTTAGTGGTGTG
AATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCT
GATATTCCTGCTCCTACCATCCCCTCC 
Marmosa_murina   ----------------------------------------------------------------------------------------------
-----------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTTGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGACCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCATTCCCATGTCTAAGTCTATACCTCGCTATGC
152 
 
CCAAAGTCTGAAGAAGAAGAAGGTCATTGTGATCCCGGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTCATCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGACCTGGTACCTGATATTCCTGCTCCTACTATCCCCTCC 
Marmosa_paraguayana   ---------------------------------------------------------------------------------------
------------------------------------------------------------
AAGTTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGACCTGAAGCATCTCGGATTACYT
TGCTTCTGACAGCCAGTGAGGAGCCCTTTCCCATGGCTAAGTCTATAGCTCGCTATAC
CCACGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTAGTACCATTGAGGAGGCGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGACCTGGTACCTGATATTCCTGCTCCTACTATCCCCTCC 
Marmosa_robinsoni   -------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
-----------
CAGAGGCGCATCAGGGTGGCGGTGATGGAGTACCATGATGGCTCCCACTCCTACATT
GAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGTAAGATGGCATCCACCAGTGAGGCACTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGACCTGAAGCATTTCGGATTGCCTTGCTTCTGACAGCCA
GTGAGGAGCCCCTTCCCACATCTAAGTCTATAATTCGCTATGCCCAAGGTCTGAAGA
AGAAGAAGGTCATTGTGATCCCAGTGGGCATAGGGCCCCATGCTAGCCTCAGGCAG
ATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTTGCTTAGTGGTGTG
AATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCT
GATATTCCTGCTCCTACCATCCCYTCC 
Marmosa_rubra   ------------------------------------------------------------------------------------------------
---------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
TGCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATAGCATCTATCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGACTGACCGACCTGAAGCATCTCGGATTGCCT
TGCTTCTGACAGCCAGTAAGGAGCCCTTTCGTACGGCTAAGAATATAGGTCACTATG
CCGGAAATCTGAAGAAGAAGAATATCATTGTGATCCCAGTGGGCTTAGGGCCCCGTG
CTAACCTCCAGCAAATTGATCACATTGTGACGAAGGCACCAGAAAACAAGGCCTTTT
TGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATATTCCTGCTCCTACCATCCCCTCC 
Marmosa_rutteri   -----------------------------------------------------------------------------------------------
----------------------------------------------------
AAGTTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTTGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAAGCGCATCAGGGTGGCGGTGGTGGAGTACCATGATGGC
153 
 
TCCCACTCCTACATTGAACTGAAGGACCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCATCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGTTGACCGACCTGAAGCATCTCGGATTACCT
TGCTTCTGACGGCCAGTGAGGAGCCCTTTCCCGTGACTAAGACTATAGCTCGCTATA
CCCAAGGTCTGAAAAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATG
CTAGCCTCAAGTACATTCGTCTCATTGAGAAGCAGGCACCAGTAAACAAGGCCTTTT
TGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATATTCCTGCTCCTACTATCCCCTCC 
Marmosops_incanus   ------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
------------
CAGAGGCGCATCAGAGTGGCTGTGGTGGAATACCATGATGGTTCCCACTCCTACATT
GAACTGAAAGATCGGAAGCGGCCCTCAGAGCTCCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGCAAGATGGCATCCATCAGTGAGGCACTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGCCCTGAAGCTTCTCGGATTGCCTTGCTTCTGATGGCCA
GTGAGGAGCCCTTACCCATGGCTAAGTCTATAGCTCGCTATACCCAAGGTCTGAAGA
AGAAGAAGGTCATTGTGATCCCAGTGGGCTTGGGGCCCCATGCTAGCCTCAAGCAGA
TTCATCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTTGCTGAGTGGTGTGA
ATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTG
ATGTTCCTGCTCCTACCATCCCCTCC 
Marmosops_noctivagus   --------------------------------------------------------------------------------------
-------------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTTGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGACGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGACCCTCAGAGCTCCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCTTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTCTAACAGCCAGTGAGGAGCCCCTTCCCATGGCCAGATCTATACCTCGCTATGC
CCWAGCGCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTGGGGCCCCATG
CTAGCCTCAGGCAKATTCGTCTCATTGAGAAACAGGCACCAGAAAACAAGGCCTTTT
TGCTGAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATGTTCCTGCTCCTACCATCCCCTCC 
Marmosops_parvidens   ----------------------------------------------------------------------------------------
-----------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCCCAGAGGCGCATCAGGGTGGCAGTGGTGGAATACCATGATGGT
TCTCACTCCTACATTGAACTGAAAGCTCGGAAGCGGCCCTCAGAGCTCCGCCGGATT
GCTAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGCTCGCTATAC
CCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGATCTGGTACCTGATGTTCCTGCTCCTACCATCCCCTCC 
154 
 
Marmosops_pinheiroi   -----------------------------------------------------------------------------------------
----------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTTGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCAGTGGTGGAATACCATGATGGT
TCTCACTCCTACATTGAACTGAAAGCTCGGAAGCGGCCCTCAGAGCTCCGCCGGATT
GCTAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCATCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGCTCGCTATAC
CCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAACGGCGGGATGACATCTTGGGCTACCTCTG
TGATCTGGTACCTGATGTTCCTGCTCCTACCATCCCCTCC 
Marmosops_spGalvez   ----------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
--------------
CAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGTTCCCACTCCTACATT
GAACTGAAAGATCGGAAGCGACCTTCAGAGCTCCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCCCTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCCTTGCTTCTAACGGCCA
GTGAGGAGCCCCTTCCCATGGCTAAGTCTATACCTCGCTATGCCCTAGGGCTGAAGA
AGAAGAAGGTCATTGTGATCCCAGTGGGCTTGGGGCCCCATGCTAGCCTCAGGCAGA
TTCGTCTCATTGAGAAACAGGCACCAGAAAACAAGGCCTTTTTGCTGAGTGGTGTGA
ATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTG
ATGTTCCTGCTCCTACCATCCCCCCC 
Metachirus_nudicaudatus   CAGAAGCCATGG---------
TTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATACCTGGAGGAAACCCCT
GAGCCACCCCTGGATAGTTTCCACTGCAGCAAGATATTGGACTTGGCTTTCCTGTTGG
ATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTTGTAG
ATATGATGGAGCGTTTGCACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAAT
ACCATGAGGGTTCCCACTCGTACATTGAACTAAAAGATCGGAAGCGGCCCTCAGAGC
TTCGTCGKATTGCCAGTTCTGTGAGATATCCTGGCAGCAAGATAGCATCTACCAGTG
AGGCGCTGAAATTTGCCCTTTTCCATATCTTTGGCAAGGCTGACCGTCCTGAAGCATC
TCGGATCGCCTTGCTTCTGACAGCCAGTGAGGAACCC------
AAGGATAAGCTTATAGCTCGCTACTCCCACAGTCTGAAGAAGAAGAAGGTCATTGTG
ATCCCAGTGGGCTTAGGGCCCCATGCTAGCCTCAAGCAGATTCGACTCATTGAGAAG
CAGGCACCAGAAAACAAAGCCTTTTTGCTTAGTGGTGTGAATGAGCTACAGCAAAGG
CGTGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTGATATTCCTGCTCCTACAA
AACCCTCC 
Monodelphis_domestica   
CAGAAGCCAGGGGACCTGCAGTTGTCCCCATCATTTACGACTGTTGCCCCAACCGCA
GAATACCTGGAGGAAACCCCTGAGCCACCCCTGCATAGCTTCTACTGTAGCAAGATG
TTGGACTTGGCTTTCCTGTTGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGG
TGCTGAAGGCTTTTGTCGTAGGTGTGATGGAGCGTTTACACATCTCTCAGAGGCGCA
TCAGGGTGGCTTTGGTGGAATACCATGAGGGCTCCCACTCCTACATTGAACTGAAGG
155 
 
ATCGGAAGCGGCCCTCAGAGCTTCGTCGGATTGCCAGTTCTGTAAGATATCCTGGAA
GCAAGATGGCATCCACCAGCGAGGTACTGAAGTTTACCCTTTTCCATGTCTTTGGCA
AGGTTGACCGTCCTGAAGCATCTCGGATTGCCTTGCTTCTGACGGCCAGTGAGGAGC
CCCGTCCCACGTCTAAGTCTATAGCTCGCTATTCCCAAGATCTGATGGAGAAGAAGG
TCATTGTGATCCCAGTGGGCTTAGGGCCCCATGCTAGCCTCAGGCAGATTCGTCTCAT
TGAGAAGCAGGCACCAGAAAACAAGGCCTTTTTGCTTAGTGGTGTGAATGAGCTAGA
GCAAAGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTGATAGTCCTGC
TCCTACCATTCCCTCC 
Monodelphis_brevicaudata   ----------------------------------------------------------------------------------
-----------------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGATCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTACGATATCCTGGAAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGTCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCGTCCCACGTCTAAGTCTATAGCTCGCTATTC
CCAAGGTCTGGCGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAGGCAGATTCATCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGACCTGGTACCTGATAGTCCTGCTCCTACCATTCCCTCC 
Monodelphis_emiliae   -----------------------------------------------------------------------------------------
----------------------------------------------------------
AAGCTGTCAGAGTCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGATCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTAAGATATCCTGGCAGCAAGATGGCATCCATCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGTCCTAAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAAGAGCCCCTTCGCATGACTAAGTTTATAGGTCACTATG
CCCAAAGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATG
CTAGCCTCAAGCATATTCGTCTCATTGAGAACAAGGCACCAGAAAACAAGGCCTTTT
TGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATATTCCTGCTCCTACCATTCCCTCC 
Monodelphis_peruviana   --------------------------------------------------------------------------------------
-------------------------------------------------------------
AAACTGTCGGAGTCTGAGTTTGAGGTGCTGAAGGCTTTTGTYGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGC
TCCCACTCTTACATTGAACTGAAGGATCGGAAGCGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTAAGATATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGTCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCTAGTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGGTCGCTATAC
CCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGC
TAGCCTCAAGCAGATTCGTCTCATCGAGAAGCAGGCACCAGAAAACAAGGCCTTTTT
GCTTAGTGGTGTGAATGAACTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCTG
TGACCTGGTACCTGATATTCCTGCTCCTACCATTCCCTCC 
156 
 
Monodelphis_scalops   -----------------------------------------------------------------------------------------
----------------------------------------------------------
AAGCTGTCAGAGTCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGTATCAGGGTGGCTGTGGTGGAATACCATGATGGC
TCCCACTCCTACATTGAACTGAAGGATCGGAAACGGCCCTCAGAGCTTCGTCGGATT
GCCAGTTCTGTAAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGTCCTGAAGCATCTCGGATTGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGCTCGCTACA
CCCAAGGTCTGAAGAAGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATG
CTAGCCTCAAGCAGATTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTT
TGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTCT
GTGACCTGGTACCTGATATTCCTGCTCCTACCATTCCCTCC 
Philander_mcilhennyi   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCGCCTCTGCATAACTTCCACTGTAGCAAGATATTGGACTTGGTTTTCCTGT
TGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGAGGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAATATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTAAACGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGAYGGCCAGTGGGGAGCCCTTGCCCATGGCTAGGAA
TATAGTTCGCTATGCCCAAAGTCTGAGCGAGAAGAAGGTCACTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGCGGCACGCGA
AAACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGGGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Philander_opossum   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACCACAGCATATGTGGAGGAAACC
CCTGAGCCGCCTCTGCATAACTTCCACTGTAGCAAGATATTGGACTTGGTTTTCCTGT
TGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGAGGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAATATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTAAACGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGACGGCCAGTGGGGAGCCCTTGCCCATGGCTAGGAA
TATAGTTCGCTATGCCCAAAGTCTGAGCGAGAAGAAGGTCACTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGCGGCACGCGA
AAACAAGGCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGGGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Philander_quica   CAGAAG------------
CAGTTGTCCCCATCATTTACGACTGCTACCCCAACTACAGCATATGTGGAGGAAACC
CCTGAGCCGCCTCTGTATAACTTCCACTGCAGCAAGCTATTGGACTTGGTTTTCCTGT
TGGATGGCTCGTCTAAGCTGTCGGAGGCTGAGTTTGAGGTGGTGAAGGCTTTTGTCG
TAGGTGTGATGGAGCGTTTACACATCTCTCAGAAACGCATCAGGGTGGCTGTGGTGG
AATACCATGATGGCTCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCCTCAG
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AGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCGAAATGGCATCCATCA
GTGAGGTATTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGC
ATCTCGGATTGCCTTGCTTCTGATGGCCAGTGGGGAGCCCTTGCCCATGGGTAGGAA
TATAGGTCACTATGCCCAAAGTCTGAGCGAGAAGAAGGTCACTGTGATTCCAGTGGG
CTTAGGGCCCCATGTTAACCTTAGGCAGATTCGTAACATTGAGAAGGCGTCACGTGA
AAACAAGCCTTTTTTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACAT
CTTGGGCTACTTCTGTGACCTGGTTCCTGATATTCCTGCCCCTACCATCCCCTCC 
Thylamys_macrurus   ------------------------------------------------------------------------------------------
---------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCCTCCCATGGCTAAGTCTATAGGTCGCTATG
CCCAAGGTCTGAAGAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCAT
GCTAGCCTCAAGCAGATCCGTATCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTT
TTGCTTAGTGGTGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTC
TGTGACCTGGTACCTGATATTCCTGCTCCTACCATCCCCTCC 
Thylamys_pallidior   -------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
--------------------------
GTGGCTGTGGTGGAATACCATGATGGTTCCCACTCCTACATTGAACTGAAAGATCGG
AAGCGGCCTTCAGAGCTTCGTCGGATTGCCAGTTCTGTGAGATATCCTGGCAGCAAG
ATGGCATCCACCAGTGAGGCACTGAAGTTTACCCTTTTCCATGTCTTTGGCAAGGCTG
ACCGCCCTGAAGCATCTCGGATCGCCTTGCTTCTGACGGCCAGTGAGGAGCCCCTTC
CCATGGCTAAGTCTATAGGTCGCTATGCCCAAGGTCTGAAGAAGAAGAAGGTCATCG
TGATCCCAGTGGGCTTAGGGCCCCATGCTAGCCTCAAGCAGATCCGTATCATTGAGA
AGCAGGCACCAGAAAACAAGGCCTTTTTGCTCAGTGGCGTGAATGAGCTAGAGCAA
AGGCGGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTGATATTCCTGCTCCTA
CCATCCCCTCC 
Thylamys_pusillus   --------------------------------------------------------------------------------------------
-------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCCTCCCATGGCTAAGTCTATAGGTCGCTATG
CCCAAGGTCTGAAGAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCAT
GCTAGCCTCAAGCAGATCCGTATCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTT
TTGCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTC
TGTGACCTGGTACCTGATATTCCTGCTCCTACCRTCCCCTCC 
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Thylamys_venustus   -------------------------------------------------------------------------------------------
--------------------------------------------------------
AAGCTGTCGGAGGCTGAGTTTGAGGTGCTGAAGGCTTTTGTCGTAGGTGTGATGGAG
CGTTTACACATCTCTCAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGT
TCCCACTCCTACATTGAACTGAAAGATCGGAAGCGGCCTTCAGAGCTTCGTCGGATT
GCCAGTTCTGTGAGATATCCTGGCAGCAAGATGGCATCCACCAGTGAGGCACTGAAG
TTTACCCTTTTCCATGTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATCGCCT
TGCTTCTGACGGCCAGTGAGGAGCCCCCTCCCATGGCTAAGTCTATAGGTCGCTATG
CCCAAGGTCTGAAGAAGAAGAAGGTCATCGTGATCCCAGTGGGCTTAGGGCCCCAT
GCTAGCCTCAAGCAGATCCGTATCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTT
TTGCTTAGTGGCGTGAATGAGCTAGAGCAAAGGCGGGATGACATCTTGGGCTACCTC
TGTGACCTGGTACCTGATATTCCTGCTCCTACCATCCCCTCC 
Tlacuatzin_canescens   -----------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------
-------------
CAGAGGCGCATCAGGGTGGCTGTGGTGGAATACCATGATGGATCCCACTCCTACATT
GAACTGAAGGATCGGAAGCGGCCCTCGGAGCTTCGTCGGATTGCCAGTTCTGTGAGA
TATCCTGGCAGCAAGATGGCATCCACCAGCGAGGCACTGAAGTTTACCCTTTTCCAT
GTCTTTGGCAAGGCTGACCGCCCTGAAGCATCTCGGATTGCTTTGCTTCTGACGGCCA
GTGAGGAGCCCCTTCCCATGGCTAAGTCTATAGCTCGCTTTACCCAAGGTCTGAAGA
AGAAGAAGGTCATTGTGATCCCAGTGGGCTTAGGGCCCCATGCTAGCCTCAAGCAGA
TTCGTCTCATTGAGAAGCAGGCACCAGAAAACAAGGCCTTTTTGCTTAGTGGTGTGA
ATGAGCTAGAGCAAAGGCAGGATGACATCTTGGGCTACCTCTGTGACCTGGTACCTG
ATGTTCCTGCTCCTACCATCCCCTCC 
 
 
 
Appendix Material 4.4.  
DidvWFTree2.tre 
((((((((((Marmosa_demerarae:2.765345451,Marmosa_paraguayana:2.765345451):1.273905464,
Marmosa_rutteri:4.039250914):4.807878906,Marmosa_lepida:8.847129821):0.6181647349,Mar
mosa_murina:9.465294557):2.563326222,((Marmosa_mexicana:6.095467925,Marmosa_robinso
ni:6.095467925):4.271309193,Marmosa_rubra:10.36677712):1.661843661):6.811332203,((((Mo
nodelphis_domestica:1.910844392,Monodelphis_brevicaudata:1.910844392):5.417041016,Mono
delphis_peruviana:7.32788541):0.5183117649,Monodelphis_emiliae:7.846197173):0.754799745
2,Monodelphis_scalops:8.600996918):10.23895606):1.563429229,Tlacuatzin_canescens:20.4033
8221):4.157254367,((((Marmosops_parvidens:4.419065303,Marmosops_pinheiroi:4.419065303)
:9.729347487,((Marmosops_spGalvez:3.685183951,Marmosops_noctivagus:3.685183951):7.422
23026,Marmosops_incanus:11.10741421):3.040998578):4.907926781,((((Thylamys_pusillus:1.6
91742116,Thylamys_macrurus:1.691742116):0.5182666689,Thylamys_pallidior:2.210008785):0
.317471128,Thylamys_venustus:2.527479913):9.042200902,(Gracilinanus_emiliae:7.154086816
,(Gracilinanus_aceramarcae:4.776400484,(Gracilinanus_microtarsus:4.134707034,Gracilinanus_
agilis:4.134707034):0.6416934509):2.377686333):4.415593998):7.486658755):4.257517681,((((
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((Philander_opossum:0.5543911959,Philander_mcilhennyi:0.5543911959):2.69796657,Philander
_quica:3.252357766):1.647067035,(((Didelphis_aurita:0.4874729729,Didelphis_marsupialis:0.4
874729729):1.661041458,Didelphis_albiventris:2.148514431):0.9146554021,Didelphis_virginia
na:3.063169833):1.836254969):2.661929493,Lutreolina_crassicaudata:7.561354295):3.4287285
53,Chironectes_minimus:10.99008285):9.138166744,Metachirus_nudicaudatus:20.12824959):3.
18560766):1.246779326):6.533314423,Glironia_venusta:31.093951):1.445331938,(Caluromys_l
anatus:4.708844969,Caluromys_philander:4.708844959):27.83043798); 
 
Appendix Material 4.5.  
Constructs.phy 
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Human_Construct 
MRGSHHHHHHGSQEPGGLVVPPTDAPVSPTTLYVEDISEPPLHDFYCSRLLDLVFLLDGS
SRLSEAEFEVLKAFVVDMMERLRISQKWVRVAVVEYHDGSHAYIGLKDRKRPSELRRIA
SQVKYAGSQVASTSEVLKYTLFQIFSKIDRPEASRIALLLMASQEPQRMSRNFVRYVQGL
KKKKVIVIPVGIGPHANLKQIRLIEKQAPENKAFVLSSVDELEQQRDEIVSYLCDLAPEAP
PPTLPPD*QA 
Monodelphis_domestica_Construct 
MRGSHHHHHHGSQKPGDLQLSPSFTTVAPTAEYLEETPEPPLHSFYCSKMLDLAFLLDGS
SKLSEAEFEVLKAFVVGVMERLHISQRRIRVALVEYHEGSHSYIELKDRKRPSELRRIASS
VRYPGSKMASTSEVLKFTLFHVFGKVDRPEASRIALLLTASEEPRPTSKSIARYSQDLMEK
KVIVIPVGLGPHASLRQIRLIEKQAPENKAFLLSGVNELEQRRDDILGYLCDLVPDSPAPTI
SS*QA* 
Monodelphis_emiliae_Construct 
MRGSHHHHHHGSQKPGDLQLSPSFTTVAPTTEYLEETPEPPLHSFYCSKMLDLAFLLDGS
NKLSESEFEVLKAFVVGVMERLHISQRRIRVAVVEYHDGSHSYIELKDRKRPSELRRIASS
VRYPGSKMASISEALKFTLFHVFGKADRPKASRIALLLTASEEPLRMTKFIGHYAQSLKK
KKVIVIPVGLGPHASLKHIRLIENKAPENKAFLLSGVNELEQRRDDILGYLCDLVPDIPAPT
IPS*QA* 
Metachirus_nudicaudatus_Construct MRGSHHHHHHGSQKPW---
LSPSFTTATPTTAYLEETPEPPLDSFHCSKILDLAFLLDGSSKLSEAEFEVLKAFVVDMME
RLHISQRRIRVAVVEYHEGSHSYIELKDRKRPSELRRIASSVRYPGSKIASTSEALKFALFH
IFGKADRPEASRIALLLTASEEP--
KDKLIARYSHSLKKKKVIVIPVGLGPHASLKQIRLIEKQAPENKAFLLSGVNELQQRRDDI
LGYLCDLVPDIPAPTKPS*QA* 
Chironectes_minimus_Construct MRGSHHHHHHGSQK--
DQKLSPSFTTATPTTAYLEETPEPPLHSFHCSKILDLAFLLDGSSKLSEAEFEVLKAFVVGV
MERLHISQRRIRVAVVEYHDGCHSYIQLKDRKRPSELRRIASSVRYPGSNMASTSEVLKF
ALFHVFGKADRPEASRIALLLTANEEPLPMAKGIELYARGLKKKKVIVIPVGLGPHASLK
QIRLIEQKAPENKAFLLSGVNELEQRRDDILDYFCDLVPDIPAPTIPS*QA* 
node_69_M8_Construct 
MRGSHHHHHHGSQKPWDQQLSPSFTTATPTTAYLEETPEPPLHSFHCSKILDLAFLLDGS
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SKLSEAEFEVLKAFVVGVMERLHISQRRIRVAVVEYHDGSHSYIELKDRKRPSELRRIASS
VRYPGSKMASTSEVLKFALFHVFGKADRPEASRIALLLTASEEPLPMAKSIARYAQSLKK
KKVIVIPVGLGPHASLKQIRLIEKQAPENKAFLLSGVNELEQRRDDILGYFCDLVPDIPAPT
IPS*QA* 
node_70_M8_Construct MRGSHHHHHHGSQK--
DQQLSPSFTTATPTTAYLEETPEPPLHSFHCSKILDLAFLLDGSSKLSEAEFEVLKAFVVGV
MERLHISQRRIRVAVVEYHDGCHSYIQLKDRKRPSELRRIASSVRYPGSNMASTSEVLKF
ALFHVFGKADRPEASRIALLLTANEEPLPMAKGIDLYAQGLKKKKVIVIPVGLGPHASLK
QIRLIEKKAPENKAFLLSGVNELEQRRDDILGYFCDLVPDIPAPTIPS*QA* 
node_71_M8_Construct MRGSHHHHHHGSQK----
QLSPSFTTATPTTAYVEETPEPPLHSFHCSKILDLAFLLDGSSKLSEAEFEVVKAFVVGVM
ERLHISQKRIRVAVVEYHDGSHSYIELKDRKRPSELRRIASSVRYPGSKMASISEVLKFTLF
HVFGKADRPEASRIALLLTASGEPLPMARNIGRYAQSLKKKKVTVIPVGLGPHVNLRQIR
NIEKEARENKAFLLSGVNELEQRRDDILGYFCDLVPDIPAPTIPS*QA* 
node_72_M8_Construct MRGSHHHHHHGSQK----
QLSPSFTTATPTTAYVEETPEPPLHNFHCSKILDLAFLLDGSSKLSEAEFEVVKAFVVGVM
ERLHISQKRIRVAVVEYHDGSHSYIELKDRKRPSELRRIASSVRYPGSKMASISEVLKFTLF
HVFGKADRPEASRIALLLTASGEPLPMARNIGRYAQSLSEKKVTVIPVGLGPHVNLRQIR
NIEKAARENKAFLLSGVNELEQRRDDILGYFCDLVPDIPAPTIPS*QA* 
node_73_M8_Construct MRGSHHHHHHGSQK----
QLSPSFTTATPTTAYVEETPEPPLHNFHCSKILDLVFLLDGSSKLSEAEFEVVKAFVVGVM
ERLHISQKRIRVAVVEYHEGSHSYIELKDRKRPSELRRIASSVRYPGSNMASISEVLKFTLF
HVFGKAKRPEASRIALLLTASGEPLPMARNIGRYAQSLSEKKVTVIPVGLGPHVNLRQIR
NIEKAARENKAFLLSGVNELEQRRDDILGYFCDLVPDIPAPTIPS*QA* 
Didelphis_aurita_Construct MRGSHHHHHHGSQK----
QLSPSFTTATPTTAYVEETPEPPLHNFHCSKILDLAFLLDGSSKLSEAEFEVVKAFVVGVM
ERLHISQKRIRVAVVEYHDGSHSYIELKDRKRPSELRRIASSVRYPGSKMASISEVLKFTLF
HVFGKADRPEASRIALLLTASGEPLPMGRNIGHYAQSLSEKKVTVIPVGLGPHVNLRQIR
NIEKVARENKAFLLSGVNELEQRRDDILGYFCDLVPDIPAPTIPS*QA* 
Didelphis_virginiana_Construct MRGSHHHHHHGSQK----
QLSPSFTTATPTTAYVEETPEPPLHNFHCSKILDLAFLLDGSSKLSEAEFEVVKAFVVGVM
ERLHISQKRIRVAVVEYHDGSHSYIELKDRKRPSELRRIASSVRYPGSKMASISEVLKFTLF
HVFGKADRPEASRIALLLTASGEPLPMARNIGRYAQSLSQKKVTVIPVGLGPHVNLRQIR
NIEKAARENKPFLLSGVNELEQRRDDILSYFCDLVPDIPAPTIPS*QA* 
Didelphis_marsupialis_Construct MRGSHHHHHHGSQK----
QLSPSFTTATPTTAYVEETPEPPLHNFHCSKILDLAFLLDGSSKLSEAEFEVVKAFVVGVM
ERLHISQKRIRVAVVEYHDGSHSYIELKDRKRPSELRRIASSVRYPGSKMASISEVLKFTLF
HVFGKADRPEASRIALLLTASGEPLPMARNIGRYAQSLSEKKVTVIPVGLGPHVNLRQIR
NIEKVARENKAFLLSGVNELEQRRDDILGYFCDLVPDIPAPTIPS*QA* 
Didelphis_albiventrus_Construct MRGSHHHHHHGSQK----
QLSPSFTTATPTTAYVEETPEPPLHNFHCSKILDLAFLLDGSSKLSEAEFEVVKAFVVGVM
ERLHISQKRIRVAVVEYHDGSHSYIELKDRKRPSELRRIASSVRYPGSKMASISEVLKFTLF
HVFGKADRPEASRIALLLTASGEPFPMARNIGRYAQSLSEKKVTVIPVGLGPHVNLRQIR
NIEKVARENKAFLLSGVNELEQRRDDILGYFCDLVPDIPAPTIPS*QA* 
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Lutreolina_crassicaudata_Construct MRGSHHHHHHGSQE----
QLSPSFTTATPTTAYVEETPEPPLHSFHCSKMLDLAFLLDGSSKLSEAEFEVVKAFVVGV
MERLHISQKRIRVAVVEYHDGSHSYIELKDRKRPSELRRIASSVRYPGSKMASISEVLKFA
LFHVFGKADRPEASRIALLLTASGEPLPIGRNIGRYAQSLKKKKVIVIPVGLGPHVNLRQIR
NIEKEARENKAFLLSGVNELEQRRDDILSYFCDLVPDIPAPIIPS*QA* 
Philander_frenatus_Construct MRGSHHHHHHGSQK----
QLSPSFTTATPTTAYVEETPEPPLYNFHCSKLLDLVFLLDGSSKLSEAEFEVVKAFVVGV
MERLHISQKRIRVAVVEYHDGSHSYIELKDRKRPSELRRIASSVRYPGSEMASISEVLKFT
LFHVFGKADRPEASRIALLLMASGEPLPMGRNIGHYAQSLSEKKVTVIPVGLGPHVNLRQ
IRNIEKASRENKPFLLSGVNELEQRRDDILGYFCDLVPDIPAPTIPS*QA* 
Philander_opossum_Construct MRGSHHHHHHGSQK----
QLSPSFTTATPTTAYVEETPEPPLHNFHCSKILDLVFLLDGSSKLSEAEFEVVKAFVVGVM
ERLHISQKRIRVAVVEYHEGSHSYIELKDRKRPSELRRIASSVRYPGSNMASISEVLKFTLF
HVFGKAKRPEASRIALLLTASGEPLPMARNIVRYAQSLSEKKVTVIPVGLGPHVNLRQIR
NIEKAARENKAFLLSGVNELEQRRDDILGYFCDLVPDIPAPTIPS*QA* 
 
 
 
 
 
Appendix Material 4.6.  
BLItz Pro software 1:1 binding model (ForteBio, Pall Corperation). 
  
Curve Fitting 
The BLItz Pro software version 1.2.1.3 subtracts a zero concentration curve from all curve data. 
Using a full-fitting model it optimizes for Rmax, Ka, and Kd given each analyte (venom) 
concentration using the equations (ForteBio knowledgebase, Pall Corporation):  
 Association Phase:  
 
Disassociation Phase:  
 
 
• Y  is the BLI signal in nm, which indicates the level of binding as a nm shift. 
• t is time in seconds. 
• ka is the association rate constant.   
• kd is the dissociation rate constant. 
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• [Analyte] refers to the provided concentration of the analyte in solution. 
• Rmax represents the fitted maximum achievable binding for an analyte to a given level of 
immobilized ligand on the biosensor surface.   
• tA represents the time at the end of association, which is also the time at the beginning 
of dissociation.   
• YA represents the calculated nm shift at the end of association (when time is at tA )  
 
This full fitted model is used to optimize observed values for Rmax, Ka, and kd, which are directly 
observed from each analyte concentration curve.  
 
Calculation of Binding Affinity 
BLItz software subsequently uses these optimized values and the equations below calculate 
kobs, Req and KD for each analyte concentration.  
 
 
 
• ka is the association rate constant. 
• kd is the dissociation rate constant. 
• kobs is the observed rate constant reflecting the overall rate of the combined association 
and dissociation of the two binding partners. 
• [Analyte] refers to the provided concentration of the analyte in solution. 
• Req (R equilibrium) is the fitted binding response value (nm shift) when the binding 
interaction reaches equilibrium between association and dissociation for a given 
analyte concentration.   
• Rmax represents the calculated maximum achievable binding for an analyte to a given 
level of immobilized ligand on the biosensor surface.   
 
 
